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1.1 Introduction 
Preservation of an intact genome is of utmost importance to all living 
organisms. However. the integrity of DNA. the carrier of genetic information 
required for proper functioning of cellular processes. is continuously 
challenged. Cells must overcome endogenous (metabolic) and exogenous 
(environmental) threats, as well as the intrinsic instability of chemical 
bonds in DNA itself (e.g. deamination and depurination). Oxidative stress. 
ultraviolet (UV) light. ionizing radiation (X-rays). and numerous chemicals 
induce a wide variety of lesions in the DNA. DNA damage can affect cellular 
processes and can have severe consequences for human health. Its direct 
effect at the cellular level is inhibition of vital processes like transcription 
and replication resulting in cell cycle arrest. Accumulation of lesions in DNA 
above certain thresholds can lead either to (programmed) cell death by 
apoptosis or to permanent alterations in the genetic code (mutations). These 
mutations can in turn cause changes in metabolic processes. inborn defects 
or overall functional decline contributing to premature aging. Mutations. 
specifically in proto-oncogenes and tUITIor suppressor genes. are directly 
responsible for tUITIor initiation and subsequent progression of the 
multistep process of carcinogenesis. 
To guard the vital genetic information and prevent the harmful 
consequences of DNA damage. an intricate network of genome caretaking 
systems has evolved (schematically depicted in Figure 1). Multiple DNA 
repair processes and cell cycle control mechanisms constitute an important 
component of this genome protection network. For a comprehensive review 
of DNA damage and the intricate network of DNA repair systems in general. 
the interested reader is referred to Friedberg, Walker, and Siede (1995) and 
Hoeijmakers (2001). 
1.2 DNA repair mechanisms 
The progression from DNA damage to mutagenesis and ultimately 
carcinogenesis can be interrupted if a cell is able to recognize and efficiently 
remove or correct the DNA damage. DNA double strand breaks induced by 
ionizing radiation. stalled replication forks or incomplete recombination 
events can be repaired by homologous recombination or non-homologous 
end-jOining (Kanaar et at, 1998: van Gent et at. 2001). Incorporations of 
inappropriate nucleotides and small (l-5 nudeotides) insertions/deletions 
introduced during DNA replication are repaired by mismatch repair (MMR). 
Chemically adducted DNA is repaired by excision of the lesion via base 
excision repair (BER) or nucleotide excision repair (NER). BER corrects base 
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Figure 1. DNA damage. repair mechanisms and consequences. (Al Common DNA dama.....l$lg 
agents (top): examples of DNA lesions induced by these agents (middle): and most relevant DNA 
repair mechanism responsible for the removal of lesions (bottom]. (B) Acute effects of DNA 
damage on cell cycle progression. leading to transient arrest in the G 1. S. GZ. and M phases (top). 
and on DNA metabolism (middle). Long-tenn consequences of DNA injury (bottom) include 
permanent changes in the DNA sequence {point mutations affecting single genes or chromosome 
aberrations which may involve multiple genes) and their biological effects. Abbre.iations: ciS-pt 
and Iv1MC. cisplatin and mitomYCin C. respectively (both DNA-crosslinking agents); 6-4PP and 
CPD. 6-4 photoproduct and cyclobutane pyrimidine dimer. respectively (both induced by L'V 
llght): HR. homologous recombination: EJ. end joining. Adapted from De Laat (PhD thesis 1998) 
and HOeijmakers (2001). 
alterations induced by endogenous or exogenous oxidative events. ionizing 
radiation and small alkylating agents (Seeberg et al. 1995). Examples of 
potentially mutagenic BER-lesions are 8-oxoguanine. 06-methylguanine. 
deaminated methylated cytosine and thymine glycol. Accumulating evidence 
implicates unrepaired BER leSions in the aging process of somatic cells 
(Martin et al. 1996). NER. the repair mechanism studied in this thesis. is 
responsible for the removal of numerous helix-distorting DNA lesions. 
among which UV-induced cis-syn-cyclobutane pyrimidine dimers (CPDs) 
and pyrimidine (6-4) pyrimidone photoproducts (6-4PPs) are e,,:tensively 
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studied (de Laat et al. 1999). The NER system. which will be described in 
more detail in the next chapter. excises the damage as a short. single 
strand DNA fragment and replaces it with a newly synthesized DNA coded 
for by the strand opposite the lesion. Other important consequences of DNA 
damage include arrest of cell cycle progression at specific pOints in G 1. S. 
G2. and M phases. to allow repair of the lesions before damage is fixed into 
mutations. Finally. when the damage is too severe to be adequately 
repaired. the cell may undergo apoptosis or enter an irreversible 
senescence-like state (Kastan 1997). 
The importance of DNA repair is highlighted by the clinical features 
of three inherited human syndromes caused by a deficiency in NER: 
xeroderma pigmentosum (XP). Cockayne syndrome (CS). and 
trtchothiodystrophy (lTD) (emphasized in the next chapter and also 
reviewed in Bootsma et al. 2001). Extreme sensitivity to sunlight is the 
hallmark of all three syndromes. In addition. distinctive features 
characterize each disorder. XP patients show mainly UV-induced cutaneous 
symptoms (including photosensitivity. pigmentation abnormallties) and 
predisposition to skin cancer. and carcinogen-induced internal tumors 
(Kraemer et al. 1984). In some cases accelerated neurologic degeneration 
due to increased neuronal death is observed. In contrast. CS and TID 
patients do not exhibit an obvious cancer predisposition. but suffer from 
severe physical and mental abnormallties. Sulfur-deficient brittle hair and 
dystrophic nails. and ichthyosis (scallng of the skin) are the additional 
typical traits of TID. 
1.3 Aim of the thesis 
The work described in this thesis aims to provide insight into the molecular 
mechanism of NER in mammals. particularly the function of the 
mammalian RAD23 repair proteins. HR23A and HR23B. Specific attention 
was given to (i) investigation of the relationship of HR23A/B with other 
repair factors. most notably XPC. (ti) generation and functional 
characterization of HR23A and HR23B knockout mice. (iii) involvement of 
HR23A/B in development. and (iv) aspects of HR23A/B within the 
ubiquitin/proteasome protein degradation system. 
Chapter II reviews the current literature on mammalian NER 
mechanisms and the clinical symptoms aSSOCiated with XP. CS and TID. in 
addition. NER-deficient mouse models and the phenotypical consequence of 
the role of NER proteins in DNA repair. transcription and other cellular 
processes are discussed. Chapter m deSCribes the functional redundancy 
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of the mammalian RAD23 proteins in stimulating the reparr activity of XPC 
in vitro. Chapter IV focuses on the primary damage recognition protein 
complex XPC-HR23B in global genome repair. The generation and 
characterization of the mouse models for HR23A and HR23B are presented 
in Chapters V and VI. 
1.4 References 
Bootsma D. Kraemer KH. Cleaver JE. and Hoeijmakers JHJ (2001) . .:'ilucleotide e."(cision repair 
syndromes: xerodenna pigmentosum. Cockayne syndrome. and tlichothiodystrophy. In: Scriver 
CR. Beaudet. AL. Sly. WS. Valle, D Vogelsteln and Kinzler (eds) The Metabolic and Molecular 
Bases ofInherited Disease. McGraw-Hill Book Co. New York 1, 677-703. 
de Laat 'WL. Jaspers ~G, and Hoeijmakers JHJ (1999). Molecular mechanism of nucleotide 
excision repair. Genes Dev 13. 768-785. 
Frtedberg Ee. Walker GC. and Siede W (1995). DNA repair and mutagenesis. ASM Press, 
Washington DC. 
Hoeijmakers JHJ (2001). Genome maintenance mechanisms for preventing cancer. Nature 411, 
366-374. 
Kanaar R Hoeijmakers JHJ, and van Gent DC (1998). Molecular mechanisms of DNA double 
strand break repair, Trends Cell BioI 8, 483-489. 
Kastan ME (1997), Checkpoint controls and cancer, Plantview, NY: Cold Spring Harbor 
Laboratory Press. 
Kraemer KH, Lee MM, and Scotto J (1984). DNA repair protects against cutaneous and internal 
neoplasia: evidence from xeroderma plgmentosum. Carcinogenesis 5,511-514. 
Martin GM, Austad S:'\", and Johnson TE (1996). Genetic analysis of ageing: role of oxidative 
damage and envirOnmental stresses. Nat Genet 13, 25-34. 
Seeberg E, Eide L, and Bjoras M (1995). The base e.xcision repair pathway. Trends B10chem Sci 
20,391-397. 
van Gent DC, Hoeijmakers JHJ, and Kanaar R (2001). Chromosomal stability and the DNA 
double-stranded break connection. l'\at Rev Genet 2, 196-206. 
14 Chapter I 
Chapter 
II 
Nucleotide Excision Repair (NER) in Mammals 
16 Chapter II 
IT.I Introduction 
Nucleotide excision repair (NER) functions to maintain the integrity of the 
genome and thereby avoid cellular dysfunctioning including cancer. This 
mechanism to remove DNA damage is evolutionary conserved throughout 
eukaryotes. with basic similarities even eAi.ending to prokaryotes. It 
counteracts the deleterious effects of a plethora of structurally unrelated 
DNA lesions. including damage induced by sunlight and cigarette smoke. 
Some of the lesions eliminated by NER are CPDs and 6-4PPs. which are the 
two major types of damage induced by the shoro.:vave UV-B component 
(290-320 run) of sunlight in human skin (Friedberg et ai. 1995). This 
eA"]llains why patients with inherited deficiencies in the NER process display 
marked hypersensitivity to sun eA1Josure. Other substrates for NER include 
bulky chemical adducts (caused e.g. by polycyclic aromatic hydrocarbons 
like N-2-acetylarninofluorene-AAF (2-AAF) and benzo[a]pyrene (B[a]P) found 
in tobacco smoke. car exhaust fumes and industrial pollution) and 
intrastrand crosslinks (generated e.g. by anticancer drugs such as cisplatin 
and psoralens). Recently. oxygen free-radIcal-induced helix distorting 5',8-
purine cyclodeo::-..ynucleotides have also been identified as important 
substrates for NER (Kuraoka et ai. 2000). The common feature of the wide 
spectrum of lesions repaired by NER is a Significant distortion of the DNA 
helix. Both helical distortion and aiteration of DNA chemistry are necessary 
for recognition by the NER machinery (Hess et al. 1997). NER has aiso been 
implicated as a back-up system for BER in the repair of smailer base 
damages induced by alkylating and oxidizing agents which are usually less 
distorting (Satoh et ai. 1993: Satoh and Lindahl 1994). The high versatility 
of the NER mechanism explains how a variety of endogenous and 
exogenous genotoxic agents may contIibute to the large spectrum of clinical 
symptoms associated with defects in one of the NER components. 
U.2 Mammalian NER proteins and molecular mechanisms 
In NER. DNA lesions are removed by a multistep -cut and patch --like 
reaction mechanism. The NER process involves about 20-30 proteins 
(presented in Figure 1) and consists of several successive steps of DNA 
damage recognition. local opening of the DNA double helix. and incision of 
the damaged strand on either side of the leSion. After excision of the 
damage-containing oligonucleotide the resulting gap is filled by DNA repair 
synthesis. followed by strand ligation (Aboussekhra et ai. 1995: de Laat et 
ai. 1999: Wood 1999). 
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Figure 1. .Model for mechanism of global genome nucleotide excision repair [NER) and 
transcription~coupled repair. Heli'(~distorting NER lesions are identified by the initial damage 
detector XPC-hHR23B-CEN2 in global genome repair (GGR), leading to partial opening of the DNA 
helix. Elongating RNA polymerase II (RNAP m initiates transcription-coupled repair (TCR). CSA 
CSB, XAB2. and probably other (co)factors (such as M.\1R (Leadon and Avrutskaya 1998) and 
BRCAl (Gowen et al. 1998)) participate in the further processing of stalled RJ.'IAP II making the 
damage accessible to repair and subsequent resumption of transcription. The subsequent stages 
of GGR and TCR may be identicaL The coordinated action ofTFIIH. XPG, XPA and RPA mediates 
the fonnation of an unwound intermediate around the lesion. XPB and XPD helicase components 
of TFIIH catalYLe ATP-dependent unwindmg, whereas XPA and RPA stabilize the open complex 
and position the other factors. The presence of XPG is required for the stabi.l.17..ation of a fully 
opened compIe'(. Dual incIsIon is performed by ERCC1-XPF and XPG stn1cture~specific 
t::ndonucleases, which cleave the damaged strand 5' and 3' of the lesion. respectively, The lesion is 
released as part of a -30mer oligonucleotide. Gap filling DXA syntheSis by the replication 
machinery followed by ligation completes the NER ,. indicates a DNA lesion. III In bold indicates 
newly synthesized DNA Model adapted from De Laat (PhD thesiS 1998) and Hoeijmakers (2001). 
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Eukaryotic NER involves at least two distinct subpathways for 
damage detection: global genome repalr (GGR or GG-NER) and 
transcription-coupled repalr (TCR or TC-NER). The GG-NER subpathway 
safeguards the entire genome. Its efficiency is lesion-dependent: for 
instance. the highly helix-distorting 6-4PPs are repalred 5-fold faster than 
CPDs in human cells in vivo (Mitchell and Nairn 1989). In contrast. TC-NER 
preferentially accounts for the fast removal of damage ill the transcribed 
strand of active genes. TC-NER is necessary to release blocks to RNA 
polymerase II (RNAP II) driven transcription (Bohr et al. 1985: Mellon et al. 
1987). Unlike GG-NER the TC-NER subpathway ellminates different lesions 
at simllar rates (van Hoffen et al. 1995) and may contribute to the rapid 
recovery of transcriptional activity after DNA damage (Hanawalt and Mellon 
1993: Friedberg 1996). Both GG-NER and TC-NER are mechanistically the 
same, except for the initial damage recognition step. 
The biological relevance of mammallan NER has been well 
documented. because several human genetic disorders. including XP. CS. 
and TID. are associated with impaired NER activity. XP is due to a 
mutation in one of seven genes (designated XPA to XPC). CS is caused by a 
defect in the CSA or eSB genes. and TID by a defect in the ITDA gene. In 
addition. specific mutations in three XP genes (XPB. XPD. and XPG) can 
cause a combination ofXP and CS. whereas mutations in XPB and XPD can 
also give rise to the photosensitive [onn of TID (for review. see Bootsma et 
al. 2001). Unlike most forms of XP and TID which are deficient in both 
subpathways of NER. patients belonging to XP group C and group E have 
defective GG-NER. whereas TC-NER silll functions normally (Venema et al. 
1990b and 1991: Hwang et al. 1999: Tang et al. 2000). In contrast. 
defective TC-NER but functional GG-NER is specifically associated with CS 
(van Hoffen et al. 1995: Venema et al. 1990a). In addition. complementation 
analysis has revealed another class of XP patients (XP-vartant). A mutation 
in the responsible gene (.XPV) does not cause impairment of NER but leads 
to defective postreplication repalr (whicb is a damage-tolerance 
mechanism). XPV was recently cloned and was identified as the gene 
encoding hRad30A. which is the damage-specific DNA polymerase 11 
involved in translesion synthesis (Masutani et al. 1999). 
The key NER genes have been identified and the core reaction has 
been reconstituted in vitro using purified proteins and DNA substrates 
containing Site-specific or random damage (Aboussekhra et al. 1995: Wood 
1999: de Laat et al 1999). In short: the molecular mechanism of NER 
involves nvo major steps: (i) lesion recognition and incision of the DNA 
strand containing the lesion and (li) gap filling replicative DNA synthesis to 
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restore the undamaged DNA. In mammalian cells. six core components are 
necessary for damage recognition and dual incision in in vitro GG-NER 
reactions: the XPC-hHR23B complex. XPA. the heterotrimeric RPA protein 
(additionally involved in DNA replication and recombination). the 
multiprotein transcription factor IIH (TFIIH. with dual involvement in basal 
transcription initiation and in NER). and the endonucleases XPG and 
ERCCI-XPF (ERCCI stands for excision repair crOSS complementation 
group I) (see Figure I). In the gap filling step of DNA repair synthesis. 
replication factor C (RFC). proliferating cell nuclear antigen (PCNA). RPA. 
DNA polymerase 8 or E holoenzyme. and DNA ligase I are involved (Araujo et 
al. 2000). Table I lists all mammalian NER genes cloned to date and 
summarizes their main properties. These steps are discussed in extenso 
below. 
II.2.1 Damage recognition (xpC-hHR2SB and probably XPE) 
The GG-NER reaction primarily starts with recognition of the DNA injury. 
This initial. damage-recognizing step is mediated by the XPC-hHR23B 
protein complex (which consists of the XP group C gene product and the 
human homolog of the Saccharomyces cerevisiae RAD23B protein 
(Masutani et al. 1994: Shivji et al. 1994). The complex formation is required 
for efficient repair activity of XPC in vitro (Sugasawa et al. 1996 and 1997: 
Batty et al. 2000). at least in pari due to the stabilization of XPC by 
hHR23B (Araki et al. 2001). The heterodimer has high affinity for both 
single- and double-stranded undamaged DNA but even higher affinity when 
DNA leSions are present (Masutani et al. 1994: Shivji et al. 1994). XPC-
hHR23B is the only NER factor shown to make stable footprints around a 
lesion. such as 6-4PP (Sugasawa et al. 1998). Since locally melted DNA 
precludes the need for XPC-hHR23B (Mu and Sancar 1997). the XPC-
hHR23B complex is thought to increase single-strandedness at the site of 
the DNA injury. so that other NER core proteins can bind (reviewed in de 
Laat et al. 1999: Wood 1999: Wood et al. 2001). After binding DNA. XPC-
hHR23B recruits the entire repair protein machinery to the injury 
(Sugasawa et al. 1998 and also discussed in Chapter 4: Yokoi et al. 2000: 
Volker et al. 2001). In a subset of XPE patients. the NER deficiency is 
caused by a mutation in the UV-damaged DNA binding protein (UV-DDB). 
Cells from these patients lack UV-DDB activity (Chu and Chang 1988: 
Keeney et al. 1992). The UV-DDB protein is composed of two subunits: 
pl25 (or DDBI) and p48 (or DDB2. carrying the causative XPE mutations). 
UV-DDB is not essential for NER in vitro (Aboussekhra et al. 1995: Rapic 
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Table 1. Main properties of cloned human l\i'ER genes 
Cbxomosome Protein Yeast 
Gene" Protein Properties 
Location Siw (an) Homolog 
)Q'A 9q34 273 RAD14 Zn2+-finger. binds different types of damaged DNA. 
transient interaction with ERCCI. RPA and TFllH 
comple.'(. 
)Q'B 2q21 782 RADZ5 3' -) 5' DNA heUca...-.e. subunit ofTFllH. es~ntioJ for 
(ERCC3) transcr1ption initiation. 
)Q'C 3p25.1 940 RAD4 Comple.'{ed with hHR23B. strong d=ge-speeific DKA 
binding. involved in global genome repn1r only, initiator of 
global genome repair. 
)Q'D 19q1S.S § 760 RAD3 5' -) S' DNA heUcasc, subunit ofTFIIH. es~ntiol for 
IERCCZ) transcription initiation. 
)Q'E llpll-12 4Z7 Identified'l[ Binds LV-damaged D:.TA causative mutations Identified in 
p48. WD-repcat conta1n1ng protein. complexed \Vlth p 125 
UV-DDB protein. 
XPF 16plS.l-lS.2 -905 RADI Alf:'O Identical to ERCCl1. comple.-..;:with ERCCI makes 5' 
(ERCC4J incision. Y structure-specific endonuclease. dual function 
in recombination. 
XPG 13q32.S-SS.1 1186 RADZ Y structure-!:'pcc!i1c endonuclease. makes 3' incision. 
(£RCCS) 
CSA 5 396 RAD28 5 WD-repeats. Involved in transcr1ption-coupled repn1r 
(ERCCS) only. 
CSB 10qll 1493 RAD26 DNA-dependent A1'Pa::>e. Involved In tr:J..nscr1ption-coupled 
IERCC6) repair only. present In (elongating] RKA polymera&e II 
complex, 
ERCCl 19q13.3 § 297 RADIO P<1rt1.:::t1 homolOg)' to E.co!i NER protein uvrC and many 
nucleases, comple.x with XPF makes 5' Incision 
Y structure-specific endonuclease. dual function in 
recombination. 
hHRZ3A 19p13.1 363 RAD23 Ublquitin-like N-term1nus, 2 ublquitln-assoc1o.ted 
domains, 
hHR23B 9q32-S3 409 RAnZ3 A!; hHR23A. fraction of hHR23B complexed \v1th XPC. 
complex binds !:'!:'DNA and is involved in globnl genome 
repair only. 
p62 THIl1 Ilp14-1S.1 548 TFBI Subunit ofTFTIH. essentiol for tran::>cription Initiation. 
pS2 THII-/ 6p21.3 513 TFB2 Subunit ofTFllH. essentlnl for transcription initiation. 
p44 Trlll-[ 5q1.3 395 SSLI DNA-binding Zn2~-i1nger. subunit ofTFlIH. cssentioJ [or 
transcription Initiation. 
P34 TrlII-[ 1Z 303 TFB4 Zn2~_i1nger, subunit ofTFIIH. cssentiol for transcr1ption 
initiation. 
Not included in this table are the genes encoding proteins Involved in the DNA synthesis !:'tep of the !'ffiR 
reaction. such as the proteins PCKA. RPA RFC, DNA ligase; aa: nmjno acids; § The £RCCl and XPD (ERCCZj 
genes are loC<:tted 1e::<:iI than 20 kb apart; 'IT A yeast gene encoding 0. product With clear overall homology to the XPE 
protein has been Identified in the y=t genome database. In addition, 0. second human gene with :illgntfi=t 
slmilarlty to XPE h:l$ been discovered (Van der Spek and Hoeljmaker!:', unpublished resultsJ. Table adapted from 
Bootsmo. et aL (2001J. 
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Otrin et al. 1998). This heterodimer may assist in damage recognition of 
lesions for which XPC-hHR23B has a low binding affinity. such as CPDs 
(Keeney et al. 1993: Hwang et al. 1999). or it may facilitate DNA repair in 
the conteo-.i: of chromatin structure (Otrin et al. 1997: Datta et al. 2001). 
However. the precise role for UV-DDB in DNA repair remains unknO\'Vl1. 
XPA. like XPC. preferentially binds damaged DNA (Jones and Wood 
1993). particularly in a single-stranded conteAi: (Buschta-Hedayat et al. 
1999). XPA is known to also bind to RPA. TFIIH and ERCCI-XPF 
endonuclease (Nagai et al. 1995: Park et al. 1995: Saijo et al. 1996: Araujo 
et al. 2000). Recently it has been shown that XPA is involved in the post-
recognition steps of the NER pathway. to verify the presence of damage and 
to organize the bineting of the repair machinery vvith the assistance of the 
single-strand DNA binding protein complex RPA (Sugasawa et al. 1998: 
Volker et al. 2001). 
n.2.2 Steps specific for GG-NER (XpC-hHR23B) and TC-NER (RNAP n. 
CSAandCSB) 
XPC-hHR23B and probably UV-DDB (XPE) are the only repair proteins that 
are specifically involved in GG-NER but are dispensable for TC-NER. The 
XPC protein has low. but significant sequence homology with the yeast 
RAD4 protein (Legerski and Peterson 1992: Masutani et al. 1994). However. 
rad4 null mutants. in contrast to XPC mutants. are defective in both GG-
NER and TC-NER (Verhage et al. 1994). This may reflect a fundamental 
difference bet\veen mammals and yeast. 
The hHR23B protein sequence includes an N-termiual ubiquitin-
like domain (Masutani et al. 1994). Other proteins that contain this 
ubiquitin-like domain are thought to function as chaperones. Hence this 
domain may perform a similar function in assembling the XPC-hHR23B 
complex. Thus far. none of the knOVlIl human NER syndromes has been 
aSSOCiated with mutations in the hHR23B gene. A simple eA-planation might 
be that the highly homologous hHR23A protein (with 57% identity and 76% 
similarity) can substitute for hHR23B function. Consistent with that 
hypothesis. both hHR23 proteins are functionally interchangeable in their 
ability to form a complex with XPC and stimuiate its repair activity in vitro 
(Sugasawa et al. 1997. see also Chapter 1II). However. in contrast to this 
hypothesis. in vivo XPC-hHR23B complexes predOminate and only trace 
amounts of hHR23A copwify with XPC (Araki 2001). instead of functional 
redundancy. another way to explain the lack of NER-disorder related 
mutations in the human HR23 genes is that the gene products are essential 
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(Chapters V and VI). In lIne with this. the 60 amino acid XPC-binding 
domain of hHR23B is sufficient for XPC stimulation (Masutani 1997). 
Furthermore. only a fraction of the cellular hHR23B is complexed with XPC 
at any given time~ the majority of hHR23B e:xists in a free form in vivo. like 
hHR23A (van der Spek et al. 1996: Sugasawa et al. 1996). Together. these 
observations suggest that the hHR23 proteins have additional functions 
outside NER and it is possible that these functions are essential to life. 
In TC-NER. it is believed that the elongating RNAP II complex 
encounters a lesion and activates the TCR pathway in a CSAjCSB-
dependent manner (Hanawalt 1994). The CSA and CSB proteins may 
function to facilitate recruitment of repair factors and make the lesions 
accessible by displacing the stalled polymerase. After damage recognition by 
RNAP n. the lesion is removed by the core NER reaction (see Figure 1). The 
CSA protein contains a consensus sequence of five so-called \VD-repeats. 
which appear to have more of a regulatory rather than a catalytic function. 
WD-repeats are common to proteins involved in multiprotein complexes 
which play diverse roles in cellular metabolism. including cell cycle 
regulation. RNA processing and gene regulation (Henning et al. 1995). CSB 
(or ERCC6) is a member of the SWIjSNF family of DNA-dependent ATPases 
which have been implicated in a wide range of nuclear processes. including 
transcription regulation. chromatin remodeling. and diverse DNA repair 
processes like NER postreplication and recombination repair (Troelstra et 
al. 1992: Eisen et al. 1995). In vitro. CSA. CSB and the p44 subunit ofTFIIH 
show interactions (Henning et al. 1995). CSA associates with XAB2 (xpA 
binding protein 2). a protein involved in TC-NER and in transcription 
(Nakatsu et al. 2000). In addition. CSB and RNAP II interact in vivo (van 
Gool et al. 1997a). consistent with a role for CS proteins in processing of a 
stalled RNAP II complex. However. the precise function of CSA and CSB in 
TC-NER remains unclear. BeSides their role in NER the CS proteins may 
act to brtdge DNA repair systems (e.g. TCR and BER) (van Oosterwijk et al. 
1996: Cooper et al. 1997: Le Page et al. 2000) . 
IT.2.S Open complex formation and lesion demarcation (XpA, RPA, 
XPB, XPD and XPG) 
The neA't conunon step in NER is the formation of an open complex. which 
requires local unwinding of the DNA helix and demarcation of the lesion. 
This is an ATP-dependent process (Evans et al. 1997a). XPC-hHR23B and 
TFIIH are essential at the earliest step of helix openlng (Evans et al. 1997a). 
The helicases of the TFIIH complex mediate the ATP-dependent melting of 
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the DNA around the lesion. DNA unwinding by the XPB and XPD helicase 
subunits of TFIIH may be facilitated by RPA (Wold 1997). In NER. RPA 
probably binds to the single-stranded region of the undamaged strand with 
a defined polarity and stabilizes the structure (de Laat et al. 1998). The 
optimal binding patch of RPA is 30 nucleotides (Kim et al. 1992). which is 
similar to the size of the fully opened repair complex (-25 nucleotides) and 
the size of the released damage-containing oligonucleotide (Huang and 
Sancar 1994). XPA and XPG are also required for the formation of the open 
complex. XPG likely has a structural function by stabilizing the preincision 
complex, since its nuclease activity is not needed for opening (Evans et al. 
1997b: Mu et al. 1997). 
The basal transcription factor TFIIH is a nine-subunit. 
multifunctional protein complex harboring helicase and protein kinase 
activities. The p89 and p80 subunits correspond to the previously identified 
XPB and XPD NER helicases (Schaeffer et al. 1993: Schaeffer et al. 1994). 
and are essential for NER (Evans et al. 1997b: Winkler et al. 2000). They 
contain ATPase-dependent 3' --; 5' (XPB) and 5' --; 3' (XPD) DNA unwinding 
activity. TFIIH is essential for local unwinding of the DNA helix around the 
lesion in NER (Evans et al. 1997b) and in the transcription initiation by 
RNAP II at the promoter (Holstege et al. 1996). In line with the crucial role 
of TFIIH in basal transcription. inactivation of the XPB and XPD genes in 
the mouse is incompatible with life (de Boer et al. 1998b: Weeda et al. 
manuscript in preparation). XPB has an essential function in transcription 
initiation. and its helicase activity is required for promoter opening and 
stimulatory for promoter escape (Bradsher et al. 2000: Tirode et al. 1999). 
In contrast. XPD catalytic activity is dispensable for in vitro transcription 
(TIrode et al. 1999: Winkler et al. 2000) and was shown to playa structural 
role in promoter escape (Bradsher et al. 2000). Additional TFIIH 
components include cyclin dependent kinase Cdk7. cyclin H and MATI. 
together constituting the cdk-activating kinase (CAR) complex associated 
with TFIIH. The CAK complex is able to phosphorylate cyclin-dependent 
kinases (CDKs) involved in cell cycle regulation. and is essential for 
phosphorylation of the C-terminal domain of RNAP II during transcription 
initiation (Nigg 1995: Svejstrup et al. 1995). Although the CAK complex is 
associated with TFIIH. it occurs also in a free form and is not essential for 
NER in vitro (Svejstrup et al. 1995: Mu et al. 1996: Araujo et al. 2000). In 
addition to a role in NER and transcription. TFIIH interacts directly with 
p53 (tumor suppressor gene involved in chechl'oint control) (Leveiliard et al. 
1996: O'Donovan et al. 1994). suggesting that TFIIH is also involved in cell 
cycle regulation and apoptosis. 
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II.2.4 Dual incision (ERCCI-XPF and XPG) 
Mer local unwinding and demarcation of the lesion, a single strand 
fragment of DNA 24-32 nucleotides long and containing the damage, is 
excised. This process requires the structure-specific endonuclease activities 
of XPG at the 3' side of the open complex (O'Donovan et al. 1994) followed 
by the ERCCljXPF complex 5' to the damage (Sijbers et al. 1996). Both 
structure-specific nucleases cleave at the junctions bernreen duplex and 
single-stranded DNA in a partially melted DNA The 3' incision by XPG is 
made first and can be detected in the absence of ERCCI-XPF (Mu et al. 
1996). In contrast. ERCCljXPF requires the physical presence. but not the 
catalytic activity of XPG to perform the 5' incision. suggesting an additional 
structural role for XPG (Mu et al. 1997: Wakasugi et al. 1997). In theory. 
both nucleases can incise the undamaged strand. However. the cleavage 
activity ofERCCI-XPF is coordinated by RPA which plays an important role 
in positioning both nucleases. The 3' side of RPA stimulates ERCCI-XPF 
whereas the 5'-oriented end inhibits endonuclease specificity ofERCCI-XPF 
(de Laat et al. 1998). Although RPA and XPG interact directly. RPA alone is 
not sufficient to confer strand specificity to XPG (de Laat et al. 1998). The 
strong interaction between XPG and TFIIH (Iyer et al. 1996) may instead 
serve to confer strand selectivity to XPG-mediated cleavage (de Laat et al. 
1999). 
II.2.S Gap f"illing and ligation (RPA, RFC, PCNA, pol 8/e, and DNA ligase 
I) 
The final step in the NER reaction is gap filling of the excised patch by DNA 
synthesis. This step is often used to measure NER activity in vitro and in 
vivo (i.e. unscheduied DNA synthesis (UDS)). Gap filling synthesis requires 
the mammallan DNA replication factors RPA RFC. PCNA and DNA 
polymerase 8 and £ for an efficient repalr synthesis (Nichols and Sancar 
1992: Shivji et al. 1992 and 1995). PCNA stimuiates DNA polymerase 8 
andj or e in DNA replication. DNA synthesis is followed by sealing of the 
remaining nick by ligation of the newly synthesized DNA most likely by 
DNA ligase 1. since mutations in the gene causes UV-hypersensitivity 
(Barnes et al. 1992). 
II.S NER in living cells 
In order to study the NER reaction in vivo. confocal laser-scanning 
microscopy has been recently adapted to the measurement of the mobility 
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of repair factors in single living cells. This novel approach is based on the 
analysis of functional NER proteins fused to green fluorescence protein 
(GFP, cloned from the jellyfish Aequorea vitoria) stably expressed in human 
fibroblasts (Houtsmuller et al. 1999), GFP-tagged molecules can be 
monitored for long periods of time because of the photostability of GFP. The 
GFP protein tag rarely affects the function and localization of the fuSion 
protein. Experiments with GFP-tagged molecules demonstrated that most 
proteins move freely within the compartments of the cell by ATP-
independent dlffusion (partikian et al. 1998). There is no clear Size limit for 
free diffuSion in vivo. because even large protein complexes such as the 
proteasome can move freely through the cytoplasm and the nucleus (Reits 
et al. 1997). Thus. utilization of GFP tags enables the application of 
fluorescence redistribution after photobleaching (FRAP) technology. In 
FRAP. fluorescent molecules in a small area of the cell are irreversibly 
photobleached by a high-powered focused laser beam (Houtsmuller et al. 
1999: Reits and NeefJes 2001). FRAP experiments permit measurement of 
the mobility of a fluorescent molecule in a defined compartment of the cell. 
Furthermore. FRAP can also be used to address a number of questions 
regarding protein localization. activity. protein interactions. conformational 
Changes and cell cycle fluctuations. 
The mobility of the fuSion protein ERCC I-GFP-XPF in the nucleus 
was studied using FRAP. In the absence of DNA damage, the ERCC I-GFP-
XPF complex \.Vas found to diffuse rapidly in the nucleus vvith a diffusion 
coefficient (12 ± 5 square micrometers per second) conSistent With its 
molecular weight. arguing against the idea that ERCC 1 is part of a NER 
holocomplex (Svejstrup et al, 1995). UV-induced DNA damage caused a 
fraction of the ERCCI-GFP-XPF molecules to become temporarfly 
immobilized. likely due to engagement of the complex in repair events. After 
4 minutes, the complex regained the mobility characteristic for ERCCI in 
undamaged cells. On the basis of these data, a model was proposed in 
which individual NER proteins assemble at the Site of DNA damage rather 
than being organized in a preassembled NER supercomplex (""repairosomeT 
The same model was supported by studies of Volker and coworkers (2001) 
With the novel technique of local UV-irradiation combined vvith fluorescent 
antibody labeling. Moreover. ERCCI-GFP-XPF seems to identiJY the 
damaged site not by a processive mechanism (DNA-scanning) but in a 
distributive fashion by diffUSion and colliSion With the other repair 
components (Houtsmuller et al. 1999). However. it is not known whether 
DNA damage detection in GG-NER by XPC-hHR23B (Sugasawa et al. 1998) 
occurs via a processive mechanism. In TC-NER. damage detection by RNAP 
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II (Hanawalt et al. 1994) is by its nature processive. and actual repair in 
this NER subpathway could take place at the nuclear matrix where 
transcription also occurs (Mullenders et al. 1984; Jackson et al. 1994). 
II.4 Connection between NER and p53 
In addition to the direct involvement of NER factors in transcription, NER is 
tightly connected to cell cycle progression via p53·dependent and p53· 
independent pathways following the accumulation of (UV-induced) DNA 
damage (Levine 1997). To complicate matters further. the p53 protein may 
playa role in modulating DNA repair (Ford et al. 1998). Moreover. p53 
physically interacts with some of the NER components (Wang et ai. 1995 
and 1996). DNA damage interfering with RNAP II driven transcription 
triggers p53 response (Ljungman et al. 1999). TIlis in turn is believed to 
cause temporary cell cycle arrest. allowing the cell time to repair the DNA 
damage before replication (Kastan et al. 1991). If the DNA damage is too 
severe and p53 accumulation is sustained. the cell undergoes apoptosis 
(Lowe et ai. 1993). To further study the roles of NER and p5S·deficiency in 
mutagenesis and tumorigenesis. mice mth a completely defective NER can 
be crossed with p5S knockout mice (Jacks et ai. 1994). An example of this 
approach (i.e. XPA/· mice (de Vries et ai. 1995) crossed with p5S-deficient 
mice) is desCribed in section 11.6. 
II.5 Human NER deficiency syndromes 
In humans. NER constitutes a major defense mechanism against the 
carcinogenic effects of sunlight. The biological consequences of a defect in 
one of the NER proteins are apparent from three rare autosomal recessive 
photosensitive diseases: XP. CS and TID. Several of the NER proteins 
participate in nuclear processes outside NER For example. all genes 
associated with TTD (XPB. XPD. and TIDA (Vermeulen et al. 2000)) are also 
implicated in basal transcription. The ERCC1-XPF complex has a dual 
involvement in repair of interstrand crosslinks probably via mitotic 
recombination. The notion of function sharing has important implications 
for the clinical consequences of inherited mutations in the NER proteins. 
The spectrum of clinical symptoms differs considerably between the three 
human NER syndromes (summariZed in Table 2 and also reviewed in 
Bootsma et al. 2001) and many of the peculiar abnormalities of CS and TID 
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Table 2. Main clinical symptoms of human NER syndromes 
Clinical symptoms XP' XPles cs 
Cutaneous 
Photosensitivity ++ ++ +* 
Pigmentation abnormalities ++ + 
Skin cancer ++ + 
Brittle harr and mills 
Icthyosis 
Developmental 
+ + 
Growth defect 
+ + 
Hypogonadism 
Neurologic 
+/- + + 
Progressive menUl degeneration 
Degeneration 
+ + 
Wizened face 
Primary defect: 
+ 
Neuronal 10% 
+ + + 
l'\eurodysmyelination 
Cellular 
UDS (% of control) 5-50% 5-50-;:;; Xormal 
l.:V-scnsitivity ++ ++ + 
ttD<X.>s not include the )(P-Vanant fonn. 
·Also CS and TID patients exist Without photosensitivity and NER defect. 
Table adapted from Bootsma ct aL (2001). 
ITD 
+* 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
5-50% 
+/" 
are difficult to attribute directly to defective NER e.g. tbe neurologic 
abnonnalities due to dysmyelination and tbe brittle hair seen in TID_ 
UltraViolet sensitive (UVS) syndrome is yet anotber clinical disorder distinct 
from XP. CS. and XP-V. Similar to NER patients. subjects witb UVS do have 
a sun-sensitive skin (Itoh et al. 1995). UV-exposure causes an irreversible 
inhibition oftranscrtption in UVS cells. however. the level of UDS is nonnal. 
These features are grossly reminiscent of CS and some XPD patients 
(Jaspers and Bootsma. unpubliShed results). The aVailable observations 
support tbe notion tbat tbe XP. CS. and TID syndromes are biochemically 
intimately connected and may be part of a broad clinical continuum. Mouse 
models of NER deficiencies have been generated (discussed in the ne),.'t 
section). which provide excellent tools for understanding the complex 
relationship between DNA repair defects and their clinical consequences. 
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n.5.l Xeroderma pigmentosum (XP) 
Parchment skin (xeroderma) and freckles (pigmentosum) are the prominent 
cutaneous hallmarks of XP patients. These manifestations are strikingly 
restricted to sun-eA.-posed areas of their skin. Typically. sun exposure of XP 
patients causes a progressive degenerative alteration of the skin and eyes 
(Bootsma et al. 2001). beginning as early as the age of 2 years (Kraemer 
1997). Furthermore. XP is associated with an elevated frequency (>1000-
fold) of sunlight-induced skin cancers. which are also largely confined to 
sun-exposed areas like the face. neck. head and even the tip of the tongue. 
XP patients mainly develop basal cell or squamous cell carcinomas (SCCs. 
seen in at least 45% of all XP patients. many of whom often have multiple 
primary neoplasms). and less frequently melanomas (5% of patients). The 
mean age of onset for skin neoplasms is 8 years. which is about 50 years 
earlier than in the general population (Kraemer 1997). The main cause of 
death in XP individuals is neoplasia. which reduces the lifespan by 
approximately 30 years. XP patients also have a 10- to 20-fold increased 
risk of developing several types of internal cancers before the age of 20 
years (Kraemer et al. 1984). Abnormallties in the inunune system. detected 
in XP patients (but not in CS and TID). are likely to contribute to the 
development of (skin) tumors (Morison et al. 1985: Mariani et al. 1992). 
A fraction of XP patients (-18%) displays progressive neurologic 
degeneration secondary to a loss of neurons. This feature seems to be 
related to the significance of the NER defect. For example XPC patients. who 
only have GG-NER defect. usually do not develop neurologic abnormallties. 
and if so. symptoms appear much later in life compared to TC-NER-
defective XPD and completely NER-deficient XPA patients (Bootsma et al. 
2001). A possible explanation for the onset of neurologic abnormallties in 
XP individuals is that defective DNA repair of endogenous. oxidative NER 
lesions in neurons biggers cell death (Kuraoka et al. 2000). 
The genetic heterogeneity of XP patients is accompanied by 
heterogeneity in severity of the repair defect and of the consequent 
symptoms. The most severely affected patients are XPA XPB. XPD and XPG 
individuals. The two most common forms of XP are XPA and XPC (Bootsma 
et al. 2001). The group of XPD patients is the most heterogeneous. with a 
level of residual repair synthesis between 15 and >50% (Matsumura et al. 
1998). Furthermore. XPF patients are moderately UV-sensitive and show 
intermediate repair synthesis. indicative of mutations that lead to poor but 
not complete abolishment of NER This could be due to the anticipated dual 
function of the ERCC1-XPF complex in NER and recombination repair 
(Davies et al. 1995: De Silva et al. 2000). A null allele for ERCC1 or XPF and 
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the consequential defect in crosslink repair are predicted to be incompatible 
with life. All XP patients of complementation groups A to G are defective in 
both NER subpathways. with the exception of XPC and XPE whose NER 
defect is limited to GG-NER (Hwang et al. 1998: Venema et al. 1990b). The 
susceptibility to sunburn of XPC patients is no different from normal 
individuals. indicating that TC-NER alone is sufficient to prevent this acute 
response to UV-e"."posure (Berg et al. 2000: van Oosten et al. 2000). XPC 
cells have a residual UDS level of 15-30% due to functional TC-NER and are 
therefore less sensitive to UV than XPA or XPD cells (Bootsma et al. 2001). 
Patients in the XP-variant group have mild to severe skin symptoms and 
usually display a normal functioning central nervous system. Unlike 
classical XP. XPV patients show a normal level of NER activity but lack the 
capacity to effiCiently replicate damaged DNA leading to error prone 
replication and a hypermutable phenotype. This phenotype. together with 
the increased frequencies of genomic rearrangements observed in XPV cells 
(Limoli et al. 2000). may cause the elevated sun-induced carcinogenesis 
seen in these patients. 
ll.5.2 Cockayne syndrome (CS) 
CS is a very pleiotropic disorder characterized by cutaneous 
photosensitivity (with or without thin or dry skin and hair). severe postnatal 
grovvth failure (cachectic dwarfism). mental retardation. and progressive 
neurologic dysfunction (eA1:ensively reviewed in Nance and Berry 1992: 
Bootsma et al. 2001). CS cells are sensitive to a number of DNA-damaging 
agents (including UV) due to a defect in TC-NER In contrast to patients 
suffering from the prototype NER-deficient disorder XP. CS individuals are 
not predisposed to skin cancer. Other common CS symptoms include 
sensorineural hearing loss. progressive ocular abnormalities (such as 
pigmentary retinopathy and/or cataracts). wizened bird-like faces. impaired 
sexual development. skeletal abnormalities (typically resulting in short 
stature). dental caries. h"YPhosis (hunchback). and premature osteoporosis 
(demineralization). The progressive neurological degeneration has a very 
early onset in CS individuals (beginning around 2 years of age) and is 
caused by dysmyelination. The mean age of death in CS is 12.5 years and 
mainly secondary to pneumonia. which in turn could be due to the 
generally poor condition of the patients (Nance and Berry 1992). 
Clearly. CS clinical symptoms are much more severe than the 
classical XP condition and go beyond photosensitivity. Photosensitivity and 
other XP-like features (such as pigmentation abnormalities and 
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predisposition to skin cancer) can be attributed to tbe NER defect. However. 
the severe developmental and neurological manifestations of CS can not be 
explained by NER (Bootsma and Hoeijmakers 1993: Vermeulen et al. 
1994b). implicating additional functions for tbe CS proteins outside NER 
(van Gool et al. 1997b). The transcriptional engagement of CSA and CSB 
(analogous to XPB and XPD) suggests that transcription defiCiency, perhaps 
induced by DNA damage. also contributes to the clinical picture. In some 
cases. CS features are found in combination VJith XP. due to specific 
mutations in tbe XPB. XPD. or XPG genes. Cells from CSA. CSB. and XPG 
individuals with severe CS symptoms are slightly senSitive to ionizing 
radiation in addition to UV-light (Leadon and Cooper 1993). It is 
hypotbesized tbat inefficient TCR of oxidative lesions (e.g. tbymine glycol) 
which block transcription underlies this ionizing radiation sensitivity 
(Cooper et al. 1997) although ionizing radiation is a poor inhibition of 
transcription in general. This indicates an additional role of CSA. CSB. and 
XPG in coupling arrested transcription witb botb BER and NER (reviewed in 
CittertD et al. 2000), and suggests a general repair-transcription coupling 
defiCiency as the major cause of the extensive variations in symptoms and 
severity of tbe CS phenotype. The developmental defects and tbe premature 
aging-related symptoms of CS can be attributed to the incomplete repair of 
endogenous oxidative damage (Martin et al. 1996: Cooper et al. 1997). 
which in turn causes cellular malfunction and/or induction of apoptosis. 
The defective TCR in CS cells enhances tbeir p53-dependent apoptotic 
response. contributing to the elimination of cells that potentially carry 
oncogenic mutations. This eA-plains the lack of cancer predisposition in CS 
after UV-exposure (yamaizumi and Sugano 1994: Ljungman and Zhang 
1996: Ljungman et al. 1999: McKay et al. 1999: Conforti et al. 2000). 
Numerous otber CS-like patients have been identified. for example CAMFAK 
(for cataracts. microcephaly. failure to tbrive. kyphoscoliosis) and COFS 
(cerebro-oculofacial syndrome). but tbese patients fail to exhibit 
pronounced photosensitivity in spite of tbe fact tbat cells of tbe patients 
display defective recovery of RNA syntbesis (Colella et al. 1999: Bootsma et 
al. 2001). suggesting tbe possibility of a partial transcription defect witbout 
tbe accompanying TC-NER defect of CS. 
II.5.S Trichothiodystrophy (TID) 
TID is caused by a neurectodennal dysplasia. which causes a collection of 
symptoms referred to by tbe acronym PIBIDS: Ilhotosensitivity. ichtbyosis. 
hrittle halrs. intellectual impalrment . .c;!ecreased fertility. and §hort stature. 
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Skeletal abnormalities are also frequently observed. including a peculiar 
bird-like face. a receding chin. and retardation of skeletal age. Moreover, 
axial osteosclerosis (abnormal hardening of the bone). peripheral 
osteoporosis (McCuaig et al. 1993). and h-yphosis (Norwood 1964) have been 
reported. The striking ectodermal symptoms (brittle hair and dystrophic 
nails) are unique for TID. However. the remainder of the clinical features 
are strikingly similar to CS. including the absence of cancer predisposition 
(de Boer and Hoeijmakers 2000: Bootsma et al. 200l). The photosensitivity 
in TID patients is due to a defect in NER caused by a mutation in one of 
three genes: XPB. XPD or ITDA. The NER defect in all but two of 20 studied 
UV -sensitive TID families can be assigned to the XPD complementation 
group (Stefanini et ai. 1993a and 1993b: Vermeulen et al. 1994a). Despite 
the NER defect. the pigmentation abnormalities are relatively mild 
compared to classical XP (ltin and Pittelkow 1990: Botta et al. 1998). The 
typical brittleness of TID hair is caused by a substantial reduction in the 
content of hair-specific cysteine-rich matrix proteins that provide the hair 
shaft with its natural strength by crosslinking the keratin filaments 
(Gillespie and Marshall 1983). Growth retardation (cachectic dwarfism) in 
TID patients is a very heterogeneous clinical symptom and - when severe -
can be associated with death in early childhood. TTD. like CS. is considered 
to be a repair/transcription syndrome [Vermeulen et al. 1994b). Mutations 
in XPD may not only affect the NER function but also cripple transcription 
by TFIIH. accounting for the typical TID and CS phenotypes. Consistent 
with this idea. all causative mutations in XPD have been found to be 
disease-specific (Winkler and HoeijmakerS 1998: de Boer and Hoeijmakers 
2000). Recently. the phenotype of two unrelated TTDA patients was directly 
attributed to a limiting amount of TFIIH. probably secondary to a mutation 
in a gene determining the complex stability. A reduced TFlIH level has an 
effect on its repair function and also on its role in basal transcription 
[Vermeulen et al. 2000). 
U.6 Mouse models for genetic defects In NER 
In recent years. mouse strains carrying defined mutations in repair genes. 
have been generated in order to study the syndromes caused by a defect in 
NER. Via conventional gene targeting methodologies. inactivated alleles or 
specific mutations (mimicking patient-specific gene alterations) were 
introduced by homologous recombination into the genome of totipotent 
embryonic stem cells. thereby creating gene knockout and specific mutant 
mouse models for XP. CS. and TTD (outlined in Table 3). The use of this 
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genetic technique will have a major impact on understanding clinical and 
fundamental features of human NER syndromes and ultimately cancer in 
general. Phenotypic characterization of the mouse models can help to 
answer questions about the role of the specific gene in NER and the 
consequences of NER deficiency in vivo. In addition. these models may 
provide clues about novel phenotypes related to NER defects that 
correspond to human syndromes in which the causative gene is yet 
unlmown. Crossing animals VJith different genetic lesions allows in vivo 
investigation of the possible interplay between NER and other mechanisms 
implicated in genetic (in)stability. such as complementary repair pathways. 
cell cycle control. and apoptosis. Finally. since the NER system targets a 
very wide spectrum of DNA lesions. mice deficient in this pathway will be a 
valuable and sensitive model for allow:ing assessment of the genotoxic effect 
of known and unknown compounds. However. several factors should be 
taken into account when studying NER-deficient mouse models. First. there 
are some important differences in the activity of NER between mouse and 
man. For instance. CPDs (but not 6-4PPs and some chemical adducts) are 
removed much less efficient from the non-transcribed strand of 
transcrtptionally active genes in rodents than in man (Bohr et al. 1985). 
However. this difference does not appear to have dramatic consequences in 
the model phenotypes since repair parameters (such as DDS. recovery of 
RNA synthesis after UV-irradiation and sensitivity to UV-light) in mouse 
embryOniC fibroblasts (MEFs) derived from the mutant mice correlate very 
well with those of human patient fibroblasts (see Table 3). However. in 
contrast to human cells. the selective repair of DNA lesions in the 
transcribed strand in rodent cells leads to a strong bias of mutations arising 
from lesions in the poorly repaired non-transcribed strand. Second. there is 
a substantial difference in the life span between mouse and man and many 
of the clinical features of the NER-deficient syndromes are age-dependent. 
For example. the accelerated neurodegeneration seen in XPA human 
patients evolves over the course of several years (longer than the life span of 
a mouse (see below)). Third. there is phenotypic diversity amongst the 
various genetic backgrounds of mutant mice (e.g. in a given genetic 
background apprOximately half of the XPA-deficient mouse embryos died in 
the midfetal stage (with signs of anemia (de Vries et al. 1995)). whlle in 
another background the mice were born at the eA.-pected Mendelian 
frequency (Nakane et al. 1995). Recent evidence indicates that the genetic 
background lnfluences not only embryonic lethality but also the life span of 
NER-deficient mice to a considerable extent. For example. the maximal life 
NER in mammals 33 
Table 3. Properties of NER mouse models and corresponding human syndromes 
uv- Relevant clinical symptoms or 
Mouse UOS (%)* Skin Cancer 
sensitivity'" differences with human 
Gene Mutltion M~ Mouse Moo Mouse Man Mouse Syndrome 
XPA KO +++ <5 <5 ++ l'\curodegeneration as in man is not 
apparent in mouse. 
XPB KO n.a. n.a. n.a. n.a. n.a. n.a. Embryonic lethal: 
XPB Truncation -H- -10% -10% +I-H- n.d. No severc phenotype in mousc. 
XPC KO + 15-30 30 -H- ++ MED in wildtype rangc. 
XPD KO n.a. n.a. n.a. n.a. n.a. ,.~ Embryonic lethal. 
XPD TID point -1- +1- 25 25 Like human TID. except 
mutation ncurody~myelination. 
CSB Truncation -H- Normal NOrm:J.l + CS symptoms mildly present. Mild growth 
retardation. Retinal degeneration. Cancer 
pronc. 
CSA KO -H- NOrm:J.l Normal n.d. As CSB. 
ERCCl KO n.a. +++ n.a. <5 n.a. n.d. Runted growth. early death through 
Truncation liver/kidney dysfunction. Signs of 
premature aging. No human syndrome. 
mHR23A KO n.a. NOrm:J.I n.:1. NOrm:J.1 n.a. n.d. No apparent phenotype. No human 
syndromc. 
mHR23B KO n.a. Norm:J.! n.:1. NOrm:J.1 n.a. n.d. No human syndrome. Intrauterine or 
prematurc death. Growth retardation. Male 
sterility. Facial dysmorphology. L"'V-
sensitivity and reduced UDS (as XPC) of 
mHR23AIB DKO ES.5 MEFs. DKOmiee 
are not viable. 
"W-sensitivity o.nd UDS (unscheduled DNA synthesis) of culturcd MEFs (mouse embryonic fibroblasts) o.nd of 
skin; Abbreviations: KO (knockout); DKO (double knockout); n.o.. [not applicnble); n.d. (not determined); ES.S 
(embryonic day 8.5); MED (roinirnnl UV-dosc required :0 inducc cr)'thernn/edernn). Table adapted from De Boer 
o.nd Hoeijmakers (1999). 
span of ERCC1-deficient mice is extended to several months in a FVB strain 
as compared to a C57BL/6 background (Weeda et aI. 1997). 
II.6.1 Damage recognition and verification proteins 
XPA 
The mouse homolog of the human XPA gene was cloned (Tanaka et al. 
1989; van Oostrom et aI. 1994) and a mouse model for the totally NER-
deficient XPA (XPA-I- mice) was generated independently in DNO laboratories 
(de Vries et aI. 1995; Nakane et aI. 1995). XPA-I· MEFs display all the 
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characteristics of a total NER deficiency. In contrast to XPA patients. XPX I · 
mice appear physiologically normal. are fertile. and show no enhanced 
mortality up to the age of 18 months (reviewed in de Vries and van Steeg 
1996). A slightly increased incidence of spontaneous liver carcinomas and 
lymphomas is found in older XPA-deficient mice (de Vries et al. 1997: van 
Steeg et al. 1998), but no clear spontaneous neurological abnormalities are 
observed. However. follovving experimental brain trauma. )(FA-deficient mice 
show delayed recovery of neuromotor defects and cognitive dysfunction 
(Tomasevic et al. 2000) . 
XPA-I - mice provide an excellent model for the susceptibility' of 
human XPA patients to skin cancer. Daily e:>"l'osure of XPA-deficient mice to 
UV-B leads to hyperkeratosis and erythema (sunburn) on the UV-e>q)osed 
skin even after relatively low doses (200 J/m2). The erythema is followed by 
a high incidence of skin tumors. primarily sees (de Vries et al. 1995: 
Nakane et al. 1995). Dally exposure to UV-B (32 or 80 J/m2) causes skin 
tumors in 100% of hairless XPA-i-mice after a short latency period (Berg et 
al. 1997). A shift from sees in wlldtype hairless mice to papillomas in XPA-
deficient hairless mice is correlated with a shift in cancer-susceptibility 
genes (p53 versus Ras) mutated in the tumors (de Vries et al. 1998). In 
addition to the effects of UV-light on the skin. hyperplasia and sees in the 
cornea of XPA-deficient mice are observed (de Vries et al. 1998). This 
mimiCS the corneal abnormalities seen in human .xFA patients. A short-
term effect of UV -B-exposure is also suppression of the immune system. 
This feature is prominent in XPA patients and XPA-deficient mice (Kripke 
1990 and 1991) and is likely to play an important role in the development of 
UV-B-induced cutaneous malignancies (Glover et al. 1994). Elevated UV-
induced inflammation and immune suppression (Miyauchi-Hashimoto et al. 
1996) as well as a suppression of natural killer cell activity are found in 
XPA-deficient mice (Miyauchi-Hashimoto et al. 1999). The latter 
phenomenon is also observed in .xFA but not in CS or TID patients 
(Morison et al. 1985: Mariani et al. 1992). In accordance with this finding. 
systemic .immunomodulation is only observed in UV-irradiated mice if both 
NER sub pathways are compromised (Garssen et al. 2000). In vivo. UV-
irradiation causes an acute inflammatory reaction in the skin, characterized 
by cutaneous vasodilatation (erythema). followed by an increase in the 
vascular permeabillty with eA"Udation of fluid (edema). Examination of mice 
with different NER genotypes ""--posed to the minimal UV-dose required to 
induce erythema/edema (MED) suggests a role of perSistent UV-
photoproducts in transcriptionally active DNA in triggering the cascade that 
leads to erythema and edema in the irradiated skin. The MED of XPA/· mice 
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is lO-fold lower than for wildtype mice (150 J/m2 versus 1500 J/m2) (Berg 
et al. 1998: Garssen et al. 2000). Defective TC-NER in XPA/· cells causes an 
irreversible block of RNA synthesis. which contributes directly to the 
occurrence of UV-induced erythema and edema (Berg et al. 1998) and 
apoptosiS (Ljungman and Zhang 1996). Consistent with this. epidermal 
cells of hairless XPA-/- mice are extremely prone to UV-illduced apoptosiS 
(van Oosten et al. 2000). 
Topical treatment of XPA-1- mice \Vith the chemical carcinogen 
dimethyl-benz[ajanthracene (DMBA) results in acute skin effects like 
acanthosis and epidermal hyperplasia. and chronic effects such as an 
increased incidence of papillomas (de Vries et al. 1995: Nakane et al. 1995). 
)(FA-deficient mice also have a predisposition to chemically-induced 
internal carcinogenesis (reviewed in van Steeg et al. 1998 and 2000). Oral 
treatment of XPA-deficient mice with a subcbronical dose of B[ajP results in 
an increased level of lymphomas in Imockout mice compared to wildtype 
mice (de Vries et al. 1997). In XPA-I-/p53+1. double mutant mice. lymphomas 
develop much earlier and with higher frequency compared to their single 
mutant counterparts (van Oostrom et al. 1999). intratracbeal treatment of 
XPA/· mice with B[ajP leads to enhanced frequency of puimonary adenomas 
and lung carcinomas (Ide et al. 2000). Oral exposure to 2-AAF and 2-amino-
l-methyl-phenylimidazo[4.5-bjpyridine (PhIP) causes increased incidence of 
liver tumors in female mice and bladder cancer in male mice (2-AAF) and 
intestinal adenomas and lymphomas (PhIP) (van Steeg et al. 1998 and 
2000). Since carcinogenesis is accelerated in XPA-1-mice. this animal model 
might contribute towards identifying the role of individual carclnogens in 
tissue-specific cancer initiation and progression (van Steeg et al. 1998 and 
2000). 
XPC 
Two independent XPC Imockout mouse models were developed (Sands et al. 
1995: Cheo et al. 1997). The mice are viable and develop normally similar to 
XPA-deficient mice. No :increased :incidence of spontaneous tumors is 
observed in XPC-deficient animals up to one year of age (Sands et al. 1995: 
Cheo et al. 1997: Friedberg et al. 1999 and 2000). UV-B irradiation of the 
mice results :in acute effects to the skin (i. e. hyperkeratosis and erythema). 
followed by a high incidence of skin- and eye tumors. The minimal UV-dose 
required to induce acute effects in XPC-deficient mice is 1500 J /m2 • whIcb 
is comparable to that of wildtype mice (Berg et al. 1998 and 2000: Garssen 
et al. 2000). In accordance. nine XPC patients showed MED within the 
normal range of healthy humans (Kondo et al. 1992). Since in mice there is 
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much less repair of CPD than in man. the difference in repair between the 
wildtype and XPC+ mice is smaller when compared to the repair state in 
normal humans and XPC patients. In accordance. UV-eA-posed 
keratinocytes of XPC+ mice do not display an enhanced apoptotic response 
compared to the wildtype mice (Ananthaswamy et al. 1999: van Oosten et 
al. 2000). Together. these data suggest that a GG-NER defiCiency causes 
skin cancer susceptibility but does not influence the sensitivity to acute 
effects ofUV-B irradiation. XPC+/~mice show an increased predisposition to 
UV -B radiation-induced skin cancers compared to wUdtype mice. indicating 
that haplo-insufficiency of the XPC gene may be operating in mice and is a 
risk factor for UV-B induced skin cancer (Cheo et al. 2000). XPC/p53 
double knockout embryos show neural tube defects. Furthermore. solar 
keratosis and skin cancer predisposition are significantly increased in 
double knockout mice compared to XPC single knockout animals (Cheo et 
al. 1996). The mouse homolog of the human BER gene HAPl/REF1/APE. 
Apex. is a redox protein that encodes the major apurinicj apyrtmidinic 
endonuclease activity in mouse cells and regulates p53 activation (Metra et 
al. 1997). XPG/-j Apex+l - mice show a further increase in UV-induced cancer 
susceptibility when compared to XPC+/Apex+!+ mice (Friedberg et al. 1999: 
Meira et al. 1997 and 2001). Double mutant mice of XPC and Msh2 
(involved in MMR) are viable and exhibit an enhanced predisposition to UV-
induced skin cancer compared to XPC+ mice. probably directly attributable 
to the general mutator-phenotype seen in MMR-deficient mice (Friedberg 
and Meira 2000). A significantly higher incidence of chemically-induced 
liver and lung tumors is observed in XPG/- mice compared to wildtype and 
heterozygous littermates after treatment with 2-AAF or N-OH-AAF (Cheo et 
al. 1999). But in XPC!· mice a p53+!' status further accelerates progression 
of AAF-induced liver twnors. Furthermore. a higher incidence of 
spontaneous testicular twnors is reported in XPCjp53 double knockout 
mice compared to xpe!+ /p53'!' mice (Cheo et al. 1999). XPC/XPA double 
knockout mice are completely NER-deficient and are phenotypically similar 
to XPA single knockout mice (Friedberg and Meira 2000: van der Horst et al_ 
manuscrtpt in preparation). 
Human RAD23 homologs hHR23A and hHR23B (highlighted in 
Chapters V and VI) 
Each of the hHR23A and hHR23B proteins can form a complex with XPC. 
and thereby function in damage recognitlon in GG-NER mHR23A and 
mHR23B knockout mice were recently generated in our laboratory and are 
described extensively in Chapters V and VI. mHR23K!- mice (see Chapter 
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VI) are viable. develop normally. and display no characteristics of an overt 
NER defect (at least up to 16 months). In contrast. mHR23H/' mice (see 
Chapter V) are viable but severely runted at birth. Furthermore. mHR23H/' 
animals are born at IO-fold decreased frequency than eA1'ected. Perinatal 
death of mHR23B knockout mice is commOTI. Intrauterine death is 
associated with a total absence of vascularization {anemia) or profuse 
internal hemorrhage as well as edema and craniofacial abnoITIlalities. 
Placental defects are also observed in mHR23BI embryos due to impaired 
vascularization of the placental labyrinth. Tills limits the maternal-fetal 
exchange of gases. and transport of nutrients to the fetus. Animals that 
survive ibis critical stage display severe growth retardation. male sterility 
(due to the complete absence of spermatogenesis). facial dysmorphology and 
ocular inflammation. mHR23B-/- female mice are fertile. albeit at a reduced 
level. The dramatic phenotype of mHR23H/' mice is very different from any 
of the human NER syndromes or mouse models. and strongly suggests that 
mHR23B is essential for proper mouse development. Furthennore. the 
immense difference between the phenotype of mHR23H/' and mHR23A/' 
mice can likely be attributed to the fact that mHR23A can only partly 
compensate for the loss of mHR23B. 
Cells of both mHR23A and mHR23B single knockout mice are UV-
resistant. suggesting that in NER the two proteins share common activities 
and are therefore functionally redundant. This conclusion is in line with the 
results of in vitro repair studies (Sugasawa et al. 1997: see also in Chapter 
III). mHR23A/B double knockout embryos (see Chapter VI) die before day 
13.5 of embryOniC development (E13.5). Importantly. total mHR23A/B-
deficient MEFs from E8.5 could be isolated and were found to be as UV-
sensitive as the XPC-l- cells. Other DNA repair parameters tested also reveal 
a striking similarity between mHR23A/B-deficient and XPC/· cells. strongly 
suggesting that a total mHR23A/B-deficiency leads to an XPC-like UV-
sensitivity. Interestingly. the XPC protein level is significantly decreased in 
mHR23A/B-deficient cells. indicating that XPC is unstable in the absence of 
both mammalian RAD23 proteins. Stable cotransfection of cDNAs encoding 
GFP-tagged XPC IXPC-GFP) and/or hHR23B into mHR23A/'/F/' cells 
rescued the UV -sensitivity. The observation that the single mHR23B-1- and 
mHR23A-I-/F/' phenotypes are so much more severe than the XPC/· 
phenotype implicates that the mammalian RAD23 proteins have additional 
functions outside NER but that mHR23A cannot compensate for all the 
activities of mHR23B. 
In view of.xFC and its strong relation with the mammalian RAD23 
proteins. mHR23A/XPC and mHR23B/XPC knockout mice were generated 
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and appeared viable (Ng et al. unpublished data). Neither mHR23A/·/XPCI· 
nor mHR23HI·/XPCI · MEFs showed an additional increase in UV-
sensitivity. and the levels of UDS and RNA synthesis recovery were similar 
to those of single XPC·I· cells. However. in contrast to mHR23A/·/XPC-l-
mice which are healthy -without gross abnormalities apart from a GG-NER 
defect. mHR23B-I-/XPCI. mutants are phenotypically similar to single 
mHR23B knockout animals. These findings support the idea that. in 
addition to a role in excision repair, mHR23 proteins are involved in another 
pathway. In view of the amino acid sequences and other properties. the 
additional role of mHR23 proteins is most likely associated with the 
ubiquitin/proteasome protein degradation pathway. The connection 
betvv"een NER and the ubiquitin system is discussed in more detail in the 
neld: section. and in Chapters V and VI. 
Il.S.2 DNA unwinding proteins 
TFllH subunits XPB and XPD 
The TFIIH complex has a second function outside NER which complicates 
the clinical effect of a mutation in the genes involved. The second function 
is initiation of basal transcription of all structural genes transcribed by 
RNAP II. This is one of the most fundamental processes in the celL 
Complete inactivation of such a function is most probably lethal. explaining 
the rarity of mutants in TFIIH genes. An XPB mouse model with a 
truncation at the position corresponding to the frameshift in the human 
XPB gene ofaXP /CS patient was recently generated and is viable (Friedberg 
and Metra 2000: Weeda et al. manuscript in preparation). Furthermore. the 
mouse XPB mutant cells are UV-sensitive and NER-deficient. 
The function of the XPD protein is. just like XPB. essential in basal 
transcription. and only subtle XPD mutations are found in XP. XP /CS and 
TID patients. Consistent vrith this. the XPD mutant mouse model in which 
the DNA helicase domains IV-VI are deleted is not viable and shows 
preimplantation lethality at the two-cell stage when nonnal embryonic 
transcription begins (de Boer et al. 1998b). However. mice carrying in both 
XPD alieles the causative point mutation of a TID patient (designated 
XPDITD mouse) are viable (de Boer et al. 1998a). Moreover. XPDITD mice 
mimic to a remarkable extent the clinical symptoms of the human patients. 
including brittle hair. developmental problems. reduced life span. and skin 
abnormalities. XPDITD cells have reduced NER capacity and are mildly 
sensitive to UV and DMBA In accordance vrith this. xpDTTD mice exhibit a 
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modest increase in inflammation and hyperplasia of the skin secondary to 
UV ""--posure. Differentiation of skin keratinocytes is impaired. XPDTID mice 
have a slightly reduced MED compared to wildtype and XPC I - mice (1200 
J/m2 versus 1500 J/m2) but not as low as in XPA-1- mice. consistent with 
the idea that TC-NER is only partially affected in XPDTID mice (de Boer et al. 
1999: Garssen et al. 2000). Whereas TID patients do not show elevated 
cancer incidence. XPDTID mice display a clear susceptibility to UV - and 
DMBA-induced skin carcinogenesis (although this is not as pronounced as 
in the totally NER-deficient XPA/- mice) confirming the idea that a defect in 
DNA repair in general predisposes to cancer (de Boer et al. 1999). 
The phenotype of xpDTI'D mice is dramatically exaggerated if the 
defect is crossed into a totally NER-deficient background. Le. xpDITD /XPA+ 
Tbe double mutant mice are growth retarded and die prematurely just after 
weaning (de Boer et al. manuscript in preparation). In contrast. the 
combination of a GG-NER and TID defect in XPC/XPDTID double mutant 
mice fails to show a strong synergism when compared to XPDTrD single 
mutant mice. Apparently. the residual TCR capacity in XPC/XPDTID double 
knockout mice is sufficient to sustain life. Given the involvement of the XPD 
and CSB proteins in transcription initiation and elongation respectively. we 
hypothesize that the premature aging features in CS and TID originate from 
a subtle transcription defect that worsens with increasing accumulation of 
unrepaired DNA damage in active genes. The generation of mouse models 
with an XP-type or XP/CS-type mutation in the XPD gene is in progress. 
IT.6.3 Incision proteins 
XPG 
The phenotypiC heterogeneity of human XPG patients is reflected by the 
different XPC-deficient mouse models. XPC-deficient mice generated by 
deletion of exon 3 of the mouse XPG gene. exhibit postnatal growth failure 
and undergo premature death (Harada et al. 1999). similar to the severe CS 
features in human XPG/CS patients. Primary XPC- I - MEFs display 
premature senescence and exhibit early onset of immortalization and 
accumulation of p53 (Harada et al. 1999). which is consistent With XPG 
having an additional function in genome stabili7..ation beSides its role in 
NER. In contrast. deletion of exon 15 of the mouse XPG gene resulted in 
mice that develop normally (Friedberg and Meira 2000). Celis of these mice 
are moderately NER-defective and UV-sensitive. 
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XPF 
The mouse XPF gene has recently been isolated and characterized (Shannon 
et aI. 2000). The predicted mouse XPF protein is 86% homologous to the 
human XPF protein. XPF mRNA levels are specifically elevated in adult 
mouse testis. Moreover. elevated levels of XPF and ERCC 1 mRNAs were 
found in meiotic and early post-meiotic spermatogenic cells. which may 
point to a role for the encoded protein ERCCI-XPF in meiotic 
recombination. However. J(pF-deficient mice have not yet been generated 
(Friedberg and Meira 2000). 
ERCCI 
ERCCl gene was the first human NER gene cloned (Westerveld et aI. 1984), 
but is not implicated in any of the known XP. CS or TID complementation 
groups. No human syndrome attributable to a mutation in ERCCl is yet 
known (van Duin et al. 1989). suggesting that complete gene inactivation in 
humans is incompatible with life. However. a functional knockout mutation 
of the ERCCl gene in mice is viable. but most ERCCI-deficient embryos die 
in utero or pertnatally. The few mutants that survived are severely runted 
and usuaJly die before weaning Le. 'Within 4 weeks of birth (Weeda et al. 
1997: McWhir et ai, 1993). One of the causes of early postnatal death is 
liver malfunction. Aneuploidy and elevated levels of the tillllor suppressor 
proteins p53 and p21 are detected in hepatocytes. suggesting the presence 
of early DNA damage-induced cell cycle arrest (McWhir et al. 1993). Other 
halimarks include aneuploid nuclei in kidney. ferritin deposition in spleen, 
and increased levels of p53 in braln and kidney (Weeda et al. 1997), The 
mutant mice have no subcutaneous fat but their neurologic status appears 
normal, As e"."pected, ERCC1-deficient MEFs show almost no repalr activity 
after ""'P0sure to UV-ligbt, and are hypersensitive to UV and chemical 
genotoxins that are substrates for NER In addition. the MEFs are sensitive 
to crosslinking agents. presumably as a consequence of an additional defect 
in one of the recombination pathways (Dronkert et al, manuscript in press). 
Some symptoms seemed to be less severe in the mouse model in which the 
encoded protein contains a C-terminal seven amino-acids truncation 
(Weeda et al, 1997). Both ERCCl mutant mouse models exhibit additional 
symptoms that point to a premature replicative senescence in liver and 
kidney cells as well as increased spontaneous transformation of Iv1EFs in 
vitro that is not observed in cells of mice with a defect in NER only (Weeda 
et al, 1997). This early onset of cell cycle arrest and polyploidy in liver and 
kidney is most likely caused by an accumulation of unremoved DNA 
damage of which some migbt be normally repalred by ERCC I-dependent 
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recombination (Mu and Sancar 1997: Sargent et al. 1997: Melton et al. 
1998: Nunez et al. 2000). The signs of premature senescence observed in 
ERCC1-deficient mice suggest that accumulation of unrepaired DNA 
damage contIibutes to early aging. Cutaneous application of DMBA at a 
dose easily tolerated by XPA Imockout mice (Nakane et al. 1995) caused 
ERCCrJ- animals to die within 3 days. reveaJing an extreme sensitivity to 
genotoxins (Weeda et al. 1997). 
Apart from the UV sensitivity. the phenotype of ERCCrl - mice is 
very different from any of the human NER syndromes. The lack of similartty 
between the mouse and the human NER mutants may in part reflect 
species differences. but the feature also may be compounded by the dual 
functionality of the ERCC1 protein. A compartson of the characteristics of 
ERCCl mutant mice with that of XPA Imockout mice (also harboring a 
complete NER defect) will be very instructive. ERCCl Imockout mice are 
considered suitable candidate mice to study the genotoxic effects of 
crosslinking agents. However. given their extremely reduced life span 
(McWhir et al. 1993: Weeda et al. 1997). an approach to develop a 
conditional mutant mouse (see Chapter VlI) is essential. 
II.6.4 TC-NER-specific proteins 
CSB 
A truncation mutation of a CSB patient was mimicked in the mouse genome 
(van der Horst et al. 1997). Similar to the human syndrome. CSB-deficient 
mice were born at Mendelian frequency and exhibit ali of the CS repair 
characteristics: UV-sensitivity. specific loss of TC-NER normal GG-NER 
and inability to resume RNA synthesis after UV-exposure. Other CS-llke 
clinical features such as growth faliure and neurological dysfunction are 
only present in a mild form in the mouse model. Although 
neurodysmyelination was not observed, the behavior of the mice in various 
tests (behavioral and motor coordination) pOints to some neurological 
impairment. The MED of CSB-deficient mice is equal to that of XPA 
Imockout animals (I.e. 150 J/m2). which is lO-fold lower than observed for 
TCR-proficient mice (XPC I - and wildtype mice) (Berg et al. 2000: Garssen et 
al. 2000). The apoptotic response in epidermal cells is also similar to that in 
XPA/- mice (van Oosten et al. 2000). In contrast to CS patients. CSB-
deficient mice appear prone to skin cancer when exposed to UV -light or to 
DMBA (van der Horst et al. 1997). This can be explained by a more efficient 
GG-NER pathway for some lesions (I.e. CPDs) in humans compared to mice. 
42 Chapter II 
Remarkably. when an additional GG-NER defect was bred into eSB-
deficient mice. a strong augmentation of the CS phenotype was observed. 
The CSBjXPA and CSBjXPC double mutant mice exhibit very severe growth 
retardation (75% less of wildtype mice). suffer from neurological problems 
(unable to walk). and die before weaning (around day 18). These 
observations suggest that a CS defect becomes exaggerated in the absence 
of GG-NER. pointing to an accumulation of endogenous damage as a 
contIibuting factor to the CS symptoms (van Gool et al. 1997b). The fact 
that CSBjXPA and CSBjXPC double mutant mice display a phenotype more 
severe than single XPA knockout animals (with a complete NER defect) 
argues that CSB has additional functions beyond its role in NER. Cells of 
combined CSjXP mice are totally defective in NER and show an XPA-like 
UV-sensitivity (van Gool et al. 1997b: van der Horst et al. manuscript in 
preparation). in view of the involvement of mHR23 in NER. CSBjmHR23A 
double knockout mice were generated. and were found to display a normal 
phenotype. CSBjmHR23A double mutant MEFs do not have an additional 
NER defect on top that seen in single ese-I· cells (Ng et al. unpublished 
data). further suggesting the existence of functional redundancy between 
the two mammalian RAD23 proteins in NER. Given that XPC and hHR23B 
are tightly complexed. crossing CSB and mHR23B knockout animals will be 
of interest in the near future. 
GSA 
CSA-deficient mice were generated very recently (van der Horst et al. 
manuscript in preparation). Animals were shown TC-NER defiCient. 
photosensitive and UV-induced skin cancer prone. and as such form a 
phenocopy of CSB.J- animals. Like CSBjXPC double mutant mice. CSAjXPC 
double knockout animals die before weaning. CSA'/-/XPC+/- mice are viable. 
but display increased incidence of skin cancer after UV-B exposure 
compared to either single mutants (van der Horst et aI. manuscript in 
preparation). Thus. inactivation of TC-NER uncovers XPC haploinsu[ficiency 
with respect to UV-induced cancer predisposition. This finding is in line 
with the increased spontaneous mutation frequency observed in aging 
xpc'l' animals (Wijnhoven et al. 2001). 
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ll.7 Connection between NER and the ubiquitin system 
n.7.1 Interaction between RAD23 and ubiquitin 
Interestingly. the developmental abnormalities detected in mHR23B'I ' mice 
(Chapter VI and the lethality in mHR23A/B double knockout animals 
(Chapter VI) are absent in XPC and other NER-deficient mouse models. This 
strongly suggests that mHR23B has an important separate function. which 
furthermore can not be fully complemented by mHR23A. The RAD23 
homologs share a number of well-conserved domains. including an N-
tenuinal ubiquitin-like (UbL-like. -80 amino acids in length) sequence. and 
two copies of a highly conserved ubiquitin-associated domain (DBA ...... 50 
amino acids long) one in the middle and one at the C-terminus of the 
proteins (schematically represented in Figure 2). These domains are not 
found in any other NER proteins. The UbL·like domain shares 23% 
sequence identity with ubiquitin. which is a very conserved polypeptide. 
composed of 76 amino acids and present in all cells. Ubiquitin functions as 
a protein tag marking its targets for non-lysosomal proteolytic degradation 
or for refolding. Ubiquitination plays a regulatory role in numerous cellular 
processes. including homeostasis. stress response. organelle biosynthesis. 
protein translocation across membranes. and DNA repair (reviewed in 
Ciechanover et al. 2000). All of these roles depend upon the covalent 
coupling of ubiquitin to cellular substrates. resulting in mono- or poly-
ubiquitination via a complex enzymatic pathway (depicted in Figure 3 and 
discussed in section 11.7.2). Poly-ubiquitination signals the proteolytic 
breakdown of substrate proteins by the proteasome. whereas mono-
ubiquitination may serve other functions. 
Studies in yeast and in mammals have shown that the strongly 
conserved UbL-like domain of RAD23 is required for maximal efficiency of 
NER (Watkins et al. 1993). In addition. the domain mediates interaction 
between RAD23 and the 26S proteasome (Schauber et al. 1998: Hiyama et 
al. 1999). suggesting a role for RAD23 in protein degradation via the 
ubiquitin/proteasome pathway. Consistent with this finding. the entire 
amino acid sequence of this region is strictly conserved between mouse and 
human. including lysine 48. which in ubiquitin is required for poly-
ubiquitination (Chau et al. 1989). Conservation of this residue further 
suggests the possibility of covalent attachment of ubiquitin to RAD23. 
The UBA domain is evolutionarily conserved from yeast to humans and is 
found in all eukaryotes (Hofinann and Bucher 1996). Although. UBA 
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XPC-BD 
231 288 
hHR23A 363aa 
82 151 205 311 363 
ubjquitin~like USA ~ 
XPC-BD 
275 332 
hHR23B 409 aa 
80 17~2 357 409 
ubiquitin~like USA USA 
Figure 2. Schematic representation of functional domains in the two htunan homologs of S. 
cerevisiae EAD23 I\TER proteins: hHR23A and hHR23B. Both proteins share 57% identity and 
76% sl.milarity in amino acid (aa) sequence. Abbreviations: UBA. ubiqu1tin~associated domain; 
XPC-ED. XPC-binding domain for XPC stimulation. 
domainS are present in many enzymes and proteins that are involved in 
pathways utilizing ubiquitination. DNA repair. and cell signaling via protein 
kinases. their cellular function is not completely understood. Such an UBA 
domain constitutes a large hydrophobic patch at a protein's surface, that 
may serve as a binding site for other proteins. The UBA domain also 
includes numerous conserved residues that contribute to the stabilization 
of the overall structure of the domain by promoting its intra- and inter-Ct.-
helical interactions (Dieckmann et a1. 1998). The most C-terrninal UBA 
domain of HR23 was recently shown to interact with the human BER 
protein 3-methyladenine DNA glycosylase (MFG. Miao et al. 2000). Based on 
this observation it was proposed that the hHR23 gene products act as 
universal DNA damage recognition accessory proteins. Previously. it was 
also found that the human inrrnunodeficiency virus (HN-l) Vpr protein 
binds specifically to the C-terrninal UBA of hHR23 (Withers-Ward et al. 
1997). It is therefore possible that HlV-l Vpr may compete with MFG. XPC. 
and other proteins for binding to hHR23. thereby affecting BER and/or 
NER and/or other processes. This permits further speculation that the 
interaction of HlV-l Vpr with the hHR23 DBA domain may be important in 
HN-induced cell cycle arrest and/or apoptosis (Withers-Ward et al. 2000). 
Furthermore. the UBA domain could be involved in the interaction of 
RAD23 with the 19S complex (see below) of the proteasome resulting in an 
alteration of the NER activity (Russell et al. 1999: Ortolan et al. 2000: 
Gillette et al. 2001). Thus. a link between NER and the 19S complex of the 
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265 proteasome mediated by RAD23 seems well established but the 
functional implications remain obscure. 
The characterization of the mammalian cells deficient in RAD23 
activity led to the discovery that XPC stability depends on the presence of 
mHR23 proteins (discussed in Chapter VI) and that DNA damage is able to 
further stabilize the XPC protein in a transient fashion. These findings 
establish the main function of the RAD23 proteins in NER which is to 
regulate the first step of the GG-NER pathway. The discovered role of 
mHR23 in protein stabilization provides an explanation of the unusual 
phenotype of the mHR23B mice and the lethality of the double mutant. and 
may have important implications for the other partners of HR23 proteins. 
n. 7.2 The ubiquitin system 
Degradation of cellular proteins is a highly complex. temporally controlled. 
and tightly regulated process that plays major roles in a broad array of 
basic pathways during cell life and death. The ubiquitin proteolytic system 
is involved in physiological regulation of many cellular processes. including 
cell cycle progreSSion. modulation of the immune and inflammatory 
responses. development. cell differentiation. signal transduction. 
spermatogenesis. and repair. These complex processes are controlled via 
degradation or processing of a single or a subset of proteins. Ubiquitin-
mediated degradation of a protein involves two distinct and successive 
steps: (i) conjugation of multiple ubiquitin molecules to the substrate. and 
(ti) degradation of the tagged protein by the 265 proteasome complex (see 
Figure 3 for a scheme of the ubiquitin/proteasome pathway). For recent 
comprehensive reviews of the mechanisms of the ubiquitin/proteasome 
system. the interested reader is referred to Laney and Hochstrasser (1999). 
Kornitzer and Ciechanover (2000). and Ciechanover et al. (2000). 
The 265 proteasome consists of two different subunits: the 195 
regulatory complex and the 205 catalytic core (Varshavsh-y 1997). The 195 
complex consists of at least 17 proteins. which can bind substrate-linked 
muitiubiquitin chains. unfold the attached proteins and translocate the 
polypeptide chains into the 205 catalytic core. A key feature of the 195 
complex is the presence of the six so-called homologous AAA ATPases that 
are thought to unfold substrate proteins in an ATP-dependent manner. 
However. it is not clear if the intact 26S proteasome is necessary for all 
proteasomal functions or whether the 19S complex can function on its own 
independently of the 205 core. 
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(1) ubiquitination process (2) degradation process 
Figure 3. The ublquitin/proteasome pathway. (1) Conjugation of ubiquitin (U) to the target 
protein substrate (8) generally requires the successive actions of three different enzymes: the 
ubiquitln-activating enzymes E1. the ubiquitin-conjugating enzymes E2. and the ligating enzymes 
E3. These enzymes are depicted as a single comple.x. but this is hypothetical. The subsequent El. 
E2. and E3 activities couple the C-tenninal carbm ... yl group of ubiqultin to a lySine residue of the 
substrate giving rise to a mono-ubiquitinated protem. Further ubiquitination of the mono-
ubiquitin moiety results in a polyubiquitinated protein. {2} Degradation of the polyubiquitinated 
proteins are recognized by the 265 proteasome comple.x (composed of two 19S regulatory particles 
attached at each side to the 208 catalytic core). and intact ubiquitin is released from the peptide 
fragments by the action of deubiquitinating enzymes (O). most likely of the ubiquitin carbo:\.yl-
terminal hydrolases and ubiquitin-specific processing proteases. Model adapted from Baarends 
and coworkers (2000). 
An important question concerns the identity of the mechanisms 
that underlie the bigh degree of specificity of the system: why are some 
proteins eAtremely stable while others are short-lived? Substrate 
recognition is governed by a large family of ubiquitin ligases that identify 
the substrates. bind them and catalyze their ubiquitination (Hochstrasser 
2000: Jackson et aI. 2000). But time and spatial regulation remain poorly 
understood. For instance. although many components of the 
ubiquitin/proteasome system are located in the nucleus and the cytosoL 
targets of the system are known to include membrane-anchored and even 
ER lumenal proteins. These proteins are thought to be "retro-transported" 
to the cytosol. ubiquitinated. and degraded by the proteasome (reviewed in 
Bonifacino and Weissman 1998: Plemper and Wolf 1999). 
With the multitude of substrates available for targeting as well as 
processes involved. it is not surprising that aberrations in the pathway were 
recently implicated in the pathogenesis of many diseases, including certain 
malignancies and neurodegeneration. For example. Angelman's syndrome is 
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associated with a defect in the ubiquitin-protein ligase £3 enzyme £6-AP 
(Kishino et al. 1997). Other examples of neurodegenerative diseases are 
Alzheimer. Parkinson. and Creutzfeld-Jacob (reviewed in Mayer et al. 1996). 
Protein aggregates in ubiquitin- and proteasome-positive intranuclear 
inclusion bodies are found in Huntington disease and spinocerebellar 
ataxias (Cummings et al. 1998: Davies et al. 1997). 
11.7.3 Interplay between spermatogenesis and the ubiquitin system 
Since numerous proteins are regulated through ubiquitination, it is not 
surprising that general inhibition of the ubiquitin system frequently results 
in a rapid dysregulation of multiple cellular processes, and subsequently in 
apoptosis. Ubiquitination of histones is also observed in histone removal 
from chromatin during spermatogenesis (Agel! et al. 1983: Nickel et al. 
1987) and is a general phenomenon found in mammalian cell types. 
However. depending upon certain cell type-specific actiVities of the ubiquitin 
system. even a partial inhibition of ubiquitination may be lethal in some 
cells. For example. the turnover of nuclear proteins during the post-meiotic 
histone-to-protamine tranSition in male germ cells probably requires 
massive breakdo'WIl of histones and transition proteins. and thus places 
high demands on the ubiquitination machinery and proteasome. 
In the mouse. quite a number of targeted gene mutations have been 
reported to lead to male infertility. With respect to the role of ubiquitination 
in spermatogenesis. inactivation of the mouse HR6B gene (encoding a 
mammalian homolog of the S.cerevisiae RAD6 ubiquitin-conjugating 
enzyme, involved in postreplication repair and damage-induced 
mutagenesis (Koken et al. 1991)) fails to cause a phenotype in the mouse 
with the exception of male-limited infertility (Roest et al. 1996). In HR6B 
knockout mice. both meiotic and post-meiotic germ cell development are 
affected, although the major consequences occur during spermatid nuclear 
condensation (Roest et al. 1996: Grootegoed et al. 1998). SurpIisingly. 
mutations in the mouse HR6A gene (encoding the second mammalian 
homolog of S.cerevisiae RAD6) affect early embryonic development 
(maternal factor infertility). whereas HR6A knockout males are completely 
fertile (Roest et al. 1996: Grootegoed et al. 1998). Additional knockout 
mouse models with a gametogenic failure suggest that the ubiquitination 
machinery is also important for gametogenesis (Baarends et al. 2000). Most 
likely. different phases of mammalian spermatogenesis require different 
specialized activities of the ubiquitin system (Baarends et al. 2000). 
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Yeast RAD23 mRNA is induced fivefold during the meiotic 
prophase. coinciding with recombination (Madura and Prakash 1990). 
However. it is not knmvn whether meiotic recombination is affected in these 
mutants since rad23 mutants undergo sporulation and produce viable 
spores. The feature of meiotic-specific induction of RAD23 e)..-pression may 
be a preserved property of the gene. perhaps pointing to an involvement in 
meiotic recombination. Disruption of mHR23B in the mouse causes 
defective spermatogenesis. resulting in absence of developing germ cells and 
a Sertoli-cell-only phenotype. Further studies show that fallure of 
spermatogenesis in mHR23B"/' animals occurs between E15.5 and day 15 
after birth. The action of mHR23B may be involved in development of a 
normal population of gonocytes (precursors of spermatogonia). which is 
capable to support initiation of spermatogenesis. In addition. or 
alternatively. mHR23B may be required for the subsequent initiation phase 
of spermatogenesis which involves spermatogonial proliferation and 
differentiation. and entry into the meiotic prophase (see Chapter V for more 
detail). 
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Summary 
Xl'C-hHR23B protein complex is specifically involved in nucleotide excision 
repair (NER) of DNA lesions on transcriptionally inactive sequences as well as 
the non-transcribed strand of active genes. Here we demonstrate that not 
only highly purified recombinant hHR23B (rhHR23B). but also a second 
human homolog of the Saccharomyces cerevisiae RAD23 repair protein. 
hHR23A stimulates tbe in vitro repair activity of recombinant human Xl'C 
(rhXPC). revealing functional redundancy between tbese human RAD23 
homologs. Co-precipitation expeIiments using His-tagged rhHR23 as well as 
sedimentation velocity analysis showed that both rhHR23 proteins in vitro 
reconstitute a physical complex with rhXPC. Both complexes were more 
active than free rhXPC. indicating that complex assembly is required for the 
stimulation. rhHR23B was shown to stimulate an early stage of NER at or 
prior to incision. Furthermore. both rhHR23 prote:ins function in a defined 
NER system reconstituted witb purified proteins. indicating direct 
involvement of hHR23 proteins in the DNA repair reaction via :interaction 
witbXl'C. 
Introduction 
Nucleotide excision repair (NER) is the main pathway for cells to remove DNA 
lesions caused by UV-irradiation as well as various chemical mutagens 
(Friedberg et al. 1995). The molecular mechanism of NER has been 
eA'tensively investigated in Escherichia coli (van Bouten 1990: Liu and Sancar 
1992: Grossman and Thiagalingam 1993: Hoeijmakers 1993). Based on 
studies witb tbis prokaryotic system. tbe NER reaction could be dissected 
into several steps: (i) recognition of DNA damage. probably accompanied by 
chromatin remodelling. (ti) introduction of asymmemc single-strand breaks 
on botb sides of tbe injury. (iii) removal of tbe short oligonucleotide 
containing tbe lesion. (iv) gap filling DNA syntbesis by DNA polymerases. and 
(v) re-sealing of the resulting nicks by DNA ligase. Although some general 
features of tbe eukaryotic NER mechanism are similar to tbe prokaryotic 
system. there are many important differences. Only six. E.eoli proteins (i.e. 
UvrA UvrB. UvrC. UvrD. DNA polymerase I and DNA ligase) are required to 
accomplish the core of the NER reaction in vitro. The eukaryotic NER system. 
however. appears to be much more complex. involving at least 20 factors 
(Hoeijmakers 1994: Wood 1996). 
Impaired NER activity has been found to be associated witb several 
rare autosomal recessive human disorders. including xeroderma 
pigmentosum (XP). Cockayne syndrome (CS) and trichotbiodystrophy (TID) 
(Bootsma et al. 1997). By cell fusion so far. seven Xl' (XP-A to G). two cs (CS-
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A and B) and three 1TD (TfD-A XP-B and XP-D) NER-deficient 
complementation groups have been identified. Many mammalian NER genes 
have been cloned using either mutant fibroblasts from patients or NER-
deficient, UV-sensitive Chinese hamster ovary cells (Boulikas 1996). For 
some of these genes. the possible role in the NER reaction has been 
suggested on the basis of their amino acid sequence as well as biochemical 
properties of the isolated gene products. On the other hand. additional 
factors :involved in the mammalian NER have been identified from extensive 
analyses of cell-free NER systems, and some models for the eukaryotic NER 
mechanism have been proposed (reviewed in Sancar 1996 and Wood 1996). 
Several laboratories have recently succeeded in reconstitution of the core of 
eukaryotic NER reactions with purified proteins (Aboussekhra et al. 1995: 
Guzder et al. 1995b: Mu et al. 1995). 
XPC protein is involved in NER of DNA lesions on transcriptionally 
inactive sequences as well as the non-transcribed strand of active genes 
(Venema et al. 1990 and 1991). and is required for in vitro NER of many 
types of DNA lesions (Masutani et al. 1994: Shivji et al.1994). However. 
certaln kinds of lesions could be repaired without XPC in vitro (Mu et al. 
1996). and the precise role of XPC in the 'global genome repair' NER 
subpathway remains to be elucidated. Human XPC protein was found to be 
tightly complexed in viDo with hHR23B (human Homolog of RAD23), which 
shows overall homology to yeast NER factor RAD23 (Masutani et al. 1994). 
Unlike yeast cells. a second RAD23 homolog, designated HR23A has been 
identified in human (Masutani et al. 1994) as well as murine cells (van der 
Spek et al. 1996b). The RAD23 gene has thus been duplicated during 
eukaryotic evolution. Indirect immunofluorescence studies revealed that XPC 
and both hHR23 proteins are predOminantly localized in the nucleus (van der 
Spek et al. 1996). Although XPC protein is bound to hHR23B in a 
quantitative manner. hHR23B is much more abundant than XPC. so that a 
majority of hHR23B is present in a free form in vivo (Sugasawa et al. 1996: 
van der Spek et al. 1996). Both the RAD23 gene duplication and the presence 
of wo forms of hHR23B suggest that tile protein may have multiple 
functions. Despite the overall sequence homology of the two human RAD23 
homologs. almost all XPC molecules appear to be complexed in vivo with 
hHR23B. not with hHR23A 
Us:ing a reconstituted in vitro NER system devoid of endogenous XPC 
and hHR23B, we have previously shown that recombinant hHR23B protein 
(rhHR23B) significantly stimulates the activity of recombinant hXPC protein 
(rhXPC) (Sugasawa et al. 1996). In the accompanying paper. we determined a 
domain in hHR23B that is responsible for XPC-binding as well as its 
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Figure 1. DepIction of endogenous XPC and hHR23B proteins from human whole cell e,uacts. (Al 
Scheme of phosphocellulose fractionation of human whole cell e. ..... tracts. (B) Whole cell extracts from 
!'<.'ER-proficient HeLa cells and XP group C cells (XP3BE) were fractionated on phosphocellulose as 
illustrated in A The presence of endogenous XPC. hHR23B and hHR23A proteins in each fraction 
was e."<aITl.ined by immunoblotting uSing polyclonal antibodies raised against each protein. 40 ~ of 
whole cell extract protein (WeE) and 20 p.g protein of CFl and CFII were loaded onto each lane. 
stimulatOIY activity (Masutani et aL 1997). Because the amino acid sequence 
of this domain is well consexved between the two human RAD23 homologs. 
the XPC-binding and stimulating activities of hHR23A have been of interest. 
Here we document and characterize the XPC-stimulating activity of both 
hHR23 proteins expressed in E.col"L 
Results 
Both hHR23 proteins stimulate the activity of XPC protein in 
fractionated XP-C cell extracts 
To detect XPC-stimulating activity of recombinant hHR23B protein. we have 
previously reported a reconstituted in vitro NER system from which 
endogenous XPC as well as hHR23B were depleted (Sugasawa et al. 1996). 
This assay system is based on the fact that. when the XP-C whole cell extract 
is fractionated on phosphocellulose as shown :in Figure 1A the bound 
fraction (CFII) is devoid of both XPC and hHR23B (Figure IB). Although XP-C 
cells still express hHR23B protein as a free fOrID_ all of the hHR23B is 
recovered in the flow-through fraction (CFI). Immunoblotting analysis 
revealed that hHR23A is also recovered :in CFI and can not be detected :in 
CFII upon the same fractionation. regardless of the presence or absence of 
XPC expression (Figure IB). Because two purified NER proteins. replication 
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Figure 2. Stimulation of in vitro NER reactions by rhHR23 proteins. Plasmid DNA substrates (AAF-
damaged and undamaged: each 250 ng) were incubated at 30<>C for 90 min with eFI! from XP-C cells 
(100 ~ and indicated purtfied proteins under standard conditions for in vitro NER reactions (see 
D..-perimental Procedures). After addition of PCNA (25 ng) and la-32PldATP (74 kBq). incubation was 
continued at 300 C for 15 min. DNA samples were purified. digested with BamHI. and then subjected 
to agar-ase gel electrophoresis. Ethidium bromide stained photograph and autoradiogram of the gel 
are shown. Incorporation of dAMP into each DNA band was calculated and depicted as a graph. The 
average values and standard errors were calculated from two independent e.-q>eriments. (solid bcus) 
incorporation in damaged plasmid: (open bars) incorporation In undamaged control plasmid. 
protein A (RPA) and proliferating cell nuclear antigen (PCNA). are sufficient to 
functionally substitute for CFI in reconstitution of the cell-free NER system 
(Shi\ji et aL 1992). both endogenous hHR23 proteins present in the XP-C cell 
extracts can be depleted by this substitution_ Thus. reconstitution of NER 
reactions using the XP-C CFII. purified RPA and PCNA enabled uS to test 
whether the purified recombinant hHR23A could functionally replace 
hHR23B in this reconstituted system_ A two-stage reaction protocol was used 
for this eA-periment_ A mixture of AAF-damaged and undamaged DNA 
substrates was incubated with CFII from XP-C cells and purified RPA in the 
presence or absence of rhXPC. rhHR23B and rhHR23A During this first 
incubation. oligonucleotides containing AAF -adducts can be excised from 
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Figure 3. Both rhHR23 proteinS bind to rhXPC. rhXPC (0.25 pmol) was incubated on ice for 1 h with 
various combination of 2.5 pmol each of His-tagged or non-tagged rhHR23 proteins as indicated 
above lanes. :;rickel-chelating Sepharose was added and His-tagged proteins were pulled down by 
centrifugation after additional 1-h incubation. Unbound (U) and bound {B} materials were subjected 
to SDS-PAGE (9% polyacrylamide gels). The presence of XPC {upper paneO. hHR23B {middle paneO 
and hHR23A {lower paneO in each fraction was assessed by immunohlotting. For detection of 
hHR23A and hHR23B. antibodies raised agalnst synthetic polypeptides corresponding to a unique 
sequence in each protein were used (Masutanl et al. 1997). 
plasmid DNA substrates. when all incision proteins are present. In the 
second stage. PCNA and radioactive dATP were added to allow DNA repair 
synthesis by DNA polymerases and to label repair patches. As shown in 
Figure 2. rhXPC alone supported DNA repair synthesis up to 3-fold over the 
background DNA synthesis (lane 3). In the presence of the same amount of 
rhXPC. addition of non-tagged rhHR23B gave a highly reproducible 
stimulation of repair synthesis to 6-fold over background (lane 4). although 
the reparr activity was significantly lower than that achieved with the 
authentic XPC-hHR23B complex purified from HeLa cells (lane 9). As 
eA-pected. the reparr reaction was dependent on the presence of RPA (lanes 5 
and 10). Interestingly. rhHR23A could also stimulate the rhXPC activity to a 
similar extent as rhHR23B (lanes 7 and 8). No further stimulation was 
observed when both hHR23 proteins were added in one reaction with rhXPC 
(lane 6). These data suggest that hHR23A can functionally substitute for 
hHR23B in terms of the XPC-stimulation in vitro. 
XPC stimulation by human RAD23 homologs 71 
hHR23 proteins stimulate XPC protein via complex formation 
To assess complex assembly behveen rhXPC and rhHR23A a His-tagged 
version of recombinant rhHR23 proteins (rhHR23-His) was used to co-
precipitate rhXPC with nickel-chelating Sepharose. As shown in Figure 3. 
rhXPC itself did not bind to tbe nickel-beads Oanes 1 and 2). In tbe presence 
of appropriate amounts of eitber rhHR23B-His or rhHR23A-His. however. 
rhXPC was co-precipitated almost completely Oanes 4 and 6). indicating tbat 
also rhHR23A is able to form a physical complex witb rhXPC. To compare tbe 
affinity of tbe two rhHR23 proteins for rhXPC. non-tagged rhHR23 proteins 
were included as a competitor in the binding reactions. "When equimolar 
amounts of non-tagged and His-tagged rhHR23B were incubated with 
rhXPC. about 50% of rhXPC was competed out from rhHR23B-His Oanes 7 
and 8). rhHR23A could compete for rhXPC-binding witb rhHR23B-His to a 
similar extent Oanes 9 and 10). indicating tbat botb rhHR23 proteins have 
comparable affinity for rhXPC. Since non-tagged rhHR23A was hardly co-
precipitated witb tbe rhXPC-rhHR23B-His complex (see lane 10). formation 
of a ternary complex involving rhXPC. rhHR23B and rhHR23A is unlikely. 
Instead. tbe two rhHR23 proteins bind to rhXPC in a competitive manner 
and. most likely. in a 1: 1 ratio. Essentially the same results were obtained 
witb rhHR23A-His Oanes 11-14). altbough slightly more rhXPC was 
competed out by non-tagged proteins when compared vvith rhHR23B-His. 
The reconstitution of rhXPC-rhHR23 complexes were further analyzed 
by sedimentation through glycerol gradients. As shown in Figure 4. free 
rhXPC (panel A) and free rhHR23B (panel B) sedimented witb peaks around 
5.65 and 2.55. respectively. When rhXPC was pre-bound to rhHR23B. tbe 
position of rhXPC peak was slightly shifted toward tbe bottom of tbe 
gradient. up to around 6.35 (panel C). This is largely consistent witb tbe 5 
value detennined for XPC-hHR23B complex purified from HeLa cells (6.25 in 
Ref. Masutani et al. 1994 and 6.15 in Ref. Shivji et al.1994). In tbe same 
gradlent. rhHR23B was divided into two peaks: one coinciding witb free 
rhHR23B. and tbe otber witb rhXPC. indicating formation of a physical 
complex between rhXPC and rhHR23B. Similar results were obtained witb 
rhXPC and rhHR23A as expected (see panels D and E). When tbe three 
recombinant proteins were pre-incubated. both rhHR23 proteins were found 
in complex forms (panel F). in agreement witb tbe results of co-precipitation 
experiments shown in Figure 3. 
To assess whether the complex is responsible for the XPC stimulation. 
tbe peak fractions of free rhXPC and rhXPC-rhHR23 complexes were assayed 
for repair activity. As shown in Figure 5A tbese three peak fractions 
contained a comparable concentration of rhXPC. When the same volume of 
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Figure 4. In vitro reconstitution of rhXPC-rhHR23 complexes. Indicated protein samples were 
fractionated through 15-35% glycerol density gradients as described in Experimental Procedures. For 
mixtures of rhXPC and rhHR23. the samples were pre-incubated on ice for 2 h before being loaded 
on the gradients. Five microliter of the indicated fractions were subjected to SD8-PAGE (6% 
acrylamide gel) and the presence of each protein was visualized by immunoblotting using antibodies 
raised against each protein. The amounts of proteins loaded on each gradient were 7.5 !& (rhXPC). 2 
~ (rhHR23B) and L 7 ~ (rhHR23A). Three marker proteins. egg white lysozyme (2.18). bovine serum 
albumin (BSA: 4.48) and yeast alcohol dehydrogenase (ADH; 7.48). were centrifuged through parallel 
gradients. and their peak positions are indicated. 
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Figure 5. Comple.x fonnatlon with rhHR23 enhances the rhXPC activity. (A) The amount of rhXPC in 
the glycerol density gradient peak fractions offree rhXPC (fraction 15 in Figure 4A). rbXPC-rhHR23B 
(fraction 17 in F1gure 4C) and rhXPC-rhHR23A (fraction 15 in Figure 4E) were compared by 
lmmunoblotting. (B) The three peak fractions used :In A were assayed for XP-C correcting activity in 
the reconstituted in vitro l';'ER system using xp-c eFlI and purtfied RPA After 90 min incubation at 
30oC. PCNA and lo:.32PldATP were added to be incubated for a further 15 min. Radioactivity 
incorporated in damaged (closed symboO and undamaged (open symboO plaSmids was quantified and 
depicted as a graph. (circle) free rhXPC: (triangle) rhXPC-rhHR23B: (square) rhXPC-rhHR23A (C) The 
amount of rhHR23B in the peak fraction of rhXPC-rhHR23B was quantified by immunoblottlng. (D) 
The glycerol density gradient peak fractions of free rhXPC and rhXPC-rhHR23B complcx were 
assayed in the presence of indicated amounts of rhHR23B under the same conditions as used in B. 
(solid bar) incorporation in damaged plaSmid: (open bar) incorporation in undamaged plasmid. In B 
and D. the mean values and standard errors were calculated from 2 to 4 independent experiments. 
these fractions was assayed. however. both of the complex fractions showed 
signlficantly higher NER activity than free rhXPC (Figure 5B). Thus the 
activity of rhXPC was enhanced by complex fonnation with rhHR23 proteins. 
As shown in F1gure 5C, I ~I of rhXPC-rhHR23B complex fraction contained 
3-10 ng ofrhHR23B. On the other hand, when rhHR23B was titrated in the 
presence of 1 ~I of free rhXPC fraction, apprOximately 10 times more (30-100 
ng) rhHR23B was needed to obtain maximal stimulation (Figure 5D), likely 
due to the fact that the efficiency of complex fonnation is dependent on the 
concentration of each component. As eA-pected. addition of 100 ng of 
rhHR23B did not further stimulate the activity of prefonned rhXPC-rhHR23B 
complex, although an excess of 1 ~ of rhHR23B markedly inhibited repair 
reactions. These data indicate that the presence of rhHR23B is not enough 
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but. instead. complex assembly between XPC and hHR23 proteins is required 
for the stimulation ofXPC activity. 
hHR23 proteins stimulate NER in an early stage of the reaction 
It has been previously shown that the XPC-hHR23B complex functions at or 
prior to incisions (Shhji et al.1994). When the XPC complex was included 
only in the second stage (Le. DNA repair synth~SiS stage). repair could be 
hardly detected. To determine which stages of NER are stimulated by hHR23 
proteins. two-stage NER reactions were carried out in the presence of free 
rhXPC. and rhHR23B was added at vartous time points. When rhHR23B was 
present only in the DNA repair synthesis stage. no stimulation was observed 
(compare lanes 6 and 7 in Fi"oure 6A). Furthermore. when rhHR23B was 
added at different time pOints in the first stage of the reaction. the level of 
DNA repair declined in proportion to incubation time before the addition of 
rhHR23B Uanes 2 to 5). Thus rhHR23B has to be present in the first stage of 
incubation to exhibit the XPC-stimulating activity. 
To see whether rhHR23B indeed stimulated NER at or prior to 
incision. DNA repair synthesis was uncoupled from the incision step. After 
the first incubation. DNA substrates were purified. and the amount of 
excised DNA damage was subsequently measured by filling the repair gaps 
with T4 DNA polymerase and radiolabeled dNTPs. As shown in Figure 6B. 
authentic XPC-hHR23B complex as well as reconstituted recombinant 
protem complex gave specific repair signals for damaged DNA (lanes 2 and 4) 
in an RPA-dependent manner Uane 3). Although free rhXPC gave some repair 
signal in this assay. co-addition of rhHR23B displayed clear stimulatory 
activity (compare lanes 5 and 6). These results thus demonstrate that 
hHR23B stimulates some early stages of the NER reaction before DNA repair 
synthesis. 
hHR23 proteins stimulate NER reconstituted with purified proteins 
It has been previously reported that damage-dependent incision reactions 
could be reconstituted in vitro with seven purified protein fractions: RP A 
XPA TFIIH. XPC-hHR23B. ERCCI-XPF. XPG. and incision factor 7 (IF7) 
(Aboussekhra et al. 1995). To test whether hHR23 proteins also show 
stimulatory activity in this defined NER system. activity of rhXPC was 
assessed in this system with or without rhHR23 proteins. In this experiment. 
UV-damaged and undamaged DNA substrates were first incubated with 
purified incision proteins. and then radioactive dATP and Klenow fragment 
were added to allow DNA repair synthesis. In the presence of appropriate 
amounts of other incision proteins. the authentic XPC-hHR23B complex gave 
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* • 
I • l: t 90 mIn t 15min 
XPCCFII PCNA HeLa XPC-hHR23B (45 n9) + + 
RPA [a.-"PJdNTP 
rhXPC mXPC-rhHR23B (GOG; 1 ""I) + 
rhXPC (GOG; 1 ""I) + + 
rhXPC {3~ n9) - + + + + + + 
rhHR23B (100 n9) 
time of rhHR23B 
addition (min) - 0 10 20 40 90 - RPA (125 "g) + + + + + + 
-_ ..... _---
-------AAF + 
-------
AAF 
+ 
-------
AAF 
+ -------
AAF + 
--GiillJ ____ _ 
234567 234567 
Figure 6. rhHR23B stimulates early stages of NER (A) In vftro :\"ER reactions were carried out with 
XP-C CFII (100 ~ protein) and RPA (125 ng) in the presence or absence of rhXPC (30 ng). After first 
stage reactions at 300 C for 90 min, PCNA (25 ng) and fc.c32PldATP (74 kBq) were added to be 
incubated further for 15 min. rhHR23B (43 ng) was added at various time points as indicated above 
each lane. Ethidium bromide stain and autoradiogram of the agarose gel are shown. (B) In vitro NER 
reactions were carried out in the presence of XP-C CFII and indicated purified protein fractions. After 
incubation at 300C for 90 rnin. DNAs were purtfied before being used for D~ synthesis reactions. 
The DNA synthesis reactions were performed at 370C for 15 min in mi'ctures (50 fll) containing 40 
mM Hepes-KOH (pH 7.8). 5 Il1;,V[ MgCh. 0.5 mM dithiothreitol. 20 ).lM each of dGTP. dCIP and dTIP. 
8 )lM !c;c-32PldATP (74 kBq). bovine serum albumin (18 pgl and T4 DNA polymerase (0.6 units: New 
England B1olabs). DXAs were purified again. digested With BamIiI, and then fractionated by agarose 
gel electrophoresis. 
a considerable repair signal (Figure 7. lane 9). Under the same conditions. 
rhXPC hardly supported repair reactions Oanes 2 and 3). but addition of 
either rhHR23B or rhHR23A resulted in strong stimulation of repair (Figure 
7. lanes 4. 7 and 8). These repair signals were completely dependent on the 
presence of TFIIH Oanes 5 and 10). confuming that the signals represented 
NER reactions. Agam. the co-addition of rhHR23A and rhHR23B failed to 
give a higher repair signal than that achieved by each single rhHR23 protein 
Oane 6). Finally. the clear effect of hHR23 proteins in the defined NER system 
made up of puIified NER components provides a strong argument against the 
theoretical possibility that the stimulation of hHR23 proteins was in fact due 
to titrating out inhibitory factor(s). 
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Figure 7. rhHR23 proteins stimulate defined NER reactions reconstituted with ptuified proteins. 
Plasmid DNA substrates (UV-damaged and undamaged) were incubated at 300C for 60 min in the 
presence of the indicated (+) purified NER proteins, Exo-free E.coli DNA polymerase I and k:c32PldA1P 
were added and incubation was continued at 300C for 10 min. DNA samples were purified. linearized 
with BamI-IT. and separated on a 1% agarose gel. A photograph of the ethidimn bromide stained gel 
and an autoradiogram of the gel are shown. The amounts of purified proteins used were: RPA (250 
ng), XPA (45 ng]. ERCCI-XPF (10 ng). TF1IH (150 ngJ.XPG (50 ng). IF7 (500 ngJ. The gel was e."q)osed 
to a Phosphorlmager (Molecular Dynamics) and the relative radioactivity incorporated in each band 
was quantified. (solid bars) incorporation in damaged. plasmid: (open bars) incorporation in 
undamaged plasmid. 
Discussion 
Functional interchangeability between the two RAD23 homologs 
In the accompanymg paper. a domain in hHR23B which is responsible for 
XPC-binding was determined (Masutani et aL 1997). This domain was shown 
to be required and even sufficient for stimulation of XPC repair activity in 
vitro. Because the amino acid sequence of this domain is well conserved 
between the two hHR23 proteins. it might be expected that hHR23A also 
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binds to XPC and stimulates repair activity. In agreement witb tbis. E.co/i-
""--pressed. highiy purified rhHR23A exhibits a similar XPC-stimulating 
activity as hHR23B [Figure 2). Furthermore. co-precipitation using His-
tagged rhHR23 proteins [Figure 3) and tbe sedimentation velocity 
experiments [Figure 4) demonstrated tbat botb rhHR23 proteins were 
capable of forming complexes witb rhXPC. This complex assembly could be 
observed without any other protein fractions or any incubation at relatively 
high temperature. indicating that special post-translational modifications. 
such as phosphmylation. of rhHR23 are not necessary for the binding itself. 
Moreover. neither an energy source such as ATP. nor a divalent cation was 
required. 
The competition eA-pertments shown in Figure 3 revealed that both 
rhHR23 proteins can bind to rhXPC witb comparable affinity under tbe 
conditions tested. Recently. possible interaction between XPC and hHR23A 
has been suggested using the yeast two hybIid system (Li et al. 1997). 
Furthennore. we have very recently detected trace amounts of hHR23A by 
immunoblotting in a highly purified XPC protein fraction from HeLa cells. 
indicating the existence of XPC-hHR23A complex in human cells (our 
unpublished results). Because tbe vast majority of XPC is bound to hHR23B. 
one might ""--pect tbat rhHR23B shows much higher affinity for rhXPC tban 
rhHR23A. This. however. turned out not to be the case. It is thus still unclear 
why most of XPC is bound to hHR23B. Altbough tbe content of hHR23B in 
the cells used seems to be higher than hHR23A the difference is not large 
enough to explain preferential binding of XPC to hHR23B (our unpublished 
observations). It is possible that specific modification of hHR23B increases its 
affinity for XPC or. alternatively. tbat auxilliary factors specifically target XPC 
to hHR23B. However. this is not absolutely necessary for the binding itself. 
as discussed above. Anotber possibility is tbat tbe subcellular locali7..ation of 
the two hHR23 proteins is different. We have recently shown by indirect 
immunofluorescence analysis that XPC as well as both hHR23 proteins are 
localized predominantly in tbe nucleus (van der Spek et al. 1996). From 
these eA"Periments. however. it was difficult to determine which fraction of 
these proteins is present in the cytoplasm. One possibility is that a minor 
amount of hHR23B is localized in tbe cytoplasm. and preferentially traps 
newly-s:ynthesized XPC protem before it is transported to the nucleus. 
Alternatively. tbe intranuclear locali7..ation of hHR23A and hHR23B may be 
different. Further studies are needed to answer these questions. 
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Importance of complex assembly for the XPC-stimulation by hHR23 
proteins 
The correlation between XPC-binding and NER stimulatory activity of various 
truncated rhHR23B proteins suggests that complex assembly is important 
for XPC-stimulation (Masutani et al. 1997). Here we demonstrate 
biochemically tbat complex assembly enhances tbe repalr activity of rhXPC. 
Because sedimentation :in glycerol gradients incompletely separates rhXPC-
rhHR23 complexes from free rhXPC. it was difficult to determine which 
proportion of rhXPC was complexed witb rhHR23s in each glycerol gradient. 
However. although not all rhXPC molecules may have formed complexes. we 
still observed a significantly higher activity of tbe comple.x fractions tban free 
rhXPC. Furthermore. when free rhXPC was assayed in the presence of 
variouS am.ounts of rhHR23B. a much higher concentration of rhHR23B was 
needed to obtain maximal stimulation. in comparison with amounts of 
rhHR23B present in tbe pre-assembled complex fractions (Figure 5C and D). 
Since tbe presence of higher concentrations of rhHR23B should make 
complex formation more efficient. these data also support the importance of 
complex assembly for tbe XPC-stimulation by hHR23 proteins. In addition. 
Figure 5D shows that the presence of a large excess of rhHR23B is inhibitory. 
Consequently. maximal stimulation is observed only wit.b.ill a certain range of 
rhHR23B doses. Thus careful titration of rhHR23B is necessary for observing 
tbe stimulatory effect by rhHR23B. 
Because the XPC-hHR23B complex was shown to function at an early 
stage of NER (Shi\ji et al.1994). it was of interest to determine which stage of 
NER is stimulated by hHR23 proteins. By carrying out DNA repalr syntbesis 
independentiy from inciSions, we demonstrate tbat tbe stimulation by hHR23 
proteins also takes place at or prior to incisions (Figure 6B). This part of the 
NER reaction still encompasses multiple steps: damage recognition. local 
melting of double-stranded DNA. dual incisions and removal of damage-
containing oligonucleotides. Yeast RAD23 protein has been previously 
clalmed (Guzder et al. 1995) to mediate physical interactions witb Rad14 as 
well as yeast TFIIH. raising a possibility tbat RAD23 promotes assembly of 
higher-order NER protein complexes. like "repairosomes" (Svejstrup et al. 
1995). However. similar interactions have not yet been established either in 
vivo or in vitro for hHR23 products and other mammalian NER proteins. 
Further studies are warranted to pinpoint tbe NER steps in which tbe hHR23 
products exert tbeir function(s). 
Stimulation by rhHR23s in the defined NER system 
Our rhHR23 proteins showed XPC-stimulating activity also in tbe defined 
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NER system reconstituted With purified proteins. which was described by 
Aboussekhra et al. (1995). Although some of the repalr proteins (Le. 1F7. 
ERCCI-XPF and TFIIH) used in these eAl'erlments were not purified to 
complete homogeneity, these observations strongly argue agamst a formal 
possibility that rhHR23s stimulate NER reactions indirectly. e.g. by titrating 
out some inhibitors present in crude fractions. 
The results of the two reconstituted NER systems using XP-C CFII 
(Figure 2) and the purified proteins (Figure 7) were qUalitatively similar. but 
we noted some quantitative differences as well. For instance, free rhXPC 
always exhibited some activity when added to the XP-C CFII. whereas the 
same amount of rhXPC hardly supported repalr in the defined NER system 
(compare lanes 2 and 3. in Figs. 3 and 7). Consequently. the stimulation by 
rhHR23s appeared to be mOTe pronounced in the defined NER reaction. One 
possible explanation is that the XP-C CFII used in these studles stili contains 
a trace amount of endogenous hHR23B and/or hHR23A Alternatively. some 
repair proteins might be present as higher-order complexes in the CFII 
fractions. whereas all repair proteins should be free at the beginning of the 
defined NER reactions. If hHR23 proteins promote such supercomplex 
assembly by itself or via change in a conformation of XPC. the defined system 
should be much more dependent on the presence of hHR23. Another 
possibility is that hHR23 proteins physicaliy stabilize XPC via complex 
formation. In the defined NER system which contains much lower protein 
concentrations compared to the crude system. free rhXPC might be more 
labile and thus depend more on the stabilizing effect of hHR23. 
Generally. setting up defined reaction systems composed of multiple 
purified proteins needs special care: rate-limiting factors depend on the 
precise ratio of the different purified proteins used. Therefore. to determine 
the activity of XPC protein. it is important to set up reactions where XPC is 
rate-limiting. Recently Reardon et al. have reported (Reardon et al. 1996) that 
rhHR23B had no stimulatory effect in their reconstituted NER system. There 
are Significant differences between the two reaction systems: one detects 
repair DNA synthesis on randomly damaged plasmid DNA whereas the other 
detects dual incision on a singly-damaged DNA substrate. Moreover. our 
defined NER system requires an extra protein fraction designated 1F7. which 
seems to be dispensable in the other system. Therefore. the discrepancy 
concerning the stimulation by rhHR23B could be athibuted to some intrinsiC 
differences between the two repair systems. including differences in quality of 
purified proteins used. As discussed above. however. stimulation of XPC 
might also be overlooked especialiy in defined NER systems. unless all 
components are carefully titrated to set up conditions under which XPC is 
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rate-limiting. It is also important to carefully titrate rhHR23B. because a 
large excess ofrhHR23B turned out to be inhibitory (Figure 5D). 
We are generating lmock-out mice of mHR23B as well as mHR23A. 
Because no natural mutant has been so far available for mammalian RAD23 
homologs. these knock-out mice and the derived mutant cells should give 
important clues to elucidate in vivo functions of this set of genes. Analysis of 
these mice is expected to give more definite answers to the current issues 
concerning the roles and possible functional redundancy of mammalian 
RAD23 homologs in NER and will complement the findings made in in vitro 
studies. 
Experimental Procedures 
Purification of repair proteins 
Recombinant human XPC protem was e:...-pressed in an insect cell line. Sf9. by a baculovirus 
e."<Pression system. and purtfied as described previously (Sugasawa et al. 1996). Non-tagged and His-
tagged versions of recombinant hHR23A and hHR23B proteins were e;.. .. pressed in E.coU and pulified 
as described in the accompanying paper (Masutani et al. 1997). Recombinant human proliferating 
cell nuclear antigen (PCNAJ was purified from E.coU BL21(DE3) harboring p17-PCNA plasmid (a 
generous gift from Dr. B. Stillman; Cold SpIing Harbor Laboratory) as described (Fien and Stillman 
1992). The final Phenyl Sepharose fractions were further loaded on an FPLC Mono 9 HRS/5 column 
equilibrated with buffer A (25 mi\1 Tris-HCI (PH 7.5), 1 roM EDTA 10% glycerol. 0,01% Triton X-IOO, 
1 mM dithiothre:itol. 0.1 mM phenylmethylsulfonyl fluortde (PMSFl] containing 0.2 M NaCl. and 
eluted With 15 ml of 0.2 to 0.7 M NaCI gradient in buffer A Peak fractions were stored at -80oC. 
Human replication protein A (RPAJ was also purified from recombinant sources using E.coU 
BL21(DE3) pLysS transformed with plld-tRPA (kindJy provided by Dr. M. Wold: DIllV. Iowa) as 
described (Hendricksen et al 1994). ERCCI-XPF complex was purified from Chinese hamster group 
1 mutant cells (43-3B) transfected with His-tagged human ERCC 1 as described previously (Sijbers et 
al. 1996). XPA. XPG. TFllH and IF? were purified as descrtbed (Aboussekhra et al 1995: Gerard et al. 
1991). As for TFllH. the fractions from the second heparin column were used for the reconstituted 
l';.'ER reactions (Hwang et al. 1996). 
Preparation and fractionation of whole cell extracts 
Lyrnphoblastold cells (GM2248B) from an XP-C patient (XP3BE) were grown In suspension with 
RPMIl640 medium containing 15% fetal calf serum and 20 roM Hepes-NaOH (PH 7.3). \\Thole cell 
extracts were prepared as described previously (Manley et al 1980: Wood et al. 1988). For 
fractionation. whole cell e.'\..tracts (-50 mg protein) were loaded onto a phosphocellulose column (cp1.2 
x 8 em) equilibrated With buffer B [25 mM Hepes-KOH (PH 7.8), 1 mM EDTA 10% glycerol. 0.01% 
Nonidet P-40, 1 mi\1 dithiothre:itol. 0.1 roM PM8Fj containing 0.1 M KCL After an e.'ctensive wash with 
the same buffer. bound proteins were eluted with buffer B containing 1 M KCl The peak fractions 
were pooled and dialyzed overnight against buffer containing 25 roM Hepes-KOH (PH 7.9), 0.1 M KCl. 
12 mM MgCb 1 mi\1 EDTA 10% glycerol. 20% sucrose and 1 roM dithiothreitoL Insoluble material 
was removed by centrifugation and the resulting supernatant fraction (column fraction II: CFII) was 
stored at -8QoC. 
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In vitro NER reactions 
Standard reaction mi'\.iures for in vitro l\'ER (50 !-tl) contained the follOWing components: 40 mM 
Hepes-KOH (pH 7.81. 7 mM :Y[gCkl. 70 mM KCI. 6.8% glycerol. 0.5 mM dithiothreitoL 2 mM ATP. 20 
).1M each of dGTP. dCTP and dTIP. 8 J.lM dATP. 23 mM phosphocreatine. 2.5 ~ of creatine 
phosphokinase. 18 ~ of bovine serum alb-wnin. 250 ng each of plasmid D:-;rA substrates. pBlue..<;cript 
n KS+ [AAF(N-acetyl-2-aminofluorene)- or UV-damaged] and pHM14 (undamaged)]. and indicated 
amounts of fractionated cell exiracts and/or purified NER proteins. After incubation performed at 
300 C for the indicated time period. 25 ng of PCNA and 74 kBq of rc/1»dATP (Amersham: -110 
TBq/mmol) were added and further incubated at 300C for 15 min. For reconstituted }..""ER reactions 
with purified proteins, e\:o-free E-coU DNA polymerase I (0.025 unit; United States Biochemical) was 
used to carry out gap filling of DNA inCised by the mammalian incision proteins. 
Glycerol gradient velocity sedimentation 
Stepwise glycerol gradients were made in polyallomer ultracentrifuge tubes (for SW60 rotor: 
Beckman) by overlaying 340 ).11 each of ll-step glycerol solution (from 35% to 15%: 2% decrease by 
each step) in buffer C [25 mM Tris-HCI (PH 7.5). 1 roM EDTA 0.3).1 KaCl. 0.05% Nonidet P-40. 1 
roM dithiothreitol. 0.1 roM PMSFj. The gradients were incubated overnight at 4 0C before loadlng 
samples. Protein samples were put in 50 III of buffer C containing 10% glycerol and incubated at 40C 
for 2 h. Mer loading samples, the gradients were centrifuged at 2t>C for 64 h at 49.000 rpm 
(Beckman: SW60 rotor). Fractions (160 Ill) were taken from the top of the gradients. As marker 
proteins. egg white lysozyme (2.1S: 30 ~. bovine serum albumin (4.43: 27 ~ and yeast alcohol 
dehydrogenase (7AS: 40 ~ were loaded on parallel gradients and fractionated e'mctIy as described 
above. Positions of the marker proteins were determined by SDS-PAGE followed by Coomassie 
Brilliant Blue staining. 
Other methods 
rhXPC binding assay was earned out as described (Masutani et al. 1997). SDS polyacrylamide gel 
electrophoresis (SDS-PAGE) was performed as described by Laemmli (1970). For lnununoblotting. 
proteins separated on SDS gels were electrotransferred onto nitrocellulose membrane (Schleicher & 
Schuell: BASS) at 5 V/cm overnight in blot buffer (25 roM Trts. 193 roM glycine. 0.01% SDS. 15% 
methanol). XPC. hHR23A and hHR23B proteins were detected using affinity-purified rabbit polyclonal 
antIbodies raised against each protein and alkaline phosphatase-conjugated anti-rabbit IgG. Protein 
concentration was determined according to the method of Bradford (Bradford 1976). using Coomassie 
protein assay reagent (Pierce) and bOvine serum albumln as a standard. 
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Summary 
The XPC-HR23B complex is specifically involved in global genome but not in 
transcrtption-coupled nucleotide excision repair (NER). Its function is 
unlmown. Using a novel DNA damage recognition-competition assay. we 
identified XPC-HR23B as tbe very first damage detector. initiating NER: it 
acts before tbe !mown damage-binding protein XPA Co-immunoprecipitation 
and DNase I footprinting show tbat XPC-HR23B binds to a variety of NER 
lesions. These results resolve tbe function of XPC-HR23B. define tbe first 
NER stages. and suggest a two-step mechanism of damage recognition 
involving damage detection by XPC-HR23B followed by damage verification 
by XPA This provides a plausible explanation for tbe eAtreme damage 
specificity exhibited by global genome repair. In analogy. in tbe transcrtption-
coupled NER subpatbway RNA polymerase II may take tbe role of XPC. After 
this initial subpathway-specific lesion detection. XPA may function as a 
common damage verifier and adaptor to the core of the NER apparatus. 
Introduction 
Fundamental problems are associated witb tbe chemical vulnerability of DNA 
as the carrier of genetic information. A myliad of lesions in DNA is caused by 
intrinsic instability of chemical bonds and by ubiquitous environmental or 
endogenous genotoxic agents. DNA damage interferes with the pIimary DNA 
functions including transcription and replication. which can lead to acute 
cell death. In addition. many DNA damaging agents are also mutagens. The 
biological consequences of mutations and persisting lesions range from the 
onset of carcinogenesis. genetic disorders. and apoptosis to general cell 
malfunctioning that may contribute to aging. To cope with these problems. 
an elaborate cellular defence nernrork has arisen early in evolution, 
encompassing sophisticated complementary repair pathways and cell cycle 
chech-points. Nucleotide excision repair (NER) is one of the most versatile and 
best studied DNA repair systems. which eliminates a wide variety of DNA 
damage (Friedberg et al. 1995). Two in part overlapping NER subpatbways 
have been discerned. One process called 'global genome repair' (GGR) 
operates genome-wide and is able to eliminate NER lesions from aJllocations 
in the genome at any moment in the cell cycle. For some types of DNA 
damage [e.g. UV-induced pyrimidine (6-4) pyrimidone photoproducts (6-
4PPs)] this process is very fast and efficient. but for otbers [e.g. UV-induced 
cyclobutane pyrimidine dImers (CPDs)j it is much slower and less effiCient 
(Mitchell 1988). Probably because tbe latter type of lesions obstruct 
transcription for a too long period of time. an additional repair system has 
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evolved designated 'transcription-coupled repair' [TCR). This process ensures 
rapid and efficient clearance of the transcribed strand of active genes from 
elongation-blocking lesions (Bohr et al. 1985: Mellon et al. 1987: Selby and 
Sancar 1993). Thus. TCR is an important back-up system for the removal of 
lesions from active parts of the genome, for which the GGR process is too 
slow. 
Several rare. autosomal recessive human disorders are associated vvith 
impaired NER activity. These include xeroderma pigmentosum (XP). 
Cockayne syndrome (CS) and trichotbiodystrophy CTTD). all of which are 
characterized by sun (UV) hypersensitivity and marked genetical 
heterogeneity. Cell fusion studies have revealed a large number of genetic 
complementation groups within these disorders: XP-A to XP-G. CS-A. CS-B. 
and 1TD-A reflecting different NER genes. These mutants as well as a series 
of laboratory-generated UV-sensitive hamster cell lines have been a valuable 
asset for delineating the biological consequences of NER deficiency and for 
cloning the complementing genes (Bootsma et al. 1998). \iVhile the protein 
products corresponding to some of these NER genes have been identified. 
mammalian cell-free systems accomplishlng NER have been dissected 
extenSively (for recent reviews. see Sancar 1996: Wood 1996). Synergistic 
progress using the genetical and biochemical approaches culminated in the 
recent reconstitution of in vitro NER Vlith purified protein factors 
(Aboussekhra et al. 1995: Mu et al. 1995). The NER reaction up to the 
asymmetric inciSions requires at least Six protein factors: XPA XPC-HR23B. 
ERCCI-XPF. XPG. transcription factor lill (1FIIH). and replication protein A 
(RPAJ. Despite the identification of individual NER components. the precise 
reaction mechanism including the crucial damage recognition step has not 
yet been firmly established. The GGR process in particular faces the 
enormous task to continually survey 5 x 109 bp DNA for trace amounts of a 
diverSity of leSions. Although XPA has been shown to bind a variety of 
damaged DNAs (Jones and Wood 1993: Asahina et al. 1994) and is 
implicated in tbis key NER event. it remains unclear whether XPA can fully 
account for the lesion specificity required in vivo. 
In XP-C patients. unlike other NER-deficient complementation groups. 
only the process of GGR but not of TCR is impaired (Venema et al. 1990: 
Venema et al. 1991). Transfection with a human cDNA expression library 
resulted in isolation of a partial XPC cDNA which corrects UV-sensitivity of 
XP-C mutant cells (Legerski and Peterson 1992). Using in vitro NER 
complementation assays. a protein complex containing the XPC gene product 
was purifted (Masutani et al. 1994: Shivji et al. 1994). The XPC protein was 
found to be tightly complexed with HR23B. one of two mammallan homologs 
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Figure 1. A schematic representation of the damage recognition-competition assay. (A) The earliest 
events of the normal NER process is depicted in a simplified hypothetical modeL (B) In vitrO damage 
recognitlon-competitlon assay using two damaged DNAs. See tc:Ai: for details. 
of Saccharomyces cerevisiae NER factor RAD23. Although the XPC-HR23B 
complex displays a high affinity for both single- and double-stranded DNA 
(Masutani et al. 1994: Shivji et al. 1994: Reardon et al. 1996). its function in 
GGR has remained enigmatic. In the present study_ we address the stage at 
which XPC-HR23B operates. and resolve the function of this GGR-specific 
NER factor. which has important implications for the crucial mechanism for 
damage detection. not only in GGR but also in TCR 
Results 
Competitive in vitro NER assay using two damaged DNA substrates 
To examine at which stage XPC-HR23B functions in NER we designed a 
competition assay using two damaged DNA substrates. outlined in Figure 1. 
Ordered assembly of the NER machinery includes as the first step 
identification of a lesion accomplished by hypothetical factor 'I\:. This is then 
followed by sequential entry of other NER factors (symbolized as 'B' and 'C') 
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Figure 2. Specificity of fractionated XP cell eJ...1:racts utilized in the present studies. (A) A scheme for 
phosphocellulose fractionation of whole cell o..1:racts. (B) The purified human XPC-HR23B protein 
complex and the mouse XPA protein were subjected to 8DS polyacrylamide gel electrophoresis. 
Proteins were visualized by silver staining (xpC-HR23B) or by Coomassie Brilliant Blue staining 
(XPA). (e and D) A mixture of AAF-darnaged and non-damaged DNAs was incubated at 30Ge for 60 
min with eFTI from XP cells and purified proteins as indicated, under the standard conditions for in 
vitro NER reaction. All reactions contained 100 p.g of CFII fractions in total. Amounts of purified 
proteins used were 45 ng for XPC-HR23B, 20 ng for XPA and 125 ng for RPA. DNA was purified from 
each reaction, and then the repair gaps were filled by T4 DNA polymerase in the presence of [0-
32PJdNTP. The DNA samples were linearized and subjected to agarose gel electrophoresis followed by 
autoradiography. 
involved ill processing of the DNA substrate leading to dual incision of the 
damaged strand (Figure IA). When two damaged DNA molecules are 
separately allowed to react with limiting amounts of 'B' resp. 'A', only the 'A-
bound DNA' is initially processed further when both DNA molecules are 
mixed and supplemented with the remaining NER factors (Figure IB). 
Although, for this scheme, the initial complex involving 'A' and a lesion has to 
be sufficiently stable to sequester most of 'A' molecules, the appearance of 
preferential repair of one of the pre-incubated DNAs provides infonnation on 
the order of factors required in the NER reaction. 
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For the pre-incubation of the different damaged DNA substrates in the 
absence of specific NER factors. we prepared whole cell extracts of different 
XP cells. each lacking a !mown NER lXP) factor. which were fractionated over 
phosphocellulose. The phosphocellulose-bound protein fraction (column 
fraction II: CFm contains all essential NER factors required up to the incision 
stage. except for RPA (Shivji et al. 1992. see also Figure 2A). For the 
subsequent gap filling repair synthesis, proliferating cell nuclear antigen 
(PCNA) is required that is also missing from CFII (Shivji et al. 1992). Thus 
incubation of damaged DNA in the presence of CFII and added RPA (but not 
peNAl results in dual inCisions around lesions and accumulation of repair 
gaps. but not repair synthesis. After purifYing the DNA substrates. a measure 
for the number of excised lesions can be obtained by filling the gaps \Vith T4 
DNA polymerase and radioactive dNTP. As e>.:pected. in the presence of 
exogenous RPA. CFII from XP-C cells [designated CFIIlXPCll requires extra 
addition of XPC-HR23B to accomplish inCisions (Figure 2C: lanes 1 and 2). 
Analogously. intact recombinant mouse XPA protein complemented the 
defect of incision activity of CFIIlXPAl (lanes 4 and 5). The purity of the 
purified proteins utilized is documented in Figure 2B. Complementation 
could be also observed when the two CFlIs were mixed in the presence ofRPA 
(Figure 2D). The addition of XPA to CFIIlXPCl (Figure 2C: lane 3) or the 
addition of XPC-HR23B to CFIIlXP A l (lane 6) resulted in only a background 
level of dNTP incorporation. These data indicate that the purified XPA and 
XPC-HR23B proteins are active and demonstrate the specificity of our 
mutant CFII preparations. These fractionated extracts and purified proteins 
were used throughout this study. 
Competition between XPA and XPC-HR23B 
To distinguish two damaged DNA substrates in in vitro NER reactions. closed 
circular plasmid DNAs of different Sizes were treated separately with the 
same concentration of N-acetoxy-2-acetyl-aminofluorene (AAF). malnly 
inducing N-(guanine-3-yl)-AAF adducts that are !mown substrates of NER 
One of the AAF-damaged DNA (DD-D was first incubated with CFIIlXPCl. 
while the other (DD-m was with CFIIlXPAl. These two mixtures were then 
combined. and supplemented mth RP A to obtain a complete set of inCision 
factors. Non-damaged DNA (ND) was also included as an internal controL 
The mixture was further incubated for various time periods to examine the 
time course of incision reactions on each of the damaged DNAs. 
Unexpectedly. Figure 3 shows that DD-II. which was pre-incubated with 
CFIIlXPAl. was preferentially repalred compared to DD-J Oanes 5-3). 
Exchange of the two damaged DNAs [Le. pre-incubation of DD-J with 
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Figure 3. Competitive NER assay using CFIIs from XP-A ruld XP-C mutant cells. (AJ T\vo AAF-
damaged DNAs (DD-I and DD-II) were separately pre-incubated at 300 C for 15 min \Vith the indicated 
protein fractions. After the two reactions were combined, non-damaged DNA (ND) and indicated 
protein fractions were added. Amounts of protein fractions used were 400 p.g for each CFII and 250 
ng for RPA. .Aliquots of the mi'rtUres were further incubated at 300C for the indicated periods of time. 
Repair gaps generated during the second incubations were filled with T4 DNA polymerase and [a-
32PJdNTP. The DNA samples were linearized and fractionated by agarose gel electrophoresis. A 
photograph of the ethidium bromide-stained gel and the corresponding autoradiogram are shown. (B) 
DNA repair synthesis in each damaged DNA was quantitated. Radioactivity incorporated into ND was 
subtracted as a background from that in damaged DNA bands at each time point. The resulting 
values were further subtracted by those at the time point of 0 min, and plotted as a time course. 
Closed circles, DNA repair synthesis in DD-I: open circles, DD-II. 
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CFII(XPA) and DD-II with CFII(XPCll resulted in a reversed repair bias (lanes 
9-121. in both cases. the damaged DNA pre-incubated with CFII(xpC-I was 
hardly repaired during the initial 15 min incubation (see Figure SB). 
Furthermore. in a control incubation. we added RPA as well as both 
CFII(xpAl and CFII(xpCl after the two damaged DNAs were mixed. so that 
all NER factors were equally available for the two damaged DNAs. Under 
these conditions. both damaged DNAs were repaired as expected (lanes 1-4). 
These data indicate that the two damaged DNAs were practically equivalent 
as substrates for in vitro NER and consequently that the repair biases 
observed were intrinsic to the CFII fractions. 
If XPA binding is the first lesion recognition event which then leads to 
assembly of all the other NER factors. one can expect that the damaged DNA 
pre-incubated in the presence of XPA is repaired preferentially. However. the 
opposite result is found supporting the idea that XPC-HR2SB functions at an 
earlier stage than XPA It has been reported that interaction with RPA 
potentiates damage-binding activity ofXPA (He et al. 19951. Because virtually 
all endogenous RPA was removed during phosphocellulose fractionation. 
eA"tra addition of RP A could be necessary for endogenous XP A in the 
CFII(xpCl to bind lesions stably. Therefore. we tested whether the presence 
of RPA during the pre-incubation influenced the observed repair bias. 
However. supplementing CFII(xpCl with purified RPA during the pre-
incubation did not alter the repair preference caused by CFlI(xpAl (Figure S. 
lanes IS-16). Thus. the XPC-HR2SB-containing CFII(xpAl appears to focus 
repair to the damage above the XPA-containing CFII(xpCl regardless of the 
presence or absence of RPA during pre-incubation. 
XPC-HR23B is sequestered by damaged DNA and this induces targeted 
repair 
The previous experhnents do not exclude the possibility that other NER 
factors present in the CFII(xp A l are necessary even prior to XPC-HR2SB for 
directing the repair machinery to the damaged DNA. To examine whether the 
XPC-HR2SB complex alone is suffiCient to induce the repair bias. DD-I was 
pre-incubated with purified XPC-HR2SB. while DD-II was without any 
proteins. After combining the two reaction mixtures. CFII(xpCl and RPA 
were added to complete the NER incision machinery. As shown in Figure 4A 
(lanes 5-8). DD-1. which was pre-incubated with XPC-HR2SB. was repaired 
better than DD-II. Addition of both CFII(xpCl and purified XPC-HR2SB after 
mixing the two damaged DNAs. resulted in the absence of any repair bias. as 
expected (lanes 1-4). Since the XPC-HR2SB fraction used was highly purified 
as shown in Figure 2B (see also Masutani et al. 1994). it is unlikely that the 
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Figure 4. Competition between XPC-HR23B and XPA (A. c and E) 1\\'0 AAF-damaged DNAs (DD-! 
and DD-m or. for lanes 9-12 in panel A. non-damaged version of pBS.XPC- (designated 'ND') were 
separately pte-incubated at 300C for 15 min with inclicated protem fractions. The two reactions were 
combined. supplemented with indicated protein fractions as well as non-damaged pHMJ4 control 
(ND). and further incubated for various periods of time as indicated. Amounts of protem fractions 
used were 400 ~ for each CFII. 90 ng for XPC-HR23B. 40 ng for XPA and 250 ng for RPA Repair 
gaps created in each damaged DNAs were labeled by T4 DNA polymerase. DNA samples were 
linearized and subjected to agarose gel electrophoresis followed by autoradiography. (E. D and F) 
Radioactivity incorporated in each band in panels A C and E was quantitated. DNA repair synthesis 
occurring in each damaged DNA was calculated as done for Figure 3B and depicted as graphs. 
Closed symbols represent repair of DO-I. wMe open symbols represent repair of DD-II. Closed Circles. 
open circles: lanes 1-4: Closed triangles, open triangles: lanes 5-8: Closed squares. open squares: 
lanes 9-12. 
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presence of minor proteins contaminating the XPC-HR23B was responsible 
for generation of this repair bias. Furthennore, recombinant XPC-HR23B 
complex (Sugasawa et al. 1997) was also capable of inducing a similar repair 
bias (data not shown). Thus the preferential repair of damaged DNA can be 
induced by pre-incubation with XPC-HR23B alone. Compared to the control 
incubations (lanes 1-4), the initial repair rate of DD-I was stimulated around 
2-fold by pre-incubation with XPC-HR23B, while, conversely, repair of DD-II 
was significantly inhibited (Figure 4B). Because all the other NER proteins 
should be available for both damaged DNAs, this repair bias appears to be 
due to sequestration of XPC-HR23B upon pre-incubation 'with DD-I. 
Interestingly, in contrast to damaged DD-I, pre-incubation vvith non-damaged 
DNA was unable to reduce subsequent repair of DD-II (Figure 4A and B; 
lanes 9-12). The above findings show that DNA damage is required for 
sequestration of XPC-HR23B. Furthermore, during the first 7.S-min 
incubation, the repair of DD-II was already comparable with that of damaged 
DNA which was allowed to be pre-incubated with XPC-HR23B (compare lanes 
6 and 10 in Figure 4A, and see also Figure 4B), indicating that the 
sequestration by damaged DNA must be a rapid process. 
Similar experiments were carried out with purified XPA and CFII(XPA). 
In marked contrast to the pre-incubation with XPC-HR23B, little repair bias 
was observed when one of the damaged DNAs was pre-incubated vvith 
purified XPA (Figure 4C and D; compare lanes 5-8 with lanes 1-4). We also 
included RPA together with XPA in the pre-incubation, but it failed to cause 
any preferential repair ~anes 9-12). To investigate the possibility that the 
absence of a repair bias was due to XPA being present in excess over the 
number of available lesions in DD-I (and thus still able to bind DD-II after 
mixing), we perfonned XPA down titration experiments. When the amount of 
XPA was reduced to 25 and 50%, no repair bias emerged while total repair of 
both damaged DNAs was equally suppressed in proportion to the XPA 
amounts included (data not shown). Apparently, XPA was not stably 
sequestered by damaged DNA during the pre-incubation, regardless of the 
presence or absence ofRPA. 
Although XPA-RPA was not capable of inducing preferential repair, it is 
not excluded that other combinations of NER factors would have been able to 
reverse the XPC-HR23B-induced preferential repair. To examine this 
possibility, DD-II was pre-incubated with purified XPC-HR23B, while DD-I 
was with CFII(XPC-) and RPA (i.e. containing all the other NER factors). Upon 
combination of the two mixtures, initial repair still occurred exclusively in 
DD-II bound to XPC-HR23B (Figure 4E and F; lanes 1-4). Thus the 
sequestration of XPC-HR23B could not be alleviated by damaged DNA pre-
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Figure 5. XPC-HR23B preferentiaJ1y binds to damaged DNAs. (AI A mi'\."ture of pBS.XPCb (non-
damaged or damaged 'With various agents as indicated) and non-damaged pHM14 (200 ng each) was 
incubated in the presence (+) or absence H of 20 ng of XPC-HR23B. AffinitY'-purified anti-XPC 
polyclonal antibodies (0.5 p.g} were added and precipitated with protein A-Sepharose beads. DNAs in 
the supernatant (unbound) and precipitate (bound) fractions were purified. linearized and 
fractionated by agarose gel electrophoresis. The DNAs were transferred onto nylon membrane and 
visualized by hybridization to 32P-Iabeled pBKS sequence. IB) The percentages of DNA recovered in 
the bound fractions were quantitated for kmes 2, 4, 6 and 8 in panel A. The mean values and 
standard errors were calculated from !\vo independent experiments. Solid bars, pBS.xPC6; shaded 
bars, pHM14. Ie) A rn..D.."ture of 200 ng of non-damaged pHM14 and varying amounts of AAF-damaged 
pBS.XPC6 was incubated with 20 ng of XPC-HR23B, and then immunoprecipitated with anti-XPC 
antibodies. Linearized DNAs in unbound and bound fractions were subjected to agarose gel 
electrophoresis followed by Southern blot analysis as done in panel A. ID} Quantitation of the result 
in panel C. The mean values and standard errors were calculated from !\vo independent e."<Periments. 
(closed circles) AAF-damaged DNA: (closed squares) non-damaged DNA. 
incubated 'With an the other NER proteins: the incision events appeared to be 
focused on the damaged DNA to which XPC-HR23B was bound. On the other 
hand, DD-II was pre-incubated with purified XPA and RPA, while DD-I was 
with CFII(xpA') (i.e. containing XPC-HR23B). In this case, DD-I was repaired 
better than DD-II, as eAl'ected Oanes 5-8). 
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XPC-HR23B is a damage-specific DNA binding protein 
The above results strongly suggest tbat XPC-HR23B first binds to DNA 
lesions and initiates assembly of pre-incision complexes. Altbough XPC-
HR23B has been shown to possess DNA-binding activity, its preference for 
DNA damage has not yet been documented. Therefore. we examined the 
damage-specificity of DNA-binding of XPC-HR23B using tbe same substrates 
as used in tbe above ""l'eriments. Closed circular plasmid DNA substrates 
witb or witbout AAF-damage were incubated witb XPC-HR23B, which was 
subsequently precipitated using anti-XPC antibodies. Coprecipitated DNA 
was purtfied. fractionated on agarose gels. and visualized by Southern blot 
hybridization. 'When a mi:>...'ture of AAF-darnaged and non-damaged DNAs was 
used, tbe damaged DNA was coprecipitated witb anti-XPC antibodies almost 
exclusively (Figure 5A lane 4: see also tbe quantitative data in Figure 5B). 
This coprecipitation was completely abolished by omission of XPC-HR23B 
from tbe binding reaction (lane 3), indicating tbat tbe DNA was precipitated 
via binding to XPC-HR23B. When tbe AAF-damaged DNA was replaced by its 
non-damaged version. XPC-HR23B was bound to both non-damaged DNAs 
(lanes 1 and 2), Similar preference of XPC-HR23B for damaged DNA was 
observed, when tbe DNA was damaged by UV (lanes 5 and 6) or cisplatin 
(lanes 7 and 8) instead of AAF. These results indicate tbat XPC-HR23B can 
bind to DNA even in tbe absence oflesions and tbat. when DNA is damaged, 
XPC-HR23B is recruited to lesions in a specific manner. Moreover. the 
damage-specific binding properties of XPC-HR23B are not a peculiarity 
limited to AAF damage. but ex.iend to other lesions that are knmvn NER 
substrates. To obtain some quantitative impression of the damage 
preference. a fixed amount (200 ng) of non-damaged DNA was incubated 
with increasing quantities of AAF-treated DNA in the presence ofXPC-HR23B 
(20 ng: Figure 5C and D). In tbe absence of damage. in steady state 25-30% 
oftbe input non-damaged DNA was bound by XPC-HR23B (lane 1). However. 
in tbe presence of AAF-damaged DNA at one-tentb tbe amount (under tbese 
conditions. DNA lesions are still in excess over the XPC molecules). more 
tban half of XPC-HR23B was competed away from tbe non-damaged DNA 
(lane 4). Thus. tbe apparant affinity ofXPC-HR23B is at least 10 times higher 
for tbe AAF-damaged DNA tban for tbe non-damaged DNA 
To examine whetber XPC-HR23B binds directly to DNA damages. 
DNase I footprinting expertments were carried out. For this purpose, we 
prepared specific DNA substrates containing a positioned 6-4PP CF\,"Ure 6A), 
When tbe 3'-end of tbe damaged strand was labeled and pre-incubated witb 
an increasing amount of XPC-HR23B. a region spanning 15 nucleotides 5' 
and 20 nucleotides 3' of tbe lesion was found protected from digestion by 
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Figure 6. Footprint analysis of XPC-HR23B bound to a UV-induced 64PP. (A) Defined DNA 
substrate containing a single 6-4PP. Sequences of the oligonucleotides used for subsirate preparation 
for DNase I footprinting assays are shoVlIl by boldfaced letters. (B and C) Protection of 6-4PPs against 
DNase I digestion by XPC-HR23B. DNA fragments containing a site-specific 6-4PP were 3'-labeled at 
the Acc651 site for the damaged (top) strand (panel B) or at the BstXI site for the non-damaged 
(bottom) strand (panel C). The labeled DNA fragments were incubated with or without increasing 
amounts of XPC-HR23B. and then briefly digested by DNase I (or mock-digested). The amounts of 
XPC-HR23B used were 5 ng (lanes 3 and 8), 10 ng (lanes 4 and 9) and 20 ng (lrules 5 and 10). As 
markers, the 'G' Maxam-Gilbert sequence ladders were prepared from the same labeled DNA 
fragments and electrophoresed alongside. The 6-4PP itself is sensitive to piperidine cleavage and gave 
heav:y bands in the Ma-xam-Gilbert ladders (indicated by asterisks in panel B). In all panels, regions 
protected and cleavage enhanced by XPC-HR23B binding are indicated by solid lines and arrows, 
respectively. Arrowheads denote sites accessible to DNase I within the protected regions. 
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DNase J (Figure 6B). Protection by the XPC-HR23B complex was also 
observed for the non-damaged strand with bound stretches of 17-18 
nucleotides on both sides of the injury (Figure 6C). Several phosphodiester 
bonds within the protected region remained still accessible to DNase I. 
Particularly, a couple of cleavage sites in the damaged strand located 8-10 
nucleotides 5' of the lesion were weakly enhanced as a result of XPC-HR23B 
binding. Control DNA substrates lacking damage failed to display any specific 
protection patterns, indicating damage-specificity of XPC-HR23B binding. 
Our findings identify the XPC-HR23B complex as a novel damage 
binding factor. The damage-dependent sequestration of XPC-HR23B observed 
in Figure 4 is most likely due to its direct binding to the lesion. If any other 
combination of NER factors would still be earlier in the NER reaction 
recruiting XPC-HR23B, we would have observed a reversed repair bias than 
actually found in Figure 4E Oanes 1-4) where DD-J was incubated with all 
NER proteins except XPC-HR23B. Hence the focusing of incision events by 
XPC-HR23B strongly indicates that its binding to the lesion leads to initiation 
of the reparr reaction. 
Discussion 
Although XPC-HR23B was first purified as a protein factor which corrects 
defective in vitro NER activity of XP-C whole cell extracts (Masutani et al. 
1994; Shivji et al. 1994), the positioning of this GGR-specific repair factor in 
the complex NER reaction has remained mysterious. Our present data 
demonstrate that the DNA-binding properties of XPC-HR23B are specific for a 
variety of lesions. In addition, we established that the complex functions at 
the very first stage of lesion identification in the GGR pathway. This is 
consistent vvith a model proposed very recently by Evans et al. (1997), in 
which TFIlH and XPC-HR23B may be involved in the initial opening of 
double-stranded DNA around the lesion. In addition, Mu et al. (1997) have 
recently reported that the first detectable NER intennediate contained the 
XPC-HR23B complex together with XPA, RPA and TFIlH, also supporting the 
idea that XPC-HR23B acts at an early stage of NER. 
A two-stage damage recognition scheme for GGR? 
Our work adds a new damage-recognition protein to the two already known 
NER factors with preferential affinity for DNA lesions: XPA and UV-DDBjXPE. 
It has been well documented that XPA preferentially binds DNA containing 
various NER lesions (Jones and Wood 1993; Asahina et al. 1994; He et al. 
1995). XPA shows a much greater affinity for 6-4PPs than for UV-induced 
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CPDs (Jones and Wood 1993), corresponding with the notion that 6-4PPs are 
eliminated in vivo much more efficiently than CPDs (Mitchell 1988). XP-A null 
mutant cell lines show an extremely high sensitivity to UV, and the XPA 
protein contains a DNA-damage binding Zn2+-finger (Tanaka et al. 1990; 
Morita et al. 1996) as found in the E.coZi UvrA protein implicated in lesion 
recognition in prokaryotic NER. Although these findings argued in favour of 
the idea that XPA is responsible for the lesion recognition step, it has 
remained unclear whether the damage-specificity of XPA (with or mthout 
RPA) is sufficient to account for the very high damage discrimination 
exhibited by the NER apparatus in vivo: the measured association constant of 
XPA for a heavily UV-irradiated (at 6 kJ 1m2) DNA fragment is about 3 x 106 
M'l, which is only 5-fold higher than that for non-irradiated DNA (Jones and 
Wood 1993). Moreover, interaction ofXPA with a single lesion has never been 
demonstrated by footprint analysis or other methods, as mentioned by Mu et 
al. (1997) Another damage-binding protein, UV-DDB/XPE, was found to 
possess a much higher affinity for some lesions than XP A (Reardon et al. 
1993; Hwang and Chu 1993). However, UV-DDB seems to play an accessory, 
but not essential role in the core NER mechanism, because it stimulates in 
vitro NER only 2-fold (Aboussekhra et al. 1995). In contrast to UV-DDB, XPC-
HR23B is essential for in vitro NER and for GGR in vivo. XPC-HR23B was 
stably sequestered by pre-incubation Vlith damaged DNA, on which incision 
events were then focused. The results in Figure 4A and B indicate that the 
lesion binding by XPC-HR23B is a rapid, not rate-limiting step: pre-
incubation of XPC-HR23B with non-damaged DNA hardly retarded the reparr 
rate of damaged DNA added later. This explains why the pre-incubation with 
XPC-HR23B did not result in a dramatic increase in the initial repair rate, but 
only in a rate proportional to the amount of XPC. 
Some lesions can be excised -at least in vitro- without the need of XPC-
HR23B. These include an artificial, cholesterol-derived adduct (Mu et al. 
1996), and a thymine dimer located within an unparred bubble-like structure 
(Mu and Sancar 1997). These findings may imply that the XPC complex after 
binding to a lesion induces a specific conformational change including local 
opening of DNA, which then allows entry of subsequent NER factors, such as 
TFIIH, XPA, and RPA (Figure 7). Apparently, the need of XPC-HR23B is 
bypassed by particular structural features associated with the cholesterol 
lesion as well as the lesion located in a DNA bubble. Our footprinting analysis 
using a 6-4PP-containing DNA fragment suggests some interesting structural 
features of the DNA complexed with XPC-HR23B. Although the XPC-HR23B 
complex covered a rather long region encompassing the injury, several 
internal sites were found still accessible to DNase I (Figure 6). Moreover, the 
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Figure 7. A nvo-stage damage recognition model for l'i.""ER. (i) A lesion located in the global genome 
(GGR) or in the transcribed strand of an active gene (TCRj. (ii) The lesion is first recognized by the 
XPC-HR23B complex (GGR) or Rl'JA polymerase (TeR). XPC-HR23B may induce some conformational 
changes of the DNA helix in the vicinity of the lesion, which would favour the subsequent assembly of 
other NER factors. (iii) XPA (possibly together v.rith RPA) participates in the DNA-protein complex to 
veritY the substrate specificity of the lesion. An involvement of TFIIH and initial opening of double-
stranded DNA may precede the function of XPA (Evans et at 1997). It is unknown whether XPC-
HR23B is displaced from the lesion or remains bound to it. In TCR, CSA and CSB might be involved 
in this step. (iv) The two DNA helicase subunits of TFIIH may fully open the double-stranded DNA 
around the lesion. (v) Two structure-specific endonucleases, ERCC1-XPF and XPG, make dual 
incisions at the 5'- and 3'-sites, respectively. 
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bineting of XPC-HR23B also resulted in enhancement of DNase I sensitivity of 
some phosphodiester bonds in the damaged strand, located 5' to the lesion 
(see Figure 6A and B). Similar 5'-hypersensitive sites in the damaged strand 
were observed upon complex formation of the E.coli UvrAB reparr proteins 
with various lesions (Van Bouten et al. 1987; Voigt et 81. 1989; Visse et al. 
1991). These sites may enable following NER proteins to participate in the 
DNA-protein complex. 
Us:ing a similar co-immunoprecipitation technique as shown in Figure 
5, our XPA preparation was also found to specifically bind AAF-damaged DNA 
(data not shown). Apparently, however, this direct bineting does not lead to 
productive repair (Figure 4). Therefore, XPA may have to bind damage in a 
somehow different fashion: a specific protein-protein and/or DNA interaction 
may be essential for XPA to recognize the lesion productively. This sequential 
action of DNO damage-binding proteins may explam the extremely high 
damage discrimination exhibited by the NER machinery in vivo. The problem 
of tracing numerous types of DNA abnormalities amidst> 1 Q6-fold excess of 
normal nucleotides must be formidable. If the assembly of a specific DNA-
protein complex induced by one damage-recognition factor is a prerequisite 
for the function of the other, one can expect that a much higher damage 
discrimination could be achievable than v:.rith each on its own. The second 
damage recognition exerted by XPA may provide an oppertunity to verilY that 
the lesion is reaJly a substrate for NER. In addition the XPA protein may help 
to organize and correctly orient the NER machinery around the DNA injury. 
Further research using a purified set of NER proteins should elucidate the 
precise mechanism of early events in GGR, including identification of the XPA 
function. 
Implication for damage recognition in transcription-coupled repair 
Although XPC functions specifically in GGR, the findings reported here have 
also important implications for TCR, the complementary NER subpathway. 
The principle of sequential damage recognition provides a tempting paraJlel 
v:.rith the mechanism of lesion detection proposed for TCR. In this process, the 
equivalent function exerted by XPC-HR23B would be accomplished by RNA 
polymerase II when it stumbles upon a lesion while transcribing a damaged 
template (Figure 7). The NER substrate specificity is then checked by XPA 
(possibly in concert with RPA and TFIIH) that is required for both GGR as well 
as TCR and thus might play an adaptor role linking the specific components 
of the two NER subpathways to the common core. Since the principal 
mechanisms by which the DNA template is screened for intactness by XPC-
HR23B and RNA polymerase II are very different, it is to be expected that the 
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damage recognition profiles of the corresponding NER subpathways are also 
different. Clearly, the proof of competence exerted by the transcription 
machinery when copying a DNA strand is probably more rigorous than the 
test performed by XPC-HR23B. This is tbe case at least for a number of 
lesions: TCR efficiently removes several types of damages (e.g. IN -induced 
CPDs) tbat are poor substrates for GGR (van HolIen et al. 1995). In fact, 
evidence has been obtained that a blocked RNA polymerase may even link 
multiple DNA repair systems to solve tbe problem of a damage-Induced 
arrested transcription machinery (Leadon and Cooper 1993; Cooper et al. 
1997). 
Altbougb tbe hitberto enigmatic role of XPC-HR23B In NER is clarified 
by our work, many questions remain unanswered. For instance, which 
structural features associated witb lesions are recognized by XPC-HR23B? A 
second issue is tbe fate of XPC-HR23B during tbe remaInder of tbe NER 
reaction. It is possible that, soon after the involvement ofTFIIH, XPA and/or 
RPA, tbe XPC-HR23B complex leaves: tbe remaInder of tbe NER reaction can 
at least in vitro be conducted without XPC, as shown by the studies using the 
cholesterol-derived lesion (Mu et al. 1996). Also tbe notion tbat TCR takes 
place vvithout XPC indicates that NER can proceed in the absence of this 
proteIn (Mu and Sancar 1997). Future research should shed light on tbese 
and other issues. 
Experim.ental Procedures 
Plasmid DNA substrates 
Plasmid pBS.XPC, which carries the 3.6-kb human XPC eDNA inserted into the Not! site of 
pBluescript KS+ (pBKS: 3.0 kb) (Masutani et ill. 1994), was digested 'With HindIII and then self-ligated 
to obtain plasmid pBS.XPCb (4.6 kb). Closed circular DNA of this plasmid, as well as pBKS and 
pHM14 (3.7 kb), was purified from each 2-liter E.coli culture. To introduce AAF-damage, pBKS and 
pBS'xPCb were treated as described previosly (van Vuuren et al. 1993), pBS'xPClI. was also 
irradiated by W (450 J /m2) or treated 'With cisplatin (a drug/nucleotide ratio = 0.0025) as described 
(Hansson and Wood 1989). The average number of lesions generated in each preparation was roughly 
estimated by determining the fraction of DNA that was resistant to digestion by appropriate 
restriction enzymes: AAF-drunaged DNA, ca. one N-{guruline-S-yl)-AAF adduct/100 nucleotides; W-
irradiated DNA, 1 thymine climer (CPD or 6-4PP)/300 nucleotides; cisplatin-treated DNA, 1 d(GpG) 
intrastrand crosslink/700 nucleotides. 
Preparation of protein fractions 
Human XPC-HR23B comple.x was purified from He1$. cells as described previously (Masutani et al. 
1994). A heterotrimeric human RPA complex was expressed in E.coli BL21(DE3) pLysS transfected 
'With plld-tRPA (a generous gift from Dr. M. S. Wold), and purified as described (Hendricksen et ill. 
1994). Mouse XPA protein was expressed in E.coli BL21 (DE3) pLysS cells, using a pET-Se construct 
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containing the mouse XPAgene (van Oostrom et al. 1994) kindly provided by Drs. C. F. van Kreyl and 
H. van Steeg. Consecutive chromatography using heparin-5epharose CL-6B. Q-Sepharose Fast Bow 
(both from Pharrnacia Biotech). Phospho-mtrogel ASR (IBF BiotecluUcs) and Mono Q HR5!5 columns 
(Phannacia Biotech) yielded a highly purified XPA preparation. The intact mouse XPA protein -was 
found to be more easily overproduced in E.coli than the human counterpart. The complementing 
activity of the purified XPA protein -was checked by microinjection of human XP-A fibroblasts. 'Nhole 
cell extracts for in vitro NER reactions were prepared from lymphoblastoid cell lines derived from 
XP3BE (GM2248B: group C) or XP7NI (group A) patients as described (Wood et aL 1988). The 
c'-tracts were fraCtionated over phosphocellulose as descrlbed previously (Sugasawa et al. 1997). 
Protein concentrations were deterrn!ned according to the method of Bradford (I97S). using bOvine 
serum albu:m:ln (BSAl as a standard. 
In vitro NER reactions 
Standard reaction rni"ctures for in vitro NER (25 ).11) contained following components: 40 mM REPES-
KOH (PH 7.8). 9.8 ID.;.\1 MgClz. 70 mM KCl. S.8%glycerol. 0.9 mMDTr. 0.4 ruM EDTA 2mMATP. 20 
flM each of dGTP. dCIP and dTrP. 8 ).1M dATP. 23 mM phosphocreatine (di-Tris). 1.25).lf!: of creatine 
phosphokinase (CrPKl. 9 ).If!: of BSA 125 ng of AAF-damaged pBKS. 125 ng of non-damaged pHMJ4. 
and indicated amounts of CFII and purified proteins. For competition experiments. tw"o separate pre-
incubations. containing 400 ng each of AAF-damaged pBS.XPC- and pBKS. were earned out at 30"C 
for 30 min in reaction rni"ctures lacking at least one NER factor. These two reaction rni'-1:ures were 
combined on ice and supplemented with missJng: NER factors and non-damaged pHl\lI14 DNA (400 
ng). adjusting the final volume of reactions to 100 ).11. The mi"ctures were then allquoted into four 
microfuge tubes. and incubated at 300 C for O. 7.5. 15. and 30 min. Reactions were terminated by 
addition of EDTA to a final concentration of 20 mM. Purified DNA samples were redissolved in 'IE 
buffer [10 mM Trts-HCI (pH 7.5). 1 ruM EDTAJ and gap filling DNA synthesis reactions were earned 
out at 370 C for 15 min in 25 ).11 ofmi'-1:ures containing 10 ID.;.\1 Tris-HCI (PH 8.0). 5 ruM MgCkl. 0.1 M 
NaCl. I mM 2-mercaptoethanol. 20 ).1M each of dGTP. dCIP and dTfP. 8 ).1M kc02pJdATP (-92.5 kEq). 
2.5 ~ of BSA. and 0.1 unit of T4 DNA polymerase (New England Biolab). DNAs were purified again. 
lineariZed with BamID. and subjected to electrophoresis through 0.8% agarose gels in 1 "X TEE buffer 
containing 0.5 ~ml of ethidium bromide. The gels were photographed under UV-illu:m:lnation. dried 
and autoradiographed with Fuji New RX films and intens:i.fy:!ng screens. DNA repair synthesis -was 
quantitated using the PhosphorImager system (.Molecular Dynamics). 
Damaged DNA binding assay 
Purtfied XPC-HR23B was mi,ed with 200 ng each of pBS.XPC· (damaged or non-damaged) and non-
damaged pHl\lI14 in 25-).11 reactions containing 40 mM HEPES-KOH (PH 7.$). 8.8 mM MgClz. 24 ruM 
KCl. 6.8% glycerol. 0.9 ID.;.\1 DIT. 0.4 mM EDTA. 2 mM ATP. 20 ).I.M each of dGTP. dCIP and dTTP. 8 
)1M dATP. 23 mM phosphocreatine (di-Tris). 1.25 ~ of CrPK and 9 ~ ofBSA After incubation for 30 
min at 30QC. 0.5 ~ of affinity-purified. polyclonal antibody raised against recombinant human XPC 
protein (Sugasawa et al. 1996) -was added and further incubated on ice for 15 min. A hundred 
microliter of ice-cold buffer B [25 ID.;.\1 Tris-HCI (PH 7.5). 1 mM EDTA. 0.1 M NaCI. and 0.5% Nonidet 
P-40] and 25).1.1 of protein A-Sepharose CL-4B (Phannacla Biotech: 1:1 suspension in buffer B) were 
added and kept on ice for 1 h with occasional mixing. After centrifugation. the resulting supernatants 
were saved as 'unbound' fractions. and the beads were washed three times with 500 )11 of ice-cold 
buffer B. The -washed precipitates were suspended in TE buffer containing 1 % SDS. and 
subsequently incubated at 50"C for 30 min. The superrmtants were recovered as 'bound' fractions by 
centrifugation. The purified DNA samples from the unbound and bound fractions were linearized by 
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BamID. fractionated through 0.8% agarose gels. and transferred onto Nylon membranes (Hybond-N: 
Amersham). The blots were hybridized to 32p-labeled pBKS sequences. 
DNase I footprinting assay 
To prepare DNA substrates for footprinting assays. two non-damaged. synthetic oligonucleotides (30-
and 38-mers. sequences of which are shown in Figure 6A) were armealed to each other and cloned 
between PstI and HindIII sites in pBKS to generate a plasmid. pBS30. The 30-mer oligonucleotide 
containing a 6-4PP [(6-4)30-mer] was chemically synthesized as described (lwai et at 1996). The 
HindIlI-PstI large fragment from pBKS was partially cligested by E.coU e:xonuclease III. and then 
mixed with single-stranded Circular DNA derived from pBS30 as well as the 5'-phosphorylated (6-
4)30-mer. This mb.."ture was heat-denatured. reannealed and then treated \vith T4 DNA ligase. 
Double-stranded closed Circular DNA containing a single 6-4PP [pBS(6-4)30] was purtfled by CsCl-
ethiditun bromide density gradient centrifugation. A control DNA substrate lacking the lesion 
[pBS(!\TI)30] was prepared in the same way. except that the non-damaged 30-mer oligonucleotide 
was used instead of the (6-4)30-mer. 
To label the damaged strand. pBS(6-4)30 was cligested by Acc65I and the recessing 3'-end was filled 
with TI DNA polymerase (Amersham) in the presence of [cr32pjdCTP. The DNA was further digested 
by PvuI to obtain a ca. 250-bp fragment containing a 6-4PP. The 3'-end of the non-damaged strand 
was labeled by sequential treatment of pBS(6-4)30 with BstXI, with T4 DNA polymerase (Takara 
Shw..o) in the presence of la-32PldCTP. and with VspI. For preparing control DNA substrates without 
6-4PPs, pBS(ND)30 was treated in the same way. For binding reactions (25 !J.1), a mb.."ture of 1-2 ng of 
the 3zP_DNA fragment (10.000-20.000 dpm) and 1 ng ofpoly{dl-dC) was incubated at 30"C for 30 min 
with various amounts of XPC-HR23B under the same conditions ut!l:ized for the damaged DNA 
binding assay described above. The reactions were chilled on ice. mixed with 25 J..lI of 5 roM CaCh. 
and then digested with 0.004 units of DNase I rrakara Shuzo) at 30"C for 2 min. After the digestion 
was terminated by addition of 50!J.I of stop solution (l% SDS, 20!DJ.\1 EDTA. 0.2 M NaCL 100!J.fUml 
of yeast tRNA). DNA was purified and subjected to denaturing polyacrylamide gel electrophoresis 
(10% polyacrylamide gel) followed by autoradiography. 
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Summary 
mHR23B encodes one of the two mammalian homologs of S.cerevisiae 
RAD23. an ubiquitin-like fusion protein involved in nucleotide exision 
repair (NER). Part of mHR23B is complexed with the XPC protein and this 
heterodimer functions as the main damage detector and initiator of global 
genome NER. While XPC defects exist in man and mice. mutants for 
mHR23A and mHR23B are not known. Here. we present a mouse model for 
mHR23B. Unlike XPC-deficient cells. mHR23B· j · mouse embryonic 
fibroblasts are not UV -sensitive and retain normal repair characteristics. In 
agreement with in vitro repair studies. this indicates that rnHR23A can 
functionally replace mHR23B in NER. UnCA-pectedly. mHR23B j • mice show 
impaired embryonic development and a high rate (90%) of intrauterine or 
neonatal death. SUIvi:V.ing animals display a variety of abnormalities 
including retarded growth. facial dysmorphology. and male sterility. Such 
abnormalities are not observed in XPC and other NER-deficient mouse 
mutants and point to a separate function of mHR23B in development. This 
function may involve regulation of protein stability via the 
ubiquitin/proteasome pathway and is not or only in part compensated for 
bymHR23A 
Introduction 
Nucleotide excision repair (NER) is the major repair system for the removal 
of DNA lesions induced by ultraviolet (UV) light and numerous chemical 
agents (Friedberg et al. 1995: Wood 1996). The "cut-and-patch" type 
reaction mechanism involves the concerted action of over 25 proteins. 
sequentiaJly implicated in recognition of DNA damage. unwinding of the 
DNA around the lesion. excision of a single-stranded piece of DNA 
containing the damage. and subsequent gap filling DNA synthesis and 
ligation (de Laat et al. 1999). NER consists of two subpathways. Genome-
wide repair is taken care of by the global genome NER (GG-NER) process. 
acting irrespective of genomic location of the lesion or cell cycle stage. Some 
lesions however (e.g. UV-induced cyclobutane pyrimidine dimers). are 
repaired less efficientiy by GG-NER. To avoid that such lesions obstruct the 
vital process of transcription for too long. the transcription-coupled repair 
[TC-NER) subpathway acts as a fast back-up system for clearance of the 
template strand of actively transcribed genes (Hanawalt 1994 and 2000). 
Defective NER is associated with three clinicaJly and geneticaJly 
heterogeneous human syndromes: xeroderma pigmentosum (XP). Cockayne 
syndrome (CS) and trichothiodystrophy (TID) (Bootsma et al. 2001). 
! 
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Patients suffering from XP (complementation groups XP-A to XP-G) exhibit 
severe sun (UV) sensitivity. ocular symptoms. and cutaneous abnormalities 
including a very strong predisposition to develop skin cancer. Most XP 
patients cany defects in GG-NER and TC-NER. but in tbe case of XP-C only 
tbe GG-NER patbway is affected [Venema et al. 1990 and 1991: van Hoffen 
et al. 1995). 
The XPC protein is essential for GG-NER of vanous types of DNA 
damage and is found in a tight complex \Vith hHR23B. one of the two 
human homologs of the Saccharomyces cerevisiae DNA repair protein 
RAD23 (Masutam et al. 1994). hHR23B stimulates tbe repair activity of 
XPC in in vitro reconstitution assays Vvith recombinant proteins (Sugasawa 
et al. 1996). A 56 amino acid segment witb a predicted amphiphatic helical 
s'tru.cture containing the XPC-binding domain of hHR23B appears sufficient 
for XPC stimulation. This suggests that hHR23B has a structural rather 
tban a catalytic function (Masutani et al. 1997). A vast majority of XPC 
protein is bound to hHR23B in vivo. However. in vitro. hHR23A the second 
human homolog of RAD23. can substitute for hHR23B in binding and 
stimulating XPC. This opens tbe possibility tbat botb proteins are to some 
e},."tent functionally interchangeable (van der Spek et al. 1996a: Sugasawa et 
al. 1997). The XPC-hHR23B complex has been identified as tbe primary 
DNA-damage sensor that initiates GG-NER and has in vivo and in vitro been 
sho\VI1 to directly interact with the essential repair jtranscription factor 
TFIIH (Sugasawa et al. 1998: Yokoi et al. 2000). The XPC-hHR23B complex 
senses different types of damage based on disrupted base paring and 
stimulates the association of TFIIH with damaged DNA in cell-free extracts 
(yokoi et al. 2000: Sugasawa et al. 2001). After tbe initial subpatbway-
specific lesion detection. tbe XPB and XPD helicase subunits of TFIIH open 
the DNA helix around the lesion. XPA together Vvith the heterotrimeric RPA 
may function as a common damage verifier before the DNA is incised on 
botb sides of tbe injury by tbe XPG and ERCCljXPF endonucleases (de 
Laat et al. 1999: Yokoi et al. 2000). 
In addition to the XPC-binding domain. yeast and mammalian 
RAD23 proteins harbor an amino-terminal ubiquitin-like (UbL) moiety and 
two so-called ubiquitin-associated (UBA) domalns (Hofmann and Bucher 
1996: Masutani et al. 1997). In yeast. tbe UbL domaln is indispensable for 
tbe repair function of RAD23 (Watkins et al. 1993: Mueller and Smerdon 
1996). Moreover. hHR23A and hHR23B interact witb tbe S5a subunlt of tbe 
26S proteasome. and hHR23A serves as a substrate for E6-associated 
protein-mediated ubiquitination (Hiyama et al. 1999: Kumar et al. 1999). 
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Figure 1. Targeted disruption of the mHR23B gene by homologous recombination. (A) Genomic 
organization and disruption strategy for mHR23B showing the gene. the targeting construct. and 
the targeted mHR23B allele. Exon III is deleted and the UM:S and Neo cassettes are inserted 
between e.xon II and e.xon rv. (B) Southern blot analysis of Sad digested DNA from ES cells 
showing the 9.6 kb and 5.5 kb fragment representing the wildtype and the targeted allele of 
mHR23B respectively. (C) Southern blot analysis of Sac! digested tall DNA from mHR23B+/-, 
mHR.23B+1-, and mHR23B'/' mice. (D) RNA blot analysis ofmHR23B mRNA in cellular e,; .... i:racts from 
mHR.23B .. / .... mHR23B+J-, and mHR.23R/- MEFs using mHR.23B eDNA as a probe. As a loading 
control for the amount of RNA the blot was reprobed with mHR23A cDNA (data not shown). (El 
Immunoblot analysis of mHR23B protein in cellular eA-tracts from mHR23B+/". mHR23B+/·. and 
mHR23B"/· :MEFs using polyclonal antibodies against the human HR23B protein (upper panel). 
Polyclonal antibodies against the human HR23A protein (lower panel) and the human XPC protein 
(data not shown) were used as a loading control and to check whether mHR23A protein is 
e.'\.-pressed in mHR23B MEFs. The asterisks indicate aspecific crossreacting bands. 
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These fmdings strongly suggest that the RAD23 homologs are involved in 
the ubiquitin/proteasome pathway. 
Although hHR23A can functionally replace hHR23B in vitro during 
NER. it is unknown whether and to which e,,-tent these two human RAD23 
homologs can substitute for each other in vivo. Moreover. while for most 
other NER genes natural and/or laboratory made human and rodent 
mutant cell lines are available. HR23-deficient cell lines have not been 
described. Thus. to address the biological relevance of mammallan RAD23 
homologs and their relationship to XPC in NER we have inactivated the 
mouse homolog of HR23B (mHR23B) by gene targeting. In the present paper 
we describe the phenotype of mHR23B-deficient mice and cells. 
Results 
Targeted disruption of the mouse mI:lR23B gene 
The mouse mHR23B locus was isolated and partly characterized. Deletion 
of exon III not only removes the sequence encoding amino acid residues 148 
to 228 of the mHR23B protein. but also results in a frame shift and 
accordingly is expected to give rise to a null-allele (Figure lA). Following 
transfection of ES cell line E14. properly targeted heterozygous ES cells 
were obtained at a frequency of 21% (Figure IB). Two independent ES 
clones verified for the absence of visible chromosomal abnormalities and 
additional randomly integrated constructs (data not shown) were used for 
blastocyst injections. Germ line transmission was obtained for both clones. 
Heterozygous offspring from matings behveen chimeric males and C57BLj6 
female mice was intercrossed VJith the aim to generate homozygous mutant 
mHR23B animals (Figure Ie). In parallel. these matings served to isolate 
mouse embryonic fibroblasts (MEFs) of different genotypes from day 13.5 
embryos. The effect of targeted disruption on the expression of the mHR23B 
gene was analyzed in MEFs: neither mHR.23B mRNA nor mHR23B protein 
could be detected in mHR23B-i- cells by RNA and immunoblot analysis 
respectively. We conclude that we have created mHR23B null-mutants 
(Figure ID and E). Homozygous mouse mutants and cell lines from the two 
independent ES transformants yielded identical results in all subsequent 
studies indicating that the findings reported below are not due to 
uncontrolled events that might have occurred in one targeted ES clone. but 
are the result of mHR23B inactivation. 
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Figure 2. Repair character1stics of mHR23B-deficient mouse embryonic fibroblasts. (A) UV 
survival curves of mHR23B+/". mHR23S+/', and mHR23F!' fibroblast lines. Identical results were 
obtained with three other ceUlines of mHR23B+!+ and mHR23S+I - and \vlth five independent other 
lines of mHR23S-/ - MEFs (data not shown). XPC I- fibroblasts were included as negative control. 
Cells were e.'\.-posed to different doses of UV (254 nm). After 4-5 days. the number of proliferating 
cells was estimated from the amount of radioactivity incorporated during a 3 hr pulse with 
[3Hlthymidine. (B) Global genome repair (UDS) in mHR23B+/+. mHR23B+/-. and mHR23F/ -
fibroblast lines. 11u'ee other lines of mHR23B+1+ and mHR23B+/-. and five independent lines of 
mHR23gl - were tested with consistent results (data not shown), XPA/- fibroblasts were measured 
to serve as negative control. Cells were irradiated with 16 Jjm2 UV (254 run) and labelled with 
[~lthym1dlne. Incorporation of radioactivity was measured by autoradiography and grain counting 
(average of 50 nuclei per ce1lline: the standard error of the mean is indicated), (C) RNA synthesis 
recovery after UV e.'\.:posure of mHR23B+/~, mHR23B+I-, and mHR23B"/- fibroblast lines. Three othcr 
lines of mHR23B+/1" and mHR23B+I -, and five other independent lines of mHR23B"/' were assayed 
with similar outcome (data not shown). CSB"I- fibroblasts were measured as negative control. 16 
hours afier exposure to different doses of UV (254 run), the residual RNA synthesis was measured 
by scintillation counting following a 1 ill pulse labelling with [JH]uridlne. For each genotype, 
comparable results were obtained by grain counting after autoradiography (data not shown), 
m.HR23B-deficient cells are NER proficient 
In view of the role of yeast RAD23 in NER and the tight interaction of 
mHR23B with XPC (Masutani et al 1994) we examined cellular survival of 
wildtype. heterozygous and homozygous mHR23B mutant MEFs after 
exposure to increasing UV-doses_ Unexpectedly. UV survival of mHR23B+1-
and mHR23H1- cells appeared indistinguishable from wildtype (Figure 2A)_ 
Moreover. mHR23B-deficient MEFs show normal DNA repair synthesis 
(unscheduled DNA synthesis (DDS): Figure 2B) and recovery of RNA 
synthesis after UV exposure (Figure 2C). indicating that neither GG-NER 
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Table 1. Intrautenne and pennatal lethality of mHR23B homozygous 
mutants at different embryonic/fetal stages 
Stage Analyzed Expected Found Deviation from 
(if Mendelian) Mendelian 
E13.5 70 17.5 14 -0 
E15.5 72 18.0 9 2x 
E18.5 162 40.5 19 2x 
Newborn 671 167.8 16 lOx 
nor TC-NER subpathways were affected. Also in other respects (e.g. 
morphology. growth rate. etc.) mHR23B-deficient MEFs behaved normally. 
Assuming that a total mHR23 inactivation would result in a DNA repair 
deficiency like in yeast (Watkins et al. 1993: Mueller and Smerdon 1996). 
these data suggest that. mHR23A not only in vitro. but also in vivo can fully 
substitute for mHR23B. at least for its function in NER. 
mHR23B-deficiency causes impaired embryonic development and 
intrauterine death 
When (phenotypically normal) heterozygous animals were crossed to 
produce mHR23B-deficient mice. the targeted mHR23B allele was found to 
segregate at a ratio far (-la-fold) below Mendelian expectance (rable I: in 
total 671 animals analyzed) suggesting that a lack of mHR23B protein 
causes intrauterine and/or perinatal death. Since mHR23B-deficient MEF 
lines were obtalned at an almost Mendelian ratio (data not shown) lethal 
events must occur after day 13.5 of gestation (EI3.5). Analysis of a large 
series of embryos at different stages of development revealed a near two-fold 
reduction in the number of viable mHR23B-deficient embryos between 
E13.5 and E15.5 (Table I). Since at E18.5 still 50% of the mHR23B-
deficient embryos was alive (and born litters contalned only 10% of the 
expected numbers of knockout animals). 80% of the remalning embryos is 
assumed to have died inunediately prior to. during. or shortly after birth. 
which is consistent With the observed high number of dead newborn 
mHR23H1- mice. 
mHR23B-deficient embryos (E13.5-EI9.5) sbowed clear signs of 
growth retardation and were readily recognized by a marked reduction in 
body size (Figure 3). This is reflected by a reduced body weight. which 
becomes more pronounced towards term (data not shown). All mHR23B"/-
embryos alive at stages EI3.5-EI9.5 appeared pale whereas major blood 
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Figure 3. Developmental impairment in mHR23B"/- embryos at EI5.5. (A~C) mHR23B+/~ (A) and 
mHR23B-I- (B and e) embryos with amniotic/cholionic plates and placentas. (D~F) mHR23B+/· (D) 
and mHR23B"/. (E and F) embryos without amniotic/cholionic plates and placentas. Embryo of 
panel A is identical to that of D, and embryo of panel B is identical to that of E. mHR23B-J-
embryos display retarded growth and impaired vasculari7..ation (B and EJ. intrauteline death (e) 
and internal bleeding (F). 
Figure 4. Placental defect in mHR23B"/· embryos at EI8.5. Histological 1 !lID- sections (A and B) 
and transmission electron micrographs (C and D) of mHR23B"'"/+ (A and e) and mHR23B·/· (B and 
DJ placentas. mHR23B"/. placenta shows swollen throphoblastic cells (small black arrows) and 
Significantly reduced vascula.li7..ation (blood vessels are indicated by large black arrows and 
endothclial cells by black arrowheads). Additionally. in contrast to normal placental labyrinth of 
wildtype. the vasculari7..ation and the vascular basement membranes in the mutant placenta seem 
to be disturbed. Scale bars represent 10 J.L111 (A~D). 
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vessels were not clearly visible (Figure 3B and E). This suggests that 
vascularization and/or blood supply was poor. In addition. large numberS 
of mHR23B+ embryos showed edema (Figure 3F). Also. embryos with 
interstitial bleeding throughout the body were found (Figure 3F). Moreover. 
in numerous mHR23B-deficient embryos (E13.5-E19.5) the eyelids were not 
closed and the mouth was widely open. which is a charactertstic feature of 
maceration following embryonic decease. Eyelid closure and fusion 
normally occur between E15.5 and E16.5 of mouse embryonic development. 
Widely open mouth normally indicates micrognathia or cleft lip resulting 
from retarded growth of the mandible. 
Preliminary histopathological examination of liVing mHR23B-
defiCient E15.5 and E18.5 embryos revealed no obvious abnormal 
architecture of vital organs and tissues. and the reduction in organ weight 
appeared proportional to the reduction in total body weight. However. in 
one mHR23B-deficient E18.5 embryo we observed an open secondary palate 
(cleft palate) resulting from imperfect closure of the palatal shelves of the 
maxilla (in normally developing embryos this is completed at E16: data not 
shown). Taken together. these data indicate that the mHR23B protein is 
required for proper embryonic development. and that mHR23A can not or 
only in part substitute for this function. 
Inactivation of mHR23B causes a placental defect 
In line vvith the pale appearance of a large number of mHR23B-deficient 
embryos. mHR23B"/· placentas at stage E18.5 (n=3) appeared pale and 
smaller when compared to mHR23B+1+ and mHR23B+1- placentas_ 
Histological examination revealed poor vascularization of mutant placentas. 
as evident from the reduced number of fetal blood vessels in the labyrinth 
(Figure 4A and B)_ Transmission electron microscopy of mHR23B-1-
placentas (n=3) revealed swollen trophoblastic cells (Figure 4C and D). In 
addition. altered morphology of the vascular basement membrane of 
mHR23B-1- placentas was observed (Figure 4D)_ The vascular basement 
membrane of mHR23B·/· placentas was darker and thicker than that of 
wildtype placentas. which might affect the exchange of gases and transport 
of nutrients and waste products_ 
mHR23H/· mice show retarded growth and facial dysmorphology 
Despite the pronounced impact of the mHR23B-deficiency on embryonic 
development. about one tenth of the expected number of homozygous 
mutant mice were found alive in litters born from heterozygous breeding 
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Figure 5. Growth retardation in mHR23F!- mice. (A) A 19-day-old wildtype male mouse (brown) 
and its smaller mHR23B-J- (black) littennate. (B) Growth curve of mHR23B mice: mHR23B+/+ (n=3 
males. open diamonds): mHR23B+1- (n=8 (5 males and 3 females). closed squares) and mHR23R!-
(n=6 (4 males and 2 females). closed triangles). The average body weights (gram) were followed in 
time over a period of 5 weeks. (el The average body weights (gram) of 93-day-old mHR23B+/- (n=8 
(5 males and 3 females)) and rnHR23B-1- (n=6 (4 males and 2 females)) mice. Males are indicated in 
black columns and females in white columns. (D) Adult mHR23B~J+ mouse. (El Eyelids are 
inflamed in adult mHR23B-1- mouse and are surrounded by a large amount of tears/eye fluid. The 
head of mHR23BJ- mouse appears irregularly shaped due to hypoplasia of ma.xilla and mandible. 
couples (Table 1)_ Like mHR23H1- embryos. newborn homozygous mutant 
mice showed a marked reduction in body size and are readily 
distinguishable from their heterozygous and wildtype litiermates (Figure 
SA). After weaning. we did not notice any further loss of mHR23B-/- animals. 
As evident from body weight measurements. mHR23BI mice display 
retarded growth. particularly in the last days before weaning (day 21). Up to 
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7 weeks after birth the average body weight of homozygous mutant males 
(n=4) and females (n=2) was still approximately 50% lower than that of 
wildtype (n=3) and heterozygous (n=8) littermates (Figure 5B). This 
situation remained throughout life (see for body weight at 3 months: Figure 
5C). Vital organs were proportionally reduced in size (data not shown). 
Adult mHR23B"1' males and females (up to 1 year and older) lacked fatty 
tissues. while excessive fat was observed in the abdominal cavity of 
v.riJdtype mice. However. histopathological examination of the vital organs. 
sciatic nerve and skeletal muscle from adult mHR23B-deficient mice (n=4) 
falled to reveal any obvious abnormality (data not shown). 
mHR23B-deficient mice showed facial dysmorphology. The nose had 
a blunted shape rather than the tapered appearance characteristic for 
rodents due to hypoplasia of the maxilla and mandible (Figure 5D and E). 
In addition. more than one third of the mHR23B-deficient mice developed 
so-called elephant teeth. 
mHR23B-deficient mice have ocular pathology 
Some 7 to 10 days after birth mHR23B-deficient mice started to develop eye 
pathology. characterized by excessive eye fluid and swelling of the eyelids. 
Animals refrained from opening the eyes widely. Probably as a result of the 
continuously drenched eyes. mHR23B-deficient mice showed excessive 
washing activities. These features persisted into adulthood with frequent 
signs of inflammation in eyelids. that could not be treated by application of 
eye ointment (Figure 5E). In addition. a large number of mHR23B-deficient 
animals seemed to suffer from itching. as evident from extensive scratching. 
which was not restricted to the head region but also involved the ears and 
the neck line. Some mHR23B-deficient mice showed corneal opacities (data 
not shown). 
Histological analysis of mHR23B-deficient mice (n=6) confirmed 
conjunctivitis. In addition. in the comer of mHR23B-defictent eyes. 
inflanunation cells containing polymorphic nuclei were observed (data not 
shown). A clear cause of the wet eyes was not detected. The tear-producing 
glands showed no overt abnormalities. In one mHR23B-deficient mouse. 
however. the number of the conjunctival Goblet cells that produce the 
mucous layer of the tear flim was reduced. The drainage of the tears was 
checked in one mHR23B-deficient animal and appeared normal. Moreover. 
we failed to observe any abnormalities in other parts of the eye. such as the 
retina (data not shown). 
To examine the possibility of any inflammatory disease. the ratio in 
19A. IgG and IgM and white blood cell counts of adult mHR23B-deficient 
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A 
B Average Weights of Body and Sexual Organs 
in Wildtype and mHR23B Knockout Male Mice 
Wildtype'" Knockout-
Body Weight (9) 37.8 18.5 
Testes (mg) 221.1 30.4 
Epididymides (mg) 79.6 31.5 
Seminal Vesicles (mg) 59.5 35.6 
., Consisted of 6 (4.S.month-old) mice (+/+ n 3; +f~ n-3) 
U Consisted of 6 (4.5-month-old) mHR23B-/- mice (n=6) 
Figure 6. mHR23g/- males display retarded growth of the testis. (A) Macrograph of adult wildtype 
(left) and mHR23B· j · (right) testes. Besides reduction in size. blood vessels are not clearly visible in 
mHR23B· j · testes. Scale bar represents 5 nun. (B) Average weights of body and sexual organs in 
wildtype and mHR23B-1- male mice. 
mice (n::::;5) was detennined. but did not reveal abnormalities. indicating 
that the immunological system is not compromised (data not shown). 
Defective spermatogenesis in mHR23B-1-male mice 
Attempts to use mHR23.B-deficient males in breeding protocols with either 
mHR23F/- or wildtype female mice did not result in pregnancies. Since 
mHR23B-i- males show mating activity (as evident from the presence of 
copulatory plugs in the female mice). their inability to produce progeny 
appears related to neither reduced body size (which may affect physical 
sexual pertormance) nor hormonal disturbances. Inspection of the 
reproductive organs of adult mHR23F/· males (3.5-7 months of age: n=ll) 
disclosed a disproportionate reduction in the size of the testes (Figure 6A). 
\Vhereas the weight of all internal organs was proportional to the two-fold 
reduction in body weight. the weight of mHR23F/· testes was about 7 -fold 
reduced. The weight of mHR23F/' epididymides and seminal vesicles was 
about 2-fold reduced (Figure 6B). 
Morphology of seminal vesicles of mHR23B-deficient males (n=2) 
showed no abnormalities. However. histological examination of the testes of 
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Figure 7. mHR23SI - males show impaired spermatogenesis and dysfunction of Sertoll cells. (A-F) 
Histological examination of 91-day-old caput epididymiS (A and B) and testis (C-F) from wildtype 
(A, C and E (E is a higher magnification of the same section as Cll and mHR23SI - mice (E, D and F 
(F is a ~gher magnification of the same section as D)). Epididymis of wildtype mouse (A) is filled 
with sperm cells, which are absent in the epididymal tubules of mHR23B"/' mouse (B). Normal 
spermatogenesis leading to spermatids (small black arrow) and spermatozoa (black arrowhead) 
towards the lumen in wildtype testis (C and E). whereas spermatogenesis is impaired 111 mHR23S!' 
testes (D and F). Seminiferous tubules of mHR23SI - testis show Sertoll cell nuclei at the normal 
position near the basal membrane (black arrow) and Sertoli cell clusters (indicated by asterisks) in 
the lumen. (G and H) HistolOgical sections of I5-day-old testis from wildtype (G) and mHR23S!- (H) 
mice. Tubules of mHR23B"I- testis show a Sertoli-cell-only phenotype. with predominant 
appearance of Sertoli cells (black arrow points to Sertoll cell nucleus) as compared to wildtype 
testis, with the presence of spermatocytes (small white arrow). Scale bars represent 100 j..lIl1 (A-H). 
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mHR23B-deficient males revealed seminiferous tubules with a small 
diameter. and relatively abundant interstitial tissue in all animals analyzed 
(n=ll: Figure 7). Most striking is the total absence of spermatogenesis. 
which is in line with absence of spenn cells in the epididymis (Figure 7B). 
In the tubules. Sertoli cells appear to be the predominant cell type (Figure 
7D and F). In the centre of most tubules. we observed a concentration of 
cells, which are typical of Sertoli cell clusters that represent Sertoli cells 
detached from the basal membrane of the seminiferous tubule (Figure 7D 
and F). Such clusters were not observed in wildtype seminiferous tubules. 
containing all stages of spermatogenesis (Figure 7C and E). Release of 
Sertoli cells from the basal membrane and clustering in the lumen has been 
observed in other mouse male sterility models. particularly in the older 
animals (Russell et al. 1996). 
The impairment of spermatogenesis in adult mHR23B-deficient mice 
might reflect a primary defect. resulting in a block at an early or later phase 
of spermatogenesis. To study this in more detail. a histological analysis was 
carried out of testis of 15-day-old mHR23B'/' animals. when 
spennatogenesis nonnally is initiated. Morphology of mHR23B-deficient 
testis revealed no initiation of spermatogenesis, as compared to normal 
initiation of spermatogenesis. with presence of pachytene spermatocytes, in 
the wildtype testis. The majority of the tubules of mHR23B-deficient testis 
at 15 days of age showed a Sertoli-cell-only phenotype. although few 
tubules contained some spermatogonia (Figure 7G and H). Histological 
examination of an E15.5 mHR23B-deficient male revealed normal urogenital 
morphology of MUllerian duct regression and Wolffian duct development. 
indicating testicular production of anti-MUllerian honnone (AMH) by Sertoli 
cells and testosterone by the interstitial Leydig cells. Although testicular 
histology of E15.5 mHR23B-deficient animals displayed nonnal Sertoli cells. 
the number of gonocytes (originating from primordial germ cells) seemed to 
be reduced. compared to wlldtype testis (Figure 8A and B). 
mHR23B';' females exhibit reduced fertility 
In contrast to mHR23B homozygous mutant males. mHR23B-/- females 
(n=5) were fertile. However. compared to mHR23B+/+ and mHR23B+/-
females. fertility of the mHR23B-deficient females was clearly reduced. 
Copulatory plugs were found after interbreeding with wlldtype or 
mHR23B+/' males. but litters born from the mHR23B-deficient females were 
conSistently smaller than nonnal (1-2 pups/litter only). Histology of 
mHR23B'/' ovaries (n~3) showed a full spectrum of follicular development 
including Graafian follicles and corpora lutea. indicating normal endocrine 
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Figure 8. mHR23B+ embryos at ElS.S show impaired development of gonocytes. Histological 
analysiS of the tubules of ElS.S testis from wildtype (A) and mHR23B/' (B) mutants. Sertoli cell 
nuclei are indicated by black arrowheads. Compared to wildtype testis, tubules of mHR23SI - testis 
show less gonocytes (black arrows). Scale bars represent 10 ).1m [A and B). 
regulation of ovarian function by follicle-stimulating hormone and 
luteinizing hormone (data not shown). 
Additional findings in mHR23B·j • mice 
A large proportion of mHR23B-deficient mice suffered frequently from 
inflamed/ swollen anus in parallel 'hith ulcers. resulting from rectal 
prolapse. Also soft oily faeces were found which may point to an intestinal 
malfunctioning. The skin of mHR23B-deficient mice (n=16) appeared 
thinner than that of wildtype mice. However. morphology of the skin of 
mHR23B-deficient mice (n=4) showed no overt abnormalities as compared 
with that of the wildtype mice (mHR23B+ j -: n=Z). In addition. the levels of 
subcutaneous fat in mHR23B·j · mice were comparable to that of wildtype 
mice (data not shown). Finally. few mHR23B-deficient mice showed 
abnormal behavior like jumping (n=3) and circling/waltzing (n=l). although 
definite conclusions await analysis using several behavioral tests 'hith a 
larger number of animals, 
Discussion 
mHR23-deficiency does not result in a NER defect 
RAD23 is unique among the yeast NER mutants in several respects. 
Despite an intermediate UV-sensitivity. suggesting partial NER impairment. 
deletion mutants in both S.cerevisiae and S.pombe display - paradoxically -
no detectable global genome and transcription-coupled repair. indicating 
that NER is completely disturbed (Verhage et al. 1996: Lombaerts et al. 
ZOOO). Within the NER machinery RADZ3 is the only component with 
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multiple connections with the ubiquitin system. The RAD23 protein has an 
uhiquitin-like N-terrninus that is essential for its function in repair in vivo 
(Watkins et al. 1993). The two ubiquitin-associated domains within the 
protein are very strongly conserved. which underlines their functional 
importance. The protein interacts physically via its uhiquitin-like domain 
with components of the 263 proteasome and inhibits multi-ubiquitination 
in vitro (Schauber et al. 1998: Russell et al. 1999). In view of its strong 
interaction with RAD4. it is likely that the main role of RAD23 in NER is 
mediated via this repair component. Remarkably. yeast RAD4 and RAD23 
appear to be involved in both NER subpathways whereas the mammalian 
counterpart of RAD4. XPC. is only tmplicated in GG-NER [Venema et al. 
1991: Mueller and Smerdon 1996). Of the two homologs of RAD23 in 
mammals. hHR23B is the main pariner of XPC (Masutani et ai. 1994). The 
XPC-hHR23B heterodimer is identified as the fIrst initiator of damage 
recognition in global genome repair. and it is also found to stimulate XPC in 
in vitro NER (Sugasawa et al. 1998). 
In this study. we have analyzed the function of mHR23B in vivo by 
generating an mHR23B knockout mouse model. Surprisingly. in contrast to 
yeast. no apparent NER-phenotype is detected in mHR23B-deficient cells. 
which are not UV -sensitive and show efficient global genome repair and 
transcription-coupled repair (Figure 2). These data demonstrate that NER 
and in particular the function of XPC is not significantly affected by the 
absence of mHR23B. Assuming that analogous to the Situation in yeast. the 
mammalian RAD23 homologs are tmportant for NER the most plausible 
interpretation for our findings is that in the absence of mHR23B. the 
mHR23A protein can functionally replace it, including the binding and 
stimulation of XPC. This is consistent with the in vitro redundancy beween 
the human HR23 homologs in NER (Sugasawa et al. 1997). and supports 
an in vivo function of HR23A in GG-NER These observations argue against 
the model that the HR23A protein specificaliy interacts with a hitherto 
unidentified second RAD4-like homolog in mammals specific for TC-NER. 
and that both together would cover the function of the single RAD4 in yeast 
(Guzder et al. 1998). However. it remains puzzling why in living cells the 
HR23B protein normaliy is predominantly associated with XPC. whereas 
this study suggests that HR23A appears to be equally able to perform this 
function in NER (van der Spek et ai. 1996a: Sugasawa et al. 1996). 
Therefore. the functional distinction between HR23A and HR23B proteins is 
still unresolved. 
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Table 2. Summary of phenotypical analysis of mHR23B homozygous mice 
Features 
Reduced body weight 
Eye pathology 
Fertility: males sterile 
females reduced fertility 
Facial dysmorphology: elephant teeth 
shape of ma."Cila/mandible 
Other findings: thin skin 
rectal prolapse 
itching/waslting 
circling (waltzing) 
6th toe 
Number of mice 
affected/screened 
16/16 
16/16 
II/II 
5/5 
>6/16 
16/16 
16/16 
>5/16 
>3/16 
1/16 
1/16 
Mice lacking mHR23B display a severe. unexpected phenotype 
Whereas no apparent NER defect could be detected. mHR23B-deficient mice 
exhibit a severe phenotype. which is quite different from the abnormalities 
observed in mouse models for other NER genes. A complete mHR23B-
deficiency causes impaired embryonic development. poor vascularization. 
growtb retardation. male sterility. and facial dysmorphology (see summary 
in Table 2). In contrast. inactivation of tbe mammalian XPC gene. tbe otber 
component of tbe XPCjmHR23B complex. results in a GG-NER defect 
which is only accompanied by UV-sensitiVity and UV-induced skin cancer 
predisposition (Sands et al. 1995: Cheo et al. 1996). Even a total NER 
defect as demonstrated by XPA-deficient mice allows apparently normal 
development and life span (de Vries et al. 1995: Nakane et al. 1995). 
Mutations in several NER factors can give rise to a spectrum of 
additional features that at first glance seem not associated with a NER 
defect. For example. patients \Vith CS show a combination of sun 
sensitivity. short stature. severe neurologic abnormalities and a 
characteristic bird-like facies. and TID patients also have ichthyosis and 
many symptoms of CS (de Boer and Hoeijrnakers 2000: Bootsma et al. 
2001). These symptoms are explained by tbe fact tbat tbe corresponding 
proteins have additional functions outside of tbe NER context. particularly 
transcription. For instance. in tbe case of tbe CSA and CSB mutants. 
sensitivity of the transcription process to a \Vider range of lesions 
128 Chapter V 
hampering transcription may contribute to the severe developmental and 
neurological complications and premature ageing of CS. Similarly. the dual 
engagement of the XPB and XPD helicases of TFIIH in both NER and basal 
transcription initiation may give rise to the typical TTD symptoms (de Boer 
et al. 1999). However. the CS and TID symptoms are qUite distinct from the 
abnormalities exhibited by the mHR23B mouse mutant. A condition with 
some resemblance to the phenotype of mHR23B-deficiency is Cerebro-
Oculo-Facio-Skeletal (COFS) syndrome. which is considered within the 
same differential diagnosis as CS (Hamel et al. 1996). COFS is a rare birth 
defect disorder with an autosomal recessive inheritance characterized by a 
progressive brain and eye defects leading to skeletal and craniofacial 
abnormalities. postnatal grmvth deficiency. early death and genital 
hypoplasia. Further research will be required to determine whether 
mHR23B is implicated in some form of this disease or in other human 
disorders. Our work demonstrates that mHR23B is essential for normal 
development of the mouse. and implies an additional function besides its 
role in GG-NER. which is not or only partialiy compensated for by mHR23A. 
mHR23B is essential for growth and development 
The phenotypic abnormalities detected during the intrauterine development 
of mHR23B-deficient mice include prenatal (or early postnatal) death. 
disturbed growth as well as abnormalities involving improper differentiation 
of the vascular basement membrane in the placental labyrinth and 
vascularization. The placenta is essential for embryonic survival beyond 
Ell.S. as it forms vascular connections necessary for maternal-fetal 
exchange of gases. nutrients and waste products (Cross et al. 1994). Thus. 
the transport of nutrients to the embryo may be limited in the damaged 
labyrinth region of homozygous mutant embryos. This may explaln a 
number of abnormal features such as early embryonic death. swollen 
trophoblast cells. small placenta and poor. delayed development resulting 
in smaller embryos. mHR23F!' embryos that live beyond E11.5 appear 
growth retarded. We speculate that these embryos have a placenta with 
sufficient function to allow survival to term but not normal gro\\7th and 
development. This may also explain the reduction in weight. 
mHR23B-deficiency is related to an ocular defect and facial 
dysmorphology 
Mice lacking mHR23B function exhibit wet eyes and inflammation of the 
eyelids and conjunctiva. We found no gross abnormalities in the tear-
producing tissues and also drainage of tears appeared normal. However. 
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the reduction of conjunctival Goblet cells that was apparent in one of the 
examined eyes may point to an involvement of vitamln A in this phenotype. 
Vitamin A is necessary for proper differentiation and maintenance of the 
mucosal epithelium. Lack of Vitamin A causes a depletion of Goblet cells. 
which alters the composition of the tear film and eventually can lead to 
xerosis and inflammation of the eye (Huang et al. 1991). Possibly mHR23B-
deficient mice suffer from vitamin A deficiency in conjunction with 
disturbed lipid resorption. This would fit with other observations found in 
mHR23B-deficient mice. such as reduced bodyweight. low amount of body 
fat. and soft. oily faeces probably due to rectal prolapse of which the cause 
is UnknOVolIl. 
mHR23B-deficient mice also display abnormalities of facial and 
tooth development. It is possible that the biting/ cheVJing process is 
disturbed. because of an imperfect positioning of the dental elements in the 
m3.)jfla and mandible. The facial abnormalities may directly result from 
subtle developmental defects in the head region. However. reduced grov.rth 
of the palatal shelves is found in one mHR23B-/- embryo. Since the closure 
of the palate is of critical importance for proper food intake and respiration. 
this could relate to the death of many mHR23B-deficient animals around 
birth. Therefore. a more systematic analysis of this feature is warranted. to 
assess the biological significance of this observation. 
mHR23B is associated with male sterility 
Disruption of mHR23B causes defective spermatogenesis. resulting in 
absence of developing germ cells and a Sertoli-cell-only phenotype. 
mHR23A and mHR23B are e>..-pressed in all mouse tissues and organs. but 
both genes show enhanced mRNA levels in testis (van der Spek et al. 
1996b). suggesting that loss of the encoded proteins may have specific 
gonadal consequences. At EI5.5. the tubules contain Sertoli cells 'hith a 
normal histological appearance. The fetal Sertoli cells have produced AMB. 
as evidenced by Mullerian duct regression. However. the number of 
gonocytes seemed somewhat reduced. At day 15 after birth. no initiation of 
spermatogenesis has taken place and many Sertoli cells have become 
detached from the basal membrane. The results indicate that failure of 
speITIlatogenesis in mHR23B-/- animals mainly occurs beween E15_5 and 
day 15 after birth. The action of mHR23B may be involved in development 
of a normal population of gonocytes. which is capable to support initiation 
of spermatogenesis. In addition. or alternatively. mHR23B may be required 
for the postnatal initiation phase of spermatogenesis. 
130 Chapter V 
It is not clear why mHR23B+ females show decreased fertiliiy. while 
ovartan histology is normal. The reduced fertiliiy of mHR23B1- females may 
in part result from the growth retardation. 
Other functional involvements of mHR23 proteins outside of NER may 
link to the ubiquitin proteolytic pathway 
Interestingly. the developmental abnormalities detected in mHR23B-1-
animals are absent in XPC and other NER-deficient mouse mutants. This 
strongly suggests that mHR23B has a separate important function, which 
may involve the ubiquitin/proteasome pathway and which cannot be taken 
over by mHR23A. In fact, studies in yeast and in mammals have shown 
that RAD23 associates with the 265 proteasome and that hHR23 proteins 
playa role in cell cycle regulation (5chauber et al. 1998: Hiyama et al. 
1999: Kumar et al. 1999). In addition. the function of the two UBA domains 
in the RAD23 homologs is not known. though they are present in different 
classes of enzymes involved in ubiquitin-dependent proteolysis (Hofmann 
and Bucher 1996). 
The ubiquitin system is essential in all cells and is involved in 
modification of protein conformation and in degradation of proteins. 
Numerous proteins are regulated through ubiquitination and inhibition of 
the ubiquitin system. therefore frequently results in a rapid dysregulation 
of multiple cellular processes. and subsequently in apoptosis. The effect of 
a partial inhibition of ubiquitination is dependent upon the cell type: 
although lethal to some cells. it is less critical to others. Knockout mouse 
models with a gametogenic failure suggest that the ubiquitination 
machinery is important in gametogenesis (Grootegoed et al. 1998: Baarends 
et al. 2000). During spermatogenesis. dramatic changes in protein 
composition take place. which \Vi.ll e}, .. -tensively require the 
ubiquitin/proteasome machinery. Probably. different phases of mammalian 
spermatogenesis require different specialized activities of the ubiquitin 
system (Baarends et al. 2000). Mouse models in which genes encoding 
ubiquitination proteins are mutated result in placental defect. embryOniC 
lethaliiy. abnormal facies. cleft palate. and scratching behavior (Harbers et 
al. 1996: Pizzuti et al. 1997: Perry et al. 1998). 
Taken together. our data suggest that the mammalian HR23 
proteins have a broader function outside of NER To provide further 
evidence. generation of single knockout mHR23A mice and cells is 
undertaken. 
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Experimental Procedures 
Construction of mHR23B targeting vector 
Isogenic mouse genomic DNA was isolated from an Ola/129-derived phage lambda library after 
probing with human HR23B cDNA sequences. A 13.6 kb SalI fragment. containing three e:"wns (lI-
IV), was subcloned :Into the SalI site of a pUC-vector. deSignated as pNlHR23Bl (16.5 kbp). 
Following several sub-clOning steps, a 2.5 kb EcoRI fragment (containing exon II) was cloned at 
the CIa! site and a 4.5 kb Ncol-Sac! fragment (containing e.'Con IV) was positioned between the 
NotI-SacII sites of the targeting vector pmHR23B-E3 (6.9 kb) representing the 5'- and 3'-arm of 
homology, respectively. Thus, in the targeting vector e."\.on ill (amino acids 148 to 228) was 
replaced with a cassette cont.ain.iJ:1g (PGK-promoter dliven) neomycin resistance gene and an UMS 
sequence (deScribed as a transcriptional stop sequence (Heard et al. 1987)). The vector also 
contained the negative selectable marker HSV-1K (herpes Simplex virus thymidine kinase gene). 
ES cell culture and transfection 
The Olal29-derived ES cell line E14 was e1ectroporated with the mHR23B targeting construct and 
cultured on gelatinized dishes as described (van der Horst et al. 1997). 0418 (Geneticin, Gibco) 
was added 24 hr after electroporation to a final concentration of 200 ).lg/ml, and the cells were 
maintained under selection for 6-8 days. Genomic DNA from :Individual G418-resistent clones was 
digested with Sac! and analy/.ed by Southern blotting uSing a genomic PCR fragment (255 bpj, 
isolated between SacI-EcoRI sites (upstream of Exon In, as a probe. Targeted clones, with the 
correct hybridizing Sad fragments. were subsequently screened with a fragment of the neomyCin 
resistance gene as a probe to confirm proper homOlogous recombination. 
Generation of the mHR2SB-deficient mice and fibroblasts 
Cells of mHR23S-targeted clones were karyotyped, and ES cells from two independent clones with 
40 chromosomes were injected into 3.5-day-old blastocysts isolated from pregnant C57BL/6 
females (van der Horst et al. 1997). Male chimeric mice were mated with C57BL/6 females to 
obtain heterozygote animals. Germline transmission was observed in the coat colour of the Fl 
offspling. Heterozygous male and female were interbred to generate mHR23B+/+, mHR23B+/', and 
mHR23g/- mice. Genotyping was performed by Southern blotting with genomic DNA prepared 
from tail biopsies of 1 0-14-day-old born pups. Primary mouse embryonic fibroblasts (at least three 
independent lines per genotype) were isolated from day 13,5 embryos obtained from matings 
between mHR23B+/' mice (FI). Part of the embryo was used for genotyplng. The remaining 
embryonic tissue was minced using a Pair of scissors and immersed in a thin layer of FlO/D11EM 
culture medium (Gibco BRL) supplemented with 15% fetal calf serum, 2mM glutamate, and 50 
).lg/ml penicillin and streptomycin. 
Northern blot analysis 
20 ).lg of total RNA samples were separated on 0.9% agarose gel and transferred to Hybond-N+ 
membrane (Arnersham Pharmacia Biotech). Total RNA was isolated from mHR23B 11EFs USing the 
acid guanidinium-phenol-chloroform (AGPC)2 method as described (Chomczynski and Sacchi 
1987). RNA blots were hybridized using mHR23A and mHR23B 32P-labeled eDNA probes. 
Protein analysis 
Immunoblot analysiS of mHR23B protein was perlormed on fibroblast e.."\.tracts obtained by 
sonification (5 x 106 cells in 300 ).ll PBS containing PMSF and CLAP). 80 ).lg of total cellular protein 
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per lane was separated on 8% SDS-polyacrylarnide gels. blotted to nitrocelluloses (Schleicher & 
Schuell). and probed with rabbit polyc1onal antibodies recognizing mHR23B. Bands were 
visualized using peroxidase-conjugated secondary antibodies. 
DNA repair assays 
UV sensitivity \.Vas determined as described (Sijbers et al. 1996). :MEFs cultures were e."":posed to 
different doses of lIV-C (254 nm. Philips TIN lamp) and allowed to grow for another 3-5 days. 
before reaching confluency. The number of proliferating cells was estimated by scintillation 
counting of the radioactivity incorporated during a 3 hr pulse with nIlthymidine (5 )..LCi/mL 
specific activity (s.a.): 40-60 Ci/mmole: Amersham). Cell survival was e.'\.-pressed as the ratio of 3H 
incorporation in irradiated and non-irradiated cells. UV-induced gIob31 genome repair was assayed 
using the UDS method as described (Vermeulen et 31. 1994). Cells were exposed to 16 J/m2 of 254 
nm UV light and labelled with [methyl-3Hlthymidine (l0 j..lCi/ml. s.a.: 40-60 Ci/mmole1. Repair 
capacity was quantified by grain counting after autoradiography. RNA synthesis recovery after UV 
irradiation was measured as follows. Cells were labelled with [2_14Clthymidine (0.05 j..lCi/ml. s.a.: 
56 Ci/mmole) for 24 hr. then e.-q>osed to different doses of 254 run UV light. allowed to recover for 
16 hr. labelled with [5,6-3H]uridine (10 j..lCi/mL s.a.: 47 Ci/mmole1 for 1 hr. and processed for 
scintillation counting. The relative rate of R~A synthesis was e.'\.-pressed as the ratio of radioactivity 
of UV-irradiated over non-irradiated cells. The method for grain counting after autoradiography 
was described according to Mayne and Lehman (l9821. 
Histology and electron microscopical analysis 
For histolOgical e.xamination, dissected tissues fL-xed in Bollin or in 10% neutral buffered formalin 
were processed and embedded in paraffin. Mounted sections (5-8 iJ.Ill1 were stained with 
hemato:-..ylin and eosin using routine procedures. For transmission electron microscopy, small 
pieces of tissue were fi.-..::ed in buffered 4% paraformaldehyde and postfixed in 1% OS04 + K:,Fe(CN)6 
(de Bruyn et al. 1973). After dehydration and embedding in Epon. liJ.Ill sections were cut and 
stained with methylene blue. 
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Summary 
Primary DNA damage sensing in mammalian global genome nucleotide 
excision repair (GG-NER) is done by the XPC protein complexed with 
HR23B. one of the two homologs of the yeast ubiquitin domain repair factor 
RAD23. Knockout mice for mHR23A and mHR23B revealed a fully 
redundant role of both RAD23 homologs in NER and a partially redundant 
function in embryOniC development. Inactivation of both genes causes 
embryonic lethallty. Analysis of a mHR23A/B double mutant cell line led to 
the discovery that XPC stability depends on HR23 and that NER damage 
further stabilizes XPC. These findings resolve the main function of RAD23 
in repair. reveal a novel level of regulation of GG-NER (e},.-plaining the long 
known phenomenon of enhanced reactivation) and clarify the link between 
NER and the ubiquitin system. Additional involvement of HR23/RAD23 in 
other cellular processes such as base excision repair. chromosome 
segregation. and cell cycle control explains the essential function of HR23 
and suggests a damage response mechanism in mammals similar to the 
50S system in E.colL 
Introduction 
A network of DNA repair systems has evolved to protect the genome against 
the deleteriOUs effects of a wide range of DNA lesions. Nucleotide excision 
repair (NER) is the primary mechanism for the removal of UV-induced 
cyclobutane pyrimidine dimers and pyrimidine (6-4) pyrimidone 
photoproducts. and numerous bulh-y chemical DNA lesions (Friedberg et al. 
1995). inherited defects in NER are the cause of the severe UV-sensitive 
syndrome xeroderma pigmentosum (XP). Patients exhibit mainly cutaneous 
symptoms. including extreme sun sensitivity. sun-induced pigmentation 
anomalles and a >2000-fold predisposition to skin cancer. XP is a 
multigenetic disease. comprising XPA to XPG genes (Bootsma et al. 2001). 
NER is a highly conserved. multistep -cut and patch- type reaction 
involving the concerted and coordinated action of approXimately 30 
proteins. These act in sequential steps of DNA damage detection. chromatin 
remodelling. helix opening. damage verification and dual incision of the 
damaged strand at some distance from the leSion. followed by removal of 
the damage-containing oligonucleotide. gap filling DNA synthesis and 
ligation. (de Laat et al. 1999: Wood et al. 2001). Two distinct NER 
subpathways are recogniZed. i.e. global genome nucleotide exCision repair 
(GG-NER). operating over the entire genome and transcription-coupled 
nucleotide exCision repair {TC-NER1. focussing on transcription-blocking 
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lesions in the transcribed strand of active genes (Hanawalt et al. 1994: 
Hanawalt 2000). Most XP genes are implicated in both NER subpathways. 
but XPC-deficient cells are unique in being selectively deficient in GG-NER 
(Venema et al. 1990 and 1991: van Hoffen et al. 1995). 
Previously. we have identified wo human homologs of the 
Saccharomyces cerevisiae NER gene EAD23. designated hHR23A and 
hHR23B (Masutani et al. 1994). All RAD23 homologs are highly conserved 
and have an ubiquitin-like (UbL) N-terminus and two ubiquitin-associated 
(DBA) domains. indicating intimate links with the ubiquitin/proteasome 
pathway (Hofmann and Bucher 1996: van der Spek et al. 1996b: Bertolaet 
et al. 2001). In yeast. the UbL domain of RAD23 is important for UV 
survival and for interaction with the 26S proteasome (Watkins et al. 1993. 
Mueller and Smerdon 1996: Schauber et al. 1998). The hHR23B gene 
product is tightly complexed with the GG-NER specific XPC protein and a 
recently identified third component centrin 2 (CEN2) (Masutani et al. 1994: 
Araki et al. 2001). The initial damage-sensing step within GG-NER is 
performed by this complex. which triggers the subsequent association of 
NER factors TFIIH. XPG. XPA. and RPA (Sugasawa et al. 1998: Yokoi et al. 
2000: Araujo et al. 2001: Volker et al. 2001). In vitro repatr studies showed 
that hHR23B stimulates the NER activity of recombinant XPC (Sugasawa et 
al. 1996). Moreover. the 60-amino-acid XPC-binding domain of hHR23B 
alone is sufficient for XPC stimulation (Masutani et al. 1997). In whole cell 
extracts the vast majority of XPC is complexed with hHR23B (van der Spek 
et al. 1996a) whereas a minor amount copurtfies with hHR23A (Araki et al. 
2001). Moreover. in vitro formed complexes between XPC and hHR23A can 
substitute for hHR23B in binding and stimulating of XPC. suggesting a 
possible functional interchangeability between the two mammalian 
homologs of RAD23 (Sugasawa et al. 1997). Since only a minority of cellular 
hHR23B and hHR23A is complexed with XPC. whereas the majority exist in 
a free form in vivo. both proteins are thought to have additional functions 
outside NER (van der Spek et al. 1996a: Sugasawa et al. 1996). 
Recently. we have inactivated the mouse RAD23 homolog mHR23B 
by gene targeting in the mouse germ line (Ng et al. submitted). mHR23B-
deficient cells are not UV-sensitive. which is in agreement with the in vitro 
findings suggesting functional redundancy of the two mammalian RAD23 
homologs (Sugasawa et al. 1997: Ng et al. submitted). However. unlike 
other NER mouse mutants. mHR23B-deficient mice show a severe 
phenotype associated with impaired embryonic development and high rates 
of intrauterine death. Surviving animals display retarded growth. male 
142 Chapter VI 
A Targeting construct 
BamH! 
Neo 
TK 
Wildtype allele 
BamHI BamHI 
II ill IV cCV_V~' ____ ~Yil=v~m~"" ______ -:== 
5.0kb _ 
Targeted allele 
B .:t I +: + 
- 5 kb 
- 3.5 kb 
0 $ J.. J.. I ~ + I I 
mHR23A-
!3-actin -
BamHI 
Neo 
C + +: 
E 
mHR23A 
(50 kDa) 
XPC 
(125 kDa) 
probe 
BamH! 
3.5 kb 
-probe 
J.. I ~ 
+ I 
-5 kb 
- 3.5 kb 
$ J.. + I ~ + I 
* 
Figure 1. Targeted disruption of the mHR23A gene by homologous recombination. (Al Genomic 
orgarw..ation and disruption strategy for mHR23A showing the gene. the targeting construct, and 
the targeted m.HR23A aJlelc. Exons III to VI (and part of Coxon II and VII) were replaced by the 
dominant selectable neomycin resistance marker transcribed in antisense orientation. (B) 
Southern blot analysis of BamBI digested DNA from ES cells shOwing the 5.0 kb and 3.5 kb 
fragment representing the wlldtype and the targeted allele of mHR23A respectively. (el Southern 
blot analysis of BamHI digested tail DNA from mHR23A .. / .... mHR23A+1-, and mHR23A/' mice. (D) 
RNA blot analysis of mHR23A mRNA in cellular e.'\."tracts from mHR23A+1+, mHR23A""-. and 
mHR23A!' .MEFs uSing mHR23A eDNA as a probe (upper panel). As a loading control for the 
amount of R~A. the blot was reprobed with ~-aetln eDNA Gower panel). (E) Immunoblot analysis of 
mHR23A protein in cellular e.'\.tracts from mHR23A .. / .... mHR23A"'/-, and mHR23A/· MEFs using 
polyclonal antibodies against the human HR23A protein (upper panel). Polydonal antibodies 
against the human XPC protein (lower panel) were used as a loading controL The asterisk 
indicates an aspectfic crossreacting band. 
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steriliiy and facial dysmorphology (Ng et al. submitted). These data 
show that mHR23B is essential for normal development of the mouse. and 
are indicative for a separate role of mHR23B outside the NER conteA-t. 
which likely involves the ubiquitin/proteasome pathway. Apparently. this 
role is not or only in part compensated for by mHR23A 
The precise role of the RAD23 proteins in NER has been enigmatic. 
To investigate the biological impact of the mammalian RAD23 proteins in 
an XPC-mediated repair mechanism. we generated mHR23A-1- mouse 
mutants by gene targeting. By crossing these animals into a mHR23S!-
background. we obtained embryos and a mouse embryoniC fibroblast line 
v.rith a complete mHR23-deficiency. Here. we report the application of these 
double mutant cells to elucidate the function of mammalian RAD23 
homologs in NER. 
Results 
Generation of mHR23A-deficient mice and cells 
To generate a mouse model for mHR23A. we made a targeting construct in 
which exons III to VI (and part of exon II and VII) were replaced by the 
dominant selectable neomycin reSistance marker transcribed in antisense 
orientation. This deletes -2/3 of the coding region including part of the UbL 
N-terminus and the entire first highly conserved UBA domain and thus is 
expected to give rise to a null-allele (Figure lA). ES cell clones canying one 
disrupted mHR23A allele (Figure IB) were obtalned. after homologous 
recombination at a frequency of approximately 16%. Two clones verified for 
the absence of visible chromosomal abnormalities and additional. randomly 
integrated constructs were used for blastocyst injections to produce germ 
line chimeras. Heterozygous offspring from matings between chimeric males 
and C57BL/6 female mice was intercrossed to generate homoZjTgous 
mutant mHR23A animals (Figure Ie) and day 13.5 embryos (E13.5) for 
isolation of mouse embryOniC fibroblasts (MEFs) of the three e":pected 
genotypes. In agreement with the absence of wildtype mHR23A mRNA the 
50 kDa wildtype mHR23A protein could not be detected in mHR23A/' 
MEFs. as shown by RNA and immunoblot analysis respectively (Figure ID 
and IE). We conclude that we have generated mHR23A null mice. The two 
independent mouse lines were biochemically and phenotypically 
indistinguishable for all parameters tested. indicating that the findings 
presented in this study are not due to random events that might have 
occurred in one targeted ES clone. but are the result of genuine mHR23A 
inactivation. 
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mHR23A-i- animals and MEFs 
Because of the role of mHR23A in NER, as suggested by in vitro experi.ments 
(Masutani et al. 1994) and the mHR23B mutant (Ng et al. submitted) we 
assessed key repair parameters in the mHR23A/· MEFs. As shown by 
Figure 2. UV survival. UV-induced unscheduled DNA synthesis (UDS). and 
RNA synthesis recovery after UV -exposure were aJl in the wildtype range. 
This indicates that global as well as transcription-coupled NER are 
unaffected. These data suggest that. in agreement with the in vitro repair 
studies. mHR23A and mHR23B are functional redundant NER proteins in 
vivo. 
Crosses between heterozygous mutant mHR23A animals yielded 
mHR23A'/- mice in a Mendelian fashion (data not shown), In striking 
contrast to mHR23B/· animals. mHR23A-deficient mice failed to display any 
detectable abnormalities and appeared indistinguishable from wildtype and 
heterozygous litterrnates for all parameters tested. such as morphology. 
maIn pathology and growth rate at least up to 16 months. In addition. male 
and female mice were -completely fertile. and their mating activity and litter 
size were normal. Apparently, mHR23A is not essential for mouse 
development and mHR23B can compensate for most functions of mHR23A. 
Total mHR23-deficiency is incompatible with animal life 
Inactivation of neither mHR23A nor mHR23B (Ng et al. submitted) results in 
a NER defect. In order to investigate the effect of a total mHR23-deficiency. 
double heterozygous matings were set up to generate mHR23A/B 
homozygous double mutant animals (mHR23A-1-/B-1-_ hereafter referred to 
as: ·DKO" for double knockout) and to obtain corresponding MEFs. 
Remarkably. in the 427 offspring analyzed no DKo"s were found (Table 1). 
indicating that inactivation of mHR23A further aggravates the severe 
developmental defects caused by a mHR23B-deficiency to a level 
incompatible with life. Surprisingly. whereas we obtained mHR23A/·/B+/· 
mutant male and female mice at Mendelian e""pectance (71/427 found and 
83/427 expected) that in all aspects were phenotypically indistingulshable 
from wildtype mice. mHR23A+/·/H/· mutant animals were not born (0/427). 
This indicates that loss of even one allele of mHR23A in a total mHR23B 
null-background affects embryogenesis and causes lethality. The observed 
gene dosage effect for mHR23A suggests that both mHR23 gene products 
are essential for proper mouse development_ 
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Table 1. Genotype analysis of DKO embryos and offspring 
Stage Analyzed Expected" Found 
(if mendelian) 
E8.5 43 7 3" 
EIO.5 14 1.8 0 
E13.5 77 9.1 0 
Newborn 427 41.4 0 
*Derived from different mHR23A+/-;B+/' and mHR23A/' 
/B+/' intercrosses: IIOne cell line established. 
To investigate at which embryonic stage a total mHR23-deficiency 
becomes lethal and to attempt to obtain a DKO cell line. we isolated 
embryos from different crossings at various stages of development. 
Although we did not observe DKO embryos at day E13.5 and EIO.5. we 
could isolate mHR23-deficient embryos at day E8.5. Importantly. three DKO 
MEF lines were obtained from E8.5 embryos (3/43. see Table 1) which were 
smaller compared to the heterozygotes and wildtype embryos. These cells 
displayed severe growth Impairment compared to wUdtype and double 
heterozygous mutant MEFs. Although this resulted in the loss of two of the 
lines. we succeeded in establishing one DKO cell line after 30 weeks 
culturing. This cell line verified for its mHR23 status by genotyping (not 
shown) permitted characterization of a total mHR23-deficiency. 
Given the embryonic lethality observed in mHR23A+/'/F/' mutant 
mice we also isolated cell lines with only one intact mHR23A allele (using 
E13.5 embryos. which were also smalier than controls). Unlike mHR23A/' 
/B+/' mutant cells which proliferated normally. mHR23A+/'/H/' MEFs 
showed poor grov.rth. 
Total mHR23-deficient cells show an XPC-like repair phenotype 
Cell survival ",,--perIments revealed that DKO MEFs are remarkably Similar 
to XPC·/- cells in terms of UV survival (Figure 2D). deficiency of UV-induced 
UDS and proficiency of RNA synthesis recovery after UV-exposure (Figure 
2E and F). In contrast. MEFs retaining only one mHR23A or mHR23B allele 
were NER competent (Figure 2D). Apparently. one out of four mHR23 copies 
is sufficient for normal NER activity. 
The strtking resemblance to the XPC /- repair phenotype prompted 
us to examine the status of the XPC protein in the DKO MEFs. Interestingly. 
XPC was undetectable in DKO cells by comparative immunofluorescence 
(Figure 3A-F). In addition. also on immunoblots a strongly reduced steady 
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Figure 2. Repair characteristics of mHR23A E13.5 primary MEFs (A-C: identical results were 
obtained for each genotype with three other independent lines (data not shown)) and DKO E8.5 
(passage 17) :vIEFs CD-F): (AD) UV survival CUP.!es; (B,E) global genome repair (liDS): (C.F) R~A 
synthesis recovery (RRS). (A) UV survival of mHR23A"/~. mHR23A+-/-, and mHR23A/' MEFs. XPC/-
fibroblasts were included as negative control. (B) DDS in mHR23A .. / .... mHR23A .. j •• and mHR23A!' 
1'IEFs. XPA/- fibroblasts were measured as negative control. {el RRS after tN-exposure of 
mHR23A+I+, mHR23A+I ·, and mHR23A/· MEFs. CSB-f. cells were used as negative control. (D) LV 
survival of MEF lines of wildtype. XPC-I ·. mHR23AI )B+I ., mHR23A+I )B"I., and mHR23A/-/B-f. 
(DKOj. (E) UDS in wildtype, XPC-I-, and DKO MEFs. (F) RRS after UV-irradiation of wild type, XPC-/', 
and DKO MEFs, 
state level of XPC is observed in whole cell extracts of DKO compared to 
wildtype (Figure 3G and H). Thus. XPC is either hardly e'-"pressed at RNA or 
protein level or unstable in the absence of both mouse RAD23 proteins. In 
view of the direct physical interaction between HR23 proteins and XPC the 
latter option seems most plausible. 
hHR23B and hXPC-GFP rescue the UV-sensitivity of DKO cells 
To provide direct evidence that the XPC-like phenotype of DKO cells is the 
consequence of the mHR23 defect we stably transfected human (h)HR23B 
cDNA into double mutant MEFs. hHR23B was able to correct the UV-
sensitivity of DKO cells, although rescue was incomplete perhaps due to 
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Figure 3. XFC e.'q)ression in DKO E8.5 11EFs. (A-F) Phase contrast (A and D) and epifluorescense 
(E, C. E and F) images of a""ed wildtype CWT. labeled with late ..... beads). XPC/· (xpc) and mHR23A/-
/B/' (DKO) lVIEFs. Cells were fi.xed by parafonnaldebydc. permeabillzed by 0.1% triton X-IOO. and 
subsequently immunolabelcd with affmity purified polyclonal antibodies against the human XPC 
protein (B and E: stained green with goat anti-rabbit Alexa 48S-labeled secondary antibody). 
Monoclonal antibodies recogniZing p62 subunit of TFIIH (C and F; stained red with goat anti-
mouse Cy3-labcled secondary antibody) were used as an internal control. .All images were taken at 
the same magnification. (G-H) Irrununoblot analysis of XPC protem in cellular e.,tracts from 
wUdtype, XPC/· and DKO ES.5 MEFs using polyclonal anti-human XPC antibodies (G). Monoclonal 
anti-p62 antibodies were used as an internal reference for the amount of protein in each lane (H). 
human-mouse differences (Figure 4A). Importantly. expression of hH23B 
induced increased levels of the endogenous rnXPC. as shown by both 
immunoblot (Figure 4C. lane 4) and immunofluorescence analysis (Figure 
4D and E). 
Since the absence of mHR23 causes a strong reduction in rnXPC we 
reasoned that (over)e:x.-pression of 'exogenous' XPC might bypass the repair 
defect of DKO cells. To that aim. we generated double mutant MEFs that 
stably express hXPC. To allow direct observation within living cells 
(Houtsmuller et a1. 1999) hXPC was C-terminally tagged with GFP 
containing an additional His6-HA double tag (Figure 4B). Functionality of 
the eDNA encoding hXPC-GFP-His6HA was demonstrated by microinjection 
and transfection of the DNA construct in XP-C cells (data not shown). 
Although hXPC-GFP expression was undetectable as assessed by 
fluorescence microscopy (Figure 4F and H) UV survival revealed that the 
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stable transformants (verified for the presence of hXPC-GFP cDNA by DNA 
blotting) had largely regained wildtype resistance (Figure 4A). indicating 
that the repair defect was rescued. Unfortunately. our XPC antibodies 
(raised against the C-terminus of the protein) failed to recognize the hXPC-
GFP because of the presence of the C-terminal tag. Also eA.-pression \VaS too 
low to be detected by the HA-epitope antibody. However. introduction of 
hXPC-GFP appeared to restore the level of the endogenous mouse XPC as 
shown by immunoblot (Figure 4C. lane 5) and immunofluorescene analysis 
(not shown). Apparently. the hXPC-GFP has a trans-effect on rnXPC 
stability. 
To investigate the stabilizing effect of mHR23B on XPC we 
cotransfected hHR23B together with hXPC-GFP cDNA into double mutant 
cells. Stably transfected clones exhibited wildtype UV -resistance (Figure 4A) 
and normalized levels of the endogenous rnXPC (Figure 4C. lane 6. and not 
shown), In contrast to the MEFs eA"pressing only hXPC-GFP. these 
transfectants displayed in a fraction of cells green fluorescent nuclei. in 
combination with bright fOCi dispersed throughout the nucleus (Figure 4G 
and I). The function of these fluorescent foci is as yet unclear. but they may 
represent storage locL These data indicate that the cotransfected hHR23B 
acts as a stabilizing factor for both hXPC-GFP and endogenous mXPC. 
DNA damage causes a dramatic increase of ilXPC-GFP 
The hXPC-GFP e""pression was heterogeneous in the XPC-GFP /hHR23B 
transfected cell population. with only 18 % of cells (88/485) exhibiting 
fluorescent nuclei (Figure 4G and IJ. This cell line provided a convenient 
tool to monltor the effect of DNA damage on XPC steady-state-level in living 
cells. To our surprise. UV-irradiation (5 and 10 J/m2) markedly increased 
the percentage of green cells as well as the intensity of the GFP signal. 
Kinetic analysis upon UV-exposure (10 J/m2) showed a time-dependent 
reversible accumulation of XPC-GFP expression (Figure SA). To follow the 
tN-induced increase of hXPC-GFP levels in more detail nuclear expression 
in living single cells was monitored in time after irradiation with 10 J/m2 . 
Before UV hardly any fluorescence is detectable (F1gure 5C and E), but 6 
hours after 10 J/m2 . the same cells and also a vast majority of the entire 
culture show green nuclei (Figure 5D and FJ. Increased XPC levels upon 
UV-irradiation was further corroborated by imrnunoblotting of whole cell 
extracts using antibodies against the HA epitope attached to the GFP tag 
(see F1gure 5B. lane 2 for 6 hrs post-UVl, UV-induced nuclear accumulation 
of hXPC-GFP was dependent on hHR23B as no fluorescence was noted in 
UV-exposed cells transfected with hXPC-GFP alone (results not shown), 
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Figure 4. Characteri7..ation of DKO cells e..'-pressmg hHR23B and XPC-GFP. (A) IN survival of 
wildtype. XPCI '. DKO. and DKO :vr.EFs cotransfected with: hHR23B (h23B). human XPC-OFP 
(hXPC). and h23B and hXPC cDNAs. Cells were e.'\..-posed to different doses of UV (254 run). For 
each cDNA construct. similar results were obtained with at least t"vo other independent stably 
transfected cell lines (data not shown). (Bl Schematic representation of XPC-EGFP-HiSI3HA-N3 
fusion protein (1208 aa). Indicated are the human XPC protem (940 aa). the enhanced green 
fluorescent protein tag (EGFP: 238 aa). and the histidine-hemagglutinin epitope tag (HiStiHA: 17 
aa). (el Immunoblot analysiS of XPC e..'-pression in cellular e.,tracts of \VI' (lane 1). XPC (lane 2). 
DKO (lane 3). and DKO MEFs cotransfected with: h23B (lane 4). hXPC (lane 5). and h23B and 
hXPC (lane 6) cDXAs. using a polyclonal anti-human XPC antibody (upper panel). Monoclonal anti-
p62 antibodies were used as a loading control (lower panel). {D-E} Phase contrast (0) and 
epifluorescense (E) images of fi.....::ed \VI' (labeled with late.....:: bcads) and DKO cells cotransfected with 
hHR23B cDNA Cells were fixed by paraformaldehyde. followed by 0.1% tliton X-lOO 
penneabili7..ation and subsequently immunolabeled with affinity purtfied polyclonal anti-human 
XPC (E: stained green with goat anti-rabbit Ale......::a 488-labeled secondary antibody). Monoclonal 
anti-p62 antiserum was used as an internal control (stained red with goat anti-mouse Cy3-labeled 
secondary antibody: data not shown). All images were taken at the same magnification. Similar 
results were obtained with DKO cells cotransfected with hXPC·GFP. and hHR23B and hXPC-GFP 
cDKAs (not shown). (F-I) Phase contrast (F and G) and epilluorescense (II and I) images of living 
DKO cells cotransfected with: hXPC-GFP (F and H). or hHR23B and hXPC-GFP (G and I) cDNAs. All 
images were taken at the same magnification. The numbers represent the XPC-GFP e.'-pressing 
cells and the non-GFP e."q)ressing cells. 
These data indicate that the level of XPC is responsive to UV -irradiation in 
an HR23-dependent fashion. 
To investigate whether ){PC accumulation is specific for NER-type 
DNA damage or just a stress related response cells were eA-posed to different 
kinds of genotoxic agents. N-aceto)"y-2-acetylaminofluorene (NA-AAF} that 
induces bulk), adducts processed by the NER machinery (Amacher et al. 
1977) elicited a very potent UV-like response in all cells within 6 to 8 hrs 
(Figure 6A-D). In contrast. exposure to y-rays (6 and 10 Gy) and mitomycin 
C (MMC. 1.2 and 2.4 ~/ml) inducing mainly double strand breaks and 
interstrand crosslinks respectively. both of which are dealt with by other 
repair pathways. failed to provoke any detectable XPC accumulation or 
enhance the UV effect when combined with UV-irradiation (data not 
shown). The possibility that UV and NA-AAF evoke a general protein 
accumulation was ruled out since cells ex-pressing GFP alone do not exhibit 
a Significant increase in fluorescence after genotoxic insults. This indicates 
that lesions specifically recognized by the NER pathway enhance the level of 
HR23-dependent hXPC-GFP. 
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Figure 5. Effect of UV on hHR23B-dependent XPC-GFP level in living DKO cells. CA) Kinetic 
analysis of living DKO cells c,:pressing XPC-GFP!hHR23B upon 10 J/m'2 UV-C in time over a 
period of 30 hours. The percentage XPC-GFP was expressed as the number of GFP e.'\:pressing cells 
divided by the number of non-GFP e.'\.-presslng cells. (Bl Immunoblot analYSis of DKO cells 
e.,\:pressing XPC-GFP/hHR23B before e.xposure to damaging agent (lane 1). 6 hr after e.'\."])osure to 
10 Jim:!; UV-C (lane 2), and 6 hr after treatment with 10 ).1M CBZ-LLL (lane 3) uSing monoclonal 
antibodies recognizing the HA ep1tope (upper panel). A monoclonal antibody against the p62 
subunit of TFIIH (lower panel) V,jas used as a loading control. Sfm:ilar outcome was obtained with 
two other independent DKO cell lines e),.1>ressing XPC-GFF/hHR23B (data not shown). (C-F) 
Combined phase contrast (red) and fluorescence (green) images (C and D), and epifluorescence 
images (E and F) of living DKO cells expressing XPC-GFP /hHR23B before UV (C and E) and 6 hr 
after 10 J/m2 UV-C (D and F). 'White arrows indicate the scratch mark on glass coverslips (24 rom 
0). The numbers represent the same living cells before and after UV-c,-posure. Identical results 
were obtained With wo other independent DKO cell lines e."qJressing XPC-GFP/hHR23B (data not 
shown). A1limages were taken at the same magnification. 
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One of the direct consequences of UV- as well as NA-AAF-induced 
DNA damage is a temporary block of transcription. To investigate whether 
hXPC-GFP accumulation requires transcription or is induced by blockage of 
transcription independent of DNA damage. transcription in DKO cells 
e"-'Pressing hXPC-GFP /hHR23B was arrested by incubation witb 5.6-
dichloro-l~-D-ribofuranosyl-benzinlidazole (DRB. 100 ~ which is able to 
reversibly inhibit transcription initiation by RNA polymerase II (Chodosh et 
al. 1989). No induction of XPC-GFP fluorescence was registered after DRB 
administration. In fact. preincubation witb DRB (2-3 hrs) prior to UV 
treatment prevented UV-induced XPC accumulation. indicating that 
transcription is required for observing the dramatic increase of XPC. 
Consistent with this result no enhanced XPC fluorescence was found with 
translational inhibitor cyclohexamide (30 and 50 M/ml. data not shown) 
demonstrating the requirement for de novo protein synthesis. 
hXPC-GFP is degraded via ubiquitin-dependent proteolysis 
To furtber examlne tbe HR23-dependent XPC stabilization. DKO cells 
expressing hXPC-GFP /hHR23B were incubated witb tbe proteasomal 
proteolysis inhibitor N-CBZ-LEU-LEU-LEU-AL (CBZ-LLL. Wiertz et al. 
1996). Like for UV-irradiation and NA-AAF treatment. all cells displayed a 
striking XPC-GFP accumulation in time (Figure 6E-H). which was reversible 
upon drug removal (not shown). and was confirmed by immunoblot 
analysis using anti-HA antibodies (Figure SB. lane 3). These data indicate 
that degradation of XPC-GFP occurs via ubiquitin-dependent proteolysis. 
Consequently. NER damage together with HR23 protein somehow interfere 
with this process. This tranSient stabilization leads to a rapid increase of 
hXPC-GFP via de novo syntbesis of mRNA and protein. 
Application of local UV damage on hXPC-GFP expressing cells 
Two mechanisms may explaln tbe tranSient stabilization of hXPC-GFP. The 
binding of XPC to DNA damage per se mlght protect it from proteolysis. 
Alternatively (or in addition) DNA damage may trigger a specific response. 
that inhibits degradation of XPC independent of its binding to lesions. To 
explore tbe mechanism by which hXPC-GFP is stabilized we employed a 
recently developed method for induction of DNA damage in a restricted part 
of the nucleus. For this purpose. monolayer cultures of DKO cells 
eA'})ressing h.XPC-GFP /hHR23B were covered with an isopore polycarbonate 
filter with pores of -S flID- in diameter. Upon UV-irradiation only at the 
position of pores UV-damage is induced. Cells were fIxed at different time 
pOints after UV to allow simultaneous immunostaining with antibodies 
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Figure 6. EiIect of NA-AAF and proteasome inhibitor on hHR23B-dependent hXPC-GFP level in 
living DKO cells. (A-D) Combined phase contrast (red) and fluorescence (green) images (A and Bl, 
and epifluorescence images (C and D) of living DKO cells e.'\-pressing XPC-GFP/hHR23B before NA-
AM' (A and C) and 8 hr after 50 ).lM: KA-AAF (B and D). VVhite arrows indicate the scratch on glass 
coverslips (24 mrn 0). The numbers represent the corresponcling living cells on coverslips before 
and after NA-AAF treatment. Identical results were obtained with 1:\\'0 other independent DKO cell 
lines expressing XPC-GFP/hHR23B (data not shown), All lInages were taken at the same 
magnification. (&-H) Combined phase contrast (red) and fluorescence [green) images (E and Fl. and 
only epifluorescence images (G and H) of living DKO cells e.'\.-pressing XPC-GFP /hHR23B before 
treatment with proteasome inhibitor CBZ-LLL (E and G) and 6 hr after 10 j.lM CBZ~LLL (F and H). 
All images were taken at the same magnification. 
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against various proteins and GFP fluorescence microscopy (Figure 7). Non-
irradiated nuclei and non-damaged regions 'Within partly irradiated nuclei 
serve as internal controls. Very rapidly (within a few minutes) after UV-
exposure GFP fluorescence and anti-HA immunostaining revealed high local 
accrual of the hXPC-GFP(His.,HA) in part of the nuclei. These XPC-GFP 
concentrations colocalize with accumulations of other NER proteins. XPA 
and p62 (subunit of TFIIH) (Figure 7 and not shown). These locations 
correspond with sites of local UV damage (Volker et al. 2001: Mone et al. 
submitted) to which all tested NER proteins have been found to specifically 
migrate (unpublished results). These findings demonstrate that in living 
cells the GFP-tagged XPC protein translocates very rapidly to sites 
containing UV lesions. When XPC stabilization occurs only after binding to 
the damage we expect an increase in fluorescent signal selectively at the 
damaged sites. On the other hand. with an overall stabilization of hXPC. it 
is expected that in time a concomittant increase of fluorescence over the 
entire nucleus (in addition to the damaged area) would be observed in 
comparison to non-damaged nuclei. The increase of hXPC-GFP (Figure 7 A) 
is initially only at the locally damaged sites. but after two hours also in the 
remainder of nuclei containing local damage a clearly higher signal is noted 
when compared to non-exposed nuclei in the vicinity (Figure 7B). These 
findings suggest that an overall intranuclear stabilization of hXPC-GFP 
occurs. 
Discussion 
Involvement and function of HR23A and HR23B proteins In NER 
The aim of this work was to shed light onto the enigmatic role of the two 
HR23 proteins in NER and to reveal the biological impact of both factors by 
the generation of mHR23A and mHR23B mutants in the mouse germ line. 
Since single mutants falled to exhibit any detectable NER defect the most 
logical interpretation is that these proteins are functionally redundant 
despite their >40% amino acid sequence divergence and size difference 
(Masutani et al. 1994). However. definite proof requires the availability of 
double mutant cells. which we were able to establish notwithstanding early 
lethallty of double mutant embryos and poor growth properties of the cells 
during adaptation to in vitro culturing (see Results). The NER-deficient 
phenotype exhibited by DKO cells and the ability of each of the HR23 genes 
to rescue this defect unequivocally established the involvement of mHR23B 
as well as mHR23A in NER and their fully overlapping functions in repair. 
Further characterization of the type of NER defect of the DKO cells 
revealed a selective impairment of the global genome NER subpathway and 
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Figure 7. UV-eA-posure through isopore fIItcr induces locally damaged spots and overall 
stab:ilization in the nuclei of DKO cells e:....-preSSing XPC-GFP /hHR23E. DKO cells eA-pressing XPC-
GFP/hHR23E were c"\.-posed to 64 J/m2 UV-C through 5.0 11m pore filters and fixed 5 min (A) and 
2 hours (B) later with paraformaldehyde. Double immunofluorescent labeling uSing antibodies 
against XPA (A. left panel: stained green with goat anti·rabbit Alexa 488-1abeled secondary 
antibody) and HA epitope (A. light panel: stained red \Vith goat anti-rat Ale.xa 594-labeled 
secondary antibody). DAPI stained (B. left panel) and epifluorescence images \Vithout antibody 
labeling (E, right panel). Arrowheads indicate the site of L'V-induced local damage in the nuclei of 
DKO cells e.'\-pressing hXPC-GFP/hHR23B. Note: Compare the increased fluorescence Signal over 
the entire nucleus of damaged cells to the signal of non-damaged nuclei for overall stabilization of 
XPC(B). 
apparently nonnal transcription-coupled repair as deduced from the fact 
that recovery of RNA synthesis after UV-irradiation is unaffected. This is 
strikingly Similar to the repair phenotype of XPC. which hitherto was 
unique among the NER mutants but deviates from the S.cerevisiae RAD23 
prototype mutant and its S.pombe equivalent. which carry a combined GG-
NER and TC-NER deficiency (Mueller and Smerdon 1996: Verhage et al. 
1996: Lombaerts et al. 2000). This unresolved mammalian-yeast difference 
is also registered for XPC and its yeast counterpart RAD4. underlining the 
parallels between HR23 and XPC. 
What is the function of HR23 in GG-NER? The remarkable 
correspondence with XPC mutants prompted us to examine the status of 
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the XPC protein in DKO cells. The virtual absence of XPC in inununoblot 
analysis and in immunofluorescence (Figure 3) provided a direct 
eAl'lanation for the HR23 phenocopy of XPC: in the absence of HR23 the 
XPC protein is apparently unstable. This resolves the function of HR23. 
reveals a novel mechanism of regulation of NER and puts a new perspective 
to the growing number of links emerging between RAD23/HR23 and the 
ubiquitin system involved in protein turn-over. First. all RAD23 homologs 
are largely made up of modules found in proteins that are engaged in the 
ubiquitin process: the UbL N-terrninus and two UBA domalns (van der Spek 
et al. 1996b). comprising -50% of the protein. Second. a number of 
experimental connections of RAD23/HR23 with the ubiquitin pathway have 
surfaced during recent years (Schauber et al. 1998: Lambertson et al. 1999: 
Ortolan et al. 2000: Suzuki et al. 2001). The UBA domalns have been 
shown to interact with ubiquitin (Bertolaet et al. 2001). The UbL domaln of 
RAD23/HR23 provides a platform for direct interaction in vivo and in vitro 
with the 19S regulatory complex of the 26S proteasome (Schauber et al. 
1998). This domaln is required for the RAD23 NER function in S.cerevisiae 
and can be replaced by the regular ubiquitin sequence (Watkins et al. 
1993). However. controversies exist on the functional implications of the 
RAD23/NER-19S/26S proteasome engagement. Russell (Russell et al. 
1999) and Gillette (Gillette et al. 2001) present evidence that the 19S 
regulatory complex represses NER independent of RAD23 :in a manner 
apparently independent of proteolysis. On the other hand. Ortolan and 
coworkers (2000) recently reported that the UbL domaln of RAD23 
negatively regulates proteolysis of (multi-ubiquitinated) protein substrates 
and proposed that this may inhibit degradation of repalr factors to promote 
NER. Interactions between HR23B and the 26S proteasome were also 
observed in human cells (Hiyama et al. 1999). In conclUSion. a link between 
NER and the 19S complex of the 26S proteasome mediated by RAD23 
seems well established but the functional implications remain obscure. 
In mammals. Araki and coworkers (2001) have recently collected 
evidence for in vitro heat lability of recombinant XPC protein. which is 
partly alleviated by the binding of HR23B. These observations suggest that 
XPC is intrinsically unstable and that association of HR23B per se helps to 
stabilize its active conformation. In the present work this is extended and 
applied to the in vivo situation: in the absence of HR23 proteins XPC is 
virtually undetectable. causing an XPC-like GG-NER defect. reintroduction 
of HR23 leads to reappearance of XPC. Indeed we could bypass the HR23 
NER defect by overexpression of hXPC. compensatirig for the short half life 
by increased synthesis of the protein. The most logical interpretation of the 
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above fmdings is that HR23 proteins normally protect XPC from 
degradation. In view of the severity of the NER defect in DKO cells 
correlating With the low cellular XPC content it appears that this is the 
main in vivo NER function of RAD23/HR23 proteins. 
Effect of DNA damage on XPCjHR23 
After generation of a cell line stably eA-pressing functional OFP-tagged XPC 
we were curtaus to know what would happen when damage is induced in 
view of the notion that ){PC is the first protein to sense DNA injury 
(Sugasawa et al. 1998: Kusumoto et al. 2001). To our surprise exposure to 
UV and NA-AAF led to a dramatic further stabilization of the XPC-GFP 
fuSion protein resulting in strong XPC-OFP signals in the nucleus within a 
few hours. This phenomenon is clearly dependent on induction of helix-
distorting lesions that are substrate of the GG-NER subpathway and is not 
due to a general stress-related response (Figures 5C-F and 6A-D). XPC-GFP 
induction occurred '\Vith largely similar kinetics when proteasome-mediated 
protein degradation is inhibited providing further proof for the idea. that 
protein stabilization is responsible for the XPC-GFP increase. Assuming 
that proteolysis was largely inhibited. the similar kinetics indicate that 
under conditions of DNA damage hardly any XPC-GFP is degraded. 
How is XPC-GFP stabilized? The experiments involving local DNA 
damage (Figure 7) reveal a very rapid (within minutes). specific 
accumulation of XPC-GFP in the damaged regions. which is found for all 
NER factors and is due to actual engagement in DNA repair events (Volker 
et al. 2001: and our unpublished results). However. on top of this we 
observed a time-dependent (within 1 or 2 hours) enhancement of XPC-GFP 
Figure 8. A novel mechanism of regulation of XPC and GG-NER by HR23 involves the ubiquitin 
system and other cellular processes. (A) In the absence of the HR23 (indicated as 23). XPC is 
intrinsically unstable and is preferentially targeted for ubiquitin-dependent proteolysis via the 195 
regulatory comple.\: of 265 proteasome. As a consequence the steady state level of XPC and thus 
the GG-r-.'ER capacity is decreased. Ubiquitin proteins are depicted as R U -. (B) HR23 together with 
CEN2 (C2) stabilize XPC by recruiting the comple.\: to the 195 regulatory comple.\: e.'<Ploiting its 
protein refolding capacity. This partly protects XPC from degradation and leads to a higher steady 
state level of XPC. (C) NER-specific DNA damage directly (via enhanced protein stability) and/or 
indirectly (via stimulation of the 195 salvage route of the proteasome system) results in a further 
increase in XPC/HR23/CEN2 protein levels. and accordin...gly GG-l\'ER capacity. This mechanism 
might also c"\.-plain the enhanced reactivation phenomena. A comparable HR23 mediated 
stablli7.ation/refolding mechanism may hold for other proteins (here indicated by "1-) and cellular 
pathways (Le. cell cycle control. cell division. and other repair pathways). in which HR23 proteins 
are involved. 
158 Chapter VI 
A mHR23A!B-<leficient 26S 
proteasome 
1. intrinsic 
instability 
2. ubiquitination 
XPC • 
B normal 
1. instability 
C2 ,23,2. ubiquitination 
XPC }I 
3. poly-
ubiquitination 
XPC • 
26S 
3a. poly-
ubiquitination 
C normal + DNA damage 
" [DN.L. damage] I 
c.g.1N;! 
I 1. instabijjty 
C2 23 2. ubiquitination C2 23 
XPC }I XPC }I 
\]) 
@C. 
? .23 
~/ .. "" 
StabiHzation 
ofXPC 
4. proteolysis ? ® 
GG-NER 
-D~~l ® 
~I C2.23 L. ___ -----' 
3b. refolding XPC 
-
19S 3. refolding C2 23 
--l)l~ XPC 
[xPClt 
-
V 
enhanced t 
reactivation 
. ......... ..- - cell cycle I 
- chromosome! 
segregation I! 
-BER 
mHR23 and DNA damage stabilize XPC 159 
signals over the entire nucleus. This argues in favor of the idea that also 
XPC-GFP molecules in undamaged parts of the nucleus become transiently 
more stable and against the possibility that only molecules actually bound 
to a lesion are protected from proteolysis. It is feasible however. that 
participation of XPC/HR23 in NER events triggerS its stabilization. For 
instance. dissociation ofXPCjHR23 from the damage might involve the 19S 
regulatory complex that could at the same time refold or othenvise mocl.ifY 
the protein into a stable. active state. 
A novel mechanism of regulation of NER - parallels with the E.coli SOS 
response. 
Figure 8 puts all our observations and otber fmdings on RAD23/HR23 and 
the ubiquitin system in a unifying model. As the main initiator of global 
genome NER (5ugasawa et al. 1998) XPC constitutes an ideal focal point for 
the regulation of the entire pathway. In line with this idea overeA-pression of 
RAD4 in yeast confers accelerated rates of NER (Lammel et al. 2000) and 
here we show that reduction of XPC leads to a corresponding decrease of 
GG·NER. As suggested by tbe in vitro heat lability it appears tbat XPC - in 
tbe absence of HR23 - is intrinsically unstable (Araki et al. 2001). As a 
consequence in vivo the protein may be preferentially targeted for ubiquitin-
dependent proteolysis via tbe 195 regulatory complex of tbe 265 
proteasome (Figure SA). This is consistent with the finding that in rad23Ll 
mutants NER is enhanced by additional mutations in tbe 195 complex. 
which may affect its role in proteolysis of critical NER factors (Gillette et al. 
2001). 5imilar findings have been made in wildtype S.cerevisiae (Lammel et 
al. 2000). Binding of HR23 to XPC may help stabilize tbe protein (Araki et 
al. 2001). In addition we suggest tbat HR23 enables reactivation of XPC by 
recruiting the protein refolding capacity of the 19S regulatory complex 
protecting XPC from degradation and boosting the steady state level (Figure 
8B). A protecting role of RAD23/HR23 in relation to NER and otber 
processes in vivo was already postulated from vartous other studies 
(5chauber et al. 1998: Ortolan et al. 2000). When cells experience a high 
level of damage tbe involvement in NER shifts tbe equilibrium of tbe XPC 
complex more to the stable conformation by stimulating the salvage option 
of tbe 195 regulatory complex (Figure 8C). This would lead to an up-
regulation of XPC protein and consequently tbe entire GG-NER patbway 
when cells are subjected to a high level of damage for prolonged periods of 
time. This rheostat model for adapting tbe level of XPC to tbe amount of 
damage explains the long knOVlIl phenomenon of enhanced reactivation: 
increased Survival of a UV-irradiated virus when the host cells have been 
160 Chapter VI 
irradiated before infection (Cornelis et al. 1980: Hagedorn et al. 1985) 
which likely is due to the fact that the UV challenge up-regulates XPC and 
GG-NER. The above model is also in agreement with most of the reported 
observations on RAD23. 
Importantly. a number of other proteins have been found to 
associate with HR23 and - like XPC - may be subject to a similar 
mechanism of transient stabilization. One interesting HR23 partner is an 
enzyme at the start of another DNA repalr mechanism: 3-Methyladenine 
(3Me-A) DNA glycosylase that initiates base excision repair of a number of 
DNA alkylation damages including 3Me-A. 3Me-G. 7Me-G. etheno-adenine. 
ethenoguanme, and hypoxanthine (reviewed in Mernisoglu and Samson 
2000). Binding ofHR23 in vitro elevates the rate of excision of hypoxanthine 
contalning substrates (Miao et al. 2000). which opens the possibility that 
this branch of base excision repair is regulated in an analogous fashion as 
is demonstrated here for XPC / GG-NER. 
Another intriguing link relevant for genome care-taking is an 
emerging series of connections of RAD23/HR23 with the cell cycle. RAD23 
exerts a partially redundant role together with RpnlO in the G2/M phase of 
the cell cycle (Lambertson et al. 1999). together with the RAD23/HR23-like 
protein Ddil in Pds I-dependent mitotic controL spindle assembly and S-
phase checkpoints (Clarke et al. 200 l) and with Dsk2 in spindle pole 
duplication (Bi&,,"inS et al. 1996). In mammals. HR23 was found to interact 
with the RpnlO homolog S5a (Hiyama et al. 1999). The link with spindle 
pole duplication has recently been strengthened by the discovery of the 
centrosome factor centrin 2 (also designated Caltractin I). as a third 
component of the XPC/HR23 complex (Araki et al. 2001). Furthermore. in 
mammals. the p53 protein is regulated in part by hHR23A via inhibition of 
CREB (cyclic AMP-responsive element bindlng) protein that acts a co-
activator of p53 transcription (Zhu et al. 2001). In addition. several viral 
proteins have been found to target the HR23 proteins presumably to 
influence the cell cycle program (Withers-Ward et al. 1997: Dieclanann et 
al. 1998: Kumar et al. 1999: Withers-Ward et al. 2000). Finally. HR23 
proteins themselves appear to be regulated in a cell cycle dependent 
manner with specific degradation during S-phase (Kumar et al. 1999). Thus 
multiple. intimate engagements between RAD23/HR23 and critical stages 
in the cell cycle are apparent. 
It is likely that the principal mechanism for regulation of XPC and 
GG-NER by HR23 also applies to many of the above mentioned HR23 
partners and the corresponding processes. In fact. these processes might 
well be functionally related to each other via HR23. A potential scenario 
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putting many of these connections in a functional perspective is depicted in 
Figure se. The HR23 damage-dependent cellular responses could be 
triggered by primary DNA damage sensors bound by HR23. such as the 
GG-NER initiator XPC. and 3-Me-A DNA glycosylase and coordinated via 
the HR23 proteins impinging upon cell cycle progression. S-phase 
checkpoints and chromosome segregation. possibly including p53 
transcription. This system is in its effect reminiscent of the well-known SOS 
response in E.coli. involving the RecA/LexA regulon. In this case DNA 
damage triggers autocleavage of the LexA repressor stimulated by RecA. AB 
a consequence a specific set of genes with diverse functions in response to 
DNA injury is up-regulated. This includes genes involved in NER. damage-
induced mutagenesis and translesion DNA synthesis and cell division 
(reviewed by Sutton et al. 2000). In addition. the multiple engagements of 
the HR23 proteins provide a plausible explanation for the - compared to 
other NER mutants devia.-o.t - phenotype of the mHR23B-deficient mice and 
the embryOniC lethality of the DKOs. 
Down-regulation of XPC 
VJhy are XPC levels not constitutively high? At flrst sight it would seem 
highly advantageous to have GG-NER always operating at maximal capacity 
instead of complex. time-consuming up-regulation as revealed here for XPC. 
However. several lines of evidence indicate that RAD4 and its mammalian 
eqUivalent XPC are highly toxic when eA'Pressed at too high levels in 
homologous and heterologous systems. Even low copy expression of RAD4 
in E.coli interfered with growth and only defective dertvatives of the gene 
could be propagated (Siede and Eckardt-Schupp 1986: Couto and Friedberg 
1989: Wei and Friedberg 1998). This suggests that the proteLq interferes 
with some important cellular process. One likely function that may affect 
the basic DNA machinery is the ability of XPC and RAD4 to bind very 
strongly to DNA in particular to a wide range of (aberrant) DNA structures. 
A fundamental dilemma is that some DNA lesions resemble normally 
occurring functional DNA conformations and the latter may erroneously be 
considered by the damage sensing machinery as DNA injury. For instance. 
XPC has recently been shown to detect helL"'{-distortions on the basis of 
disrupted base-pairing and also to bind to regular mismatches (Sugasawa 
et aL 2001). This highlights the basic quandary of the twilight zone between 
specific forms of intact DNA and true DNA damage. Thus. titrating XPC to 
low levels may reduce abortive or untargeted repair interfering with natural 
DNA transactions. Intriguingly. by overe;.:pression of exogenous hXPC we 
observed that at the same time the endogenous mXPC was co-stabibzed 
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(Figure 4). One interpretation of this trans-effect is that the pathway 
responsible for degradation of mXPC becomes saturated by the high 
production of exogenous hXPC driven by the strong SV 40 promoter. This in 
tum points to a quite specific proteolysis mechanism that normally keeps 
XPC concentrations low. 
Concluding remarks and future perspectives 
The generation of the first mammalian cells deficient in rnHR23 starting 
from mHR23A and mHR23B single mutants permitted the elucidation of the 
main NER function of RAD23 revealed a novel level of regulation in the NER 
pathway and clarified the link between NER and the ubiquitin system. The 
damage-induced. mHR23-dependent stabilization of XPC provides an 
explanation for long knovvn phenomena such as enhanced reactivation that 
lacked an adequate mechanistic basis. The multiple engagements of 
mHR23 proteins may connect stress response mechanisms including cell 
cycle control to known damage sensors like XPC paralleling the E.co1i SOS 
system. Interestingly. RAD23 transcription is also damage inducible in 
yeast (Madura and Prakash 1990). although this property appears not 
preserved in human keratinocytes (van der Spek et al. 1996b). The GFP 
tagging of XPC will pennit in vivo analysis of dynamic properties of this 
crucial NER factor including rapid migration of the XPC-GFP to local 
damage observed in this study using sophisticated photobleaching 
techniques (Houtsmuller et al. 1999). Finally. the cell line ",,-pressing GFP-
tagged XPC will also be useful for screening and detection of genotoxic 
agents that induce (helix-distorting) lesions recognized by GG-NER. 
Experimental Procedures 
Construction of mHR23A targeting vector 
Isogenic mouse genomic DNA was derived from an Qla129 ES cell-derived phage lambda library 
after probing with human HR23A cDNA sequences. An mHR23A targeting construct was generated 
by changing the BglII site of clone pG7M23Agl (containing a 4 kb EcoRl fragment) into a Clal site, 
which resulted in deletion of sequences downstream the BglII site in e.'(on II (clone pG7M23Ag7). 
Ne.'Ct, the EcoRI site was removed by filling-in the overhangs with Kienow, resulting in clone 
pG7M23A","9. After changing the BstxI site in a Sall site. the 3 kb XhoI-Sail fragment (including 
the Clal. HindIII. and BamHI sites in the 3' MeS) was cloned into Sail digested pGEM5, resulting 
in clone pG5M23Ag17. :'-re,'\..i., the 3' arm of the construct. conSiSting of a Kienow-blunted 1.5 kb 
SmaI-XbaI fragment starting at the SmaI site in e.'(on VII, was inserted in the blunted ~deI site of 
pG5M23Ag17 (giving pG5M23Ag20), followed by insertion of a Keo marker cassette in antisense 
orientation in the Clal site (giving pG5M23Ag24). Finally, the Notl-NsiI insert of pG5M23Ag24 was 
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recloned into a pG£M-9Zf(-) based vector containing a 2.8 kb thymidine kinase (TK) marker 
cassette (giving pG5M23Ag30). 
ES cell culture and transfection 
The Ola129-derived ES cell line £14 was electroporated with the rnHR23A targeting construct and 
cultured on gelatinized dishes as descrtbed (van der Horst et al. 1997). G418 (GenetiCin. Gibco. 
fmal concentration 200 flg/ml) was added 24 hr after electroporation and cells were maintained 
under selection for 6-8 days. Genomic DNA from G418-resistent clones was digested with BamHI 
and subjected to Southern blot analysis using a 0.6 kb XbaI-RsaI fragment (3' e"\.-temal to the 
construct) as a probe. Targeted clones were subsequently screened with a Neo eDNA probe (CIa! 
fragment) to conBrm proper homologous recombination in the S· ann. 
Generation of the mHR23A/' and mHR23A//B'/' (DKO) mice and fibroblasts 
Targeted mHR23A clones were karyotyped and cells from two independent clones with 40 
chromosomes were injected into 3.S-day-old blastocysts isolated from pregnant CS7BL/6 females 
(van der Horst et al. 1997). Male chimeric mice were mated with CS7BL/6 females to obtain 
heterozygote animals. Gerrnline tranSmission was observed in the coat colour of the Fl offspring. 
Heterozygous males and females for mHR23A were interbred to generated mHR23A .. / .... mHR23A"'/-. 
and mHR23A/· mice. For the generation of double mutant mJ-IR23A/B mice. male and female 
animals heterozygous for both mHR23A and mHR23B (Ng et 81. submitted) were interbred. 
Genotyping was performed by Southern blot analysis or by PCR analysis (as described below) of 
genomic DNA prepared from tail biopsies of I 0-14-day-old pups. 
Prtmary mHR23A MEFs (three independent lines per genotype) were isolated from day 
13.S embryos (E13.S1 obtained from matings between mHR23A"'/·mice. Double mutant mHR23A/B 
MEFs were isolated from day 8.S embryos (£8.S) dertved from different crossings between 
mHR23A"'/'/B"'/' and mHR23A/·/B .. j · mice. Part of the embryo was used for genotyping and the 
remaining tissue was minced using a pair of SCissors and immersed in a t:hin layer of FlO/DMEM 
culture medium (Gibco BRL) supplemented with IS% fetal calf serum. 2mM glutamate. and 50 
).ig,/ml penicillin and streptomyCin. Spontaneously immortalized (established) cell lines were 
obtained by continuous subculturing of prtmary MEFs. 
£8.S embryos were dissected. and the yolk sacs were used for genotyping as described 
(Gurtner et 81. 1995). In short. the yolk sac of E8.S embryos was collected in 20 f.Il of water and 
frozen in dry ice immediately. samples were heated for S min at 9SoC and incubated with 1 f.Il of 
proteinase K (10 mg/ml) for 1 hr at ssoe. Proteinase K was heat-inactivated for S min at 95°C. 
PCR analysis was performed using the three-prtmer sets descrtbed below for 30 cycles (93°C. 1 
min: SsoC. 1 min: 72°e. 90 sec) using mHR23A and mHR23B primers (as described below). 
Prtmer set 1: mHR23Apl (S'-atg-gga-ctt-~~-cat-agg-tga-3·). mHR23Ap2 {S'-tct-tca-gcc-
agg-cct-ctt-ac-31 and anti-sense neo (S'-atc-tgc-gtg-ttc-gaa-ttc-gcc-aat-g-31 giving 243 and 3S0 bp 
PCR fragments from the wildtype and targeted allele respectively. Plimer set 2: mHR23Bpl (S'-gta-
aag-gca-ttg-aaa-gag-aag-3'), mHR23Bp2 (S'-cta-cag-tct-tgt-ttc-tga-cag-3') and anti-sense pgkS (S·-
tag-ggg-a~-agt-aga-agg-tg-3·) giving 202 and 600 bp PCR fragments from the wildtype and 
targeted allele respectively. 
DNA Repair Assays 
UV sensitivity was detennined as described (Sijbers et al. 1996). MEF cultures were e:cposed to 
different doses of UV -C light (254 nm, Philips TUV lamp) and allowed to grow for another 3-5 days, 
before reaching confiuency. The number of proliferating cells was estimated by sCintillation 
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counting of the radioaCtivity incorporated during a 3 hr pulse with [3Hlthymidine (5 ].lei/ml. 
specific activity (s.a.): 50 Ci/mmole: Amersham). Cell survival was e,-pressed as the ratio of 3H 
incorporation in irradiated and non-irradiated cells. 
UV-induced global genome repair was assayed uSing the DDS method as described 
(Vermeulen et al. 1994). Cells were e'-'Posed to 16 J/m2 of 254 nm UV light and labelled with 
[methyl-111thymidine (10 !lCi/ml. s.a.: 50 Ci/mmole). Repair capacity was quantified by grain 
counting after autoradiography. Incorporation of radioactivity was measured by autoradiography 
and grain counting (average of 50 nuclei per cell line: the standard error of the mean is indicated). 
RNA synthesis recovery was measured according to (Mayne and Lehmarm 1982). Cells 
were e'-'P0sed to 10 J/m2 of 254 run UV light. allowed to recover for 16 hr. labelled with [5.6-
11]uridine (10 ].lCi/ml. s.a.: 50 Ci/mmole). and processed for autoradiography. The relative rate of 
RNA synthesis was e'\.-pressed as the quotient of the number of autoradiographic grains over the 
UV -e'qlosed nuclei and the number of grains over the nuclei of nonirradiated cells (average of 50 
nuclei per cell line: the standard error of the mean is indicated). 
RNA and protein analysis 
Total RNA was isolated from mFiR23A MEFs using a RNeasy Mini Kit (Qiagen). 20 ].lg of total R'J'A 
was separated on a 0.9% agarose gel and transferred to Hybond-N+ membrane (Amersham 
Pharmacia Biotech). RNA blots were hybridized using mHR23A and ,6-actin 32P_IabeJed cDNA 
probes. 
Immunoblot analysis was performed on fibroblast e'dracts obtained by sonification (5 x 
10° cells in 300 J.Ll phosphate-buffered saline (PBS)) or e;..:traction. In the latter case. NP lysis buffer 
{25 mM Tris-HCI (pH 8.0), 1 :rrt;.\([ EDTA. 10% glyceroL 0.01% :-;ronidet P-40, 1 mM dithiothreitoL 
0.25 mM PMSF. and protease inhibitor mix {chymostatin. leupeptin. antipain. and pepstatin All 
was added to a monolayer of :vIEFs. After 30 min on ice the lysate was collected with a cell scraper 
and clarilled by 2 times centrifugation at 4 QC. I\'P lySis buffer containing 0.3 NaCl was added to the 
cell pellet and homogenized by sonification. 
SDS polyacrylamide gel electrophoresis \Itas performed by loading 25-50 !lg of total 
cellular protein per lane on 6-8% gels. Proteins were blotted to nitrocellulose membranes 
(Schleicher & Schuell) and probed with polyclonal antibodies recognl%ing human HR23A or XPC, or 
with monoclonal antibodies recognizing the HA epitope (HAll. BAbCO) or p62 subunit ofTFliH 
(C39). Proteins were visualized using alkaline phosphatase-labeled goat anti-rabbit or perO:-ddase-
conjugated goat anti-rabbit or goat anti-mouse secondary antibodies. 
Immunofluorescence labeling 
Cells were grown on glass coverslips at 60-80% confluency. After washing twice with PBS. cells 
were fixed with 2% paraformaldehyde in PBS for 10 min at room tempcraturc (RT) and 
penneabilized with 0.1% Triton X-lOa in PBS for 2x 10 min at RI. After e'Ctensivc washing (three 
times of 5 min each) with PBS· (pBS supplemented with 0.15% glycine and 0.5% BSA) cells were 
incubated with affinity purified primary antibodies in PBS· in a moist chamber for 11-12 hr at RI. 
After \\"ashing five times in PBS"', cells were incubated with the secondary antibodies for 1112 hr in 
PBS'" in a mOist chamber at RI. FollOwing 5 times washes with PBS'" and once with PBS, coverslips 
were preserved with VectashieldTI-'l Mounting Medium (Vector Laboratories) containing 4'-6-
diamino-2-phenylindole (DAPI. 1.5 !lg/!Jl). 
Primary antibodies used: affinity purified. rabbit polyclonal anti-human XPC: rabbit 
polyclonal anti-XPA (a kind gift from Dr. K. Tanaka): mouse monoclonal anti-p62 ofTFIIH subunit 
(3C9): and high affinity, rat monoclonal anti-HA (3F1O: Boeringer). Secondary antibodies were: 
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goat anti-rat Ale..-xa 594-conjugated and goat anti-rabbit Ale..xa. 4SS-conjugated antibodIes 
(Molecular probes): and goat anti-mouse Cy3-conjugated antibodies (Jackson ImmunoResearch 
Laboratories). 
Generation of XPC-GFP fusion cDNA construct and cottansfection studies 
Full length human XPC eDNA (ScaI-Asp71SI fragment) was cloned in EcoRI-Asp71S1 digested 
eukaryotic e..'-1'ression vector pEGFP-N3 (Clontech) containing a 3' histidine-hemagIutinine tag 
(generated by insertion of a doublestranded ollgonucleotide in SspBI-Notl digested pEGFP-N3: 
kindly provided by D. Hoogstraten). For simplicity. the resulting tagged cDNA construct hXPC-
EGFP-Hisr;HA-Ns is referred to as hXPC-GFP. 
Full length cDNAs of the hHR23B (in an pSLM vector. Phannacia bIotech) and hXPC-
GFP were cotransfected into DKO MEFs using puromyCin as selectable marker. The transfection 
was performed using SuperFect Transfection Reagent (Qiagen) and puromycin was added 24 hr 
after transfection to a fmal concentration of l\lg/ml. and the cells were maintained under selection 
for 20-40 days. Stable puromycin-resistant clones were isolated and lntegration of the eDNA 
construct was confmned by DNA blotting (data not shown). 
Exposure of cells to DNA damaging agents 
Cells stably e..'\.1'ressing hXPC-GFP were rinsed With PBS. e:-.1'osed to li'V-C light (254 nm: Philips 
TUV lamp. dose as indicated in the te..xt) and subsequently cultured at 37 QC for various time 
periods (as indicated in the te:-.i.). XPC was detected either by immunoblot analySis or by 
visualization in living cells using light microscopy. A similar approach was used to study the effect 
of K-aceto.,-y-2-acetylaminofluorene (NA-AAF: kindly provided by Dr. van Zeeland: final 
concentration 50 or 100 )1M). mitomycin C (MMC: Sigma: final concentration 1.2 or 204 Ilg/ml). 
iOnizing radiation (y-rays from a l::l,CS source: Single dose of 6 and 10 Gy). the proteasome inhibitor 
N-CBZ-LEU-LEU-LEU-AL (CBZ-LLL: Sigma: final concentration 5 or 10 jJ.M). the transcription 
inhibitor 5.6-dichloro-lj3-D-rtbofuranosyl-benzimidazole (DRB: Sigma: final concentration of 100 
).lM. 2-3 hrs). and the translation inhibitor cyclohe."mm.ide (CHX: Boehringer: flnal concentration 30 
or 50 Ilg/ml. 1-3 hrs.) were added to the culture medium. 
Local UV -irradiation was obtained by covering cells grown on glass coverslips with an 
isopore polycarbonate filter with pores of 5.0 ).l.Ill diameter (Millipore. TMTP) during L'V-irradiation 
(4 x 16 J/m"1. UV-CJ. Immediately after e."'g)Osure, the filter was removed and medium was added 
back to the cells and culturing was continued. Mter various time penods {as indicated in the ted}. 
cells were processed for immunolabeling. 
To identify cells in mi'\.1:ures of control and mutant fibroblasts, cells were labeled With 
late.x beads (diameter 0.79 ).l.Ill: Polybead Carbm .. -ylate Microspheres, PolysciencesJ added to 
fibroblasts cultures 2 days prtor to mi'illlg of the cells. Cells were thoroughly washed in PBS (3x) 
before trypsin:i7..ation to remove the non-incorporated beads and seeded in a 1:1 ratio on coverslips 
and cultured for 2 days. 
Light microscopy and image analysis 
Immunofluorescent microscopy images were obtained with either a Leitz Alistoplan microscope 
equipped with epifluorescene optics and a PlanApo 63x/ lAO oil immersion lens or a Leica DMRBE 
microscope equipped with epifluorescene optics and a PL Fluotar 100x/ L30 oil immersion lens. 
For the detection of GFP-tagged proteins in the living cell. we have used an Olympus IX70 
microscope equipped with epifluorescene optics and Olympus PlanA.po 60x/1.40 oil immersion 
lens. GFP images were obtained after excitation With 455-490 and long pass emiSSion filter {>510 
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run). Cy~3 images were obtained after excitation with 515-560 and long pass emision filter (580 
nm). 
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Concluding remarks and perspectives 
The XPC-hHR23B complex (which also includes centrin 2: Araki et al. 2001) 
is responsible for initiating DNA damage recognition in GG-NER (Chapter 
IV). The heterotrimer then recruits additional NER factors to the site of 
damage. In vitro. hHR23A and hHR23B are functionally interchangeable in 
their ability to form a complex with XPC and to stimulate its repair activity 
in the NER reactions (Chapter !II). In vivo. the two HR23 homologs are also 
functionally redundant in NER as witnessed by the observation that 
mHR23A- and mHR23B-deficient cells both have a wildtype capacity for 
DNA repair (Chapters V and 'VI). However. in the intact organism. the 
functional redundancy of the homologs is incomplete: mHR23A knockout 
mice have an apparently normal phenotype. whereas in striking contrast. 
mHR23B-1- mice have a very severe phenotype. indicating that mHR23A can 
not fully substitute for the absence of mHR23B. Unexpectedly. the 
phenotype of mHR23B/' mice (anticipated to eliminate the GG-NER 
pathway) is much more severe than the phenotype of mice completely 
defiCient in NER (GG-NER and TC-NER). mHR23B.J. mice are born at sub-
Mendelian frequency. runted and die prematurely. implying that mHR23B 
is essential for proper mouse development_ This provides irrefutable 
evidence that the mHR23B protein (and based on homology. likely mHR23A) 
has additional functions outside of NER which are critical for life. 
As might be anticipated on the basis of the mHR23B.J. phenotype. 
mHR23A/B double mutant mice are not born (Chapter VI). Characterization 
of mHR23A/B-deficient cells derived from viable mouse embryos of day 8.5 
revealed an XPC-Ilke NER phenotype (absence of GG-NER). Furthermore. 
the XPC protein itself is unstable in the mHR23A/B-deficient cells. 
indicating that the mHR23 proteins are required for the stabilization of 
XPC. The mHR23A/B-deficient cells were transfected with fluorescently-
tagged XPC (XPC-GFP) to allow visualization of the XPC protein in living 
cells_ Treatment of these cells with DNA damaging agents that induce 
lesions specifically recognized by NER further increases the stability of XPC-
GFP. but only if HR23 is also expressed in the double mutant cells. 
Furthermore. the degradation of XPC in the absence of its binding partner 
HR23 may occur via ubiquitin-dependent proteolysis. In addition. XPC-GFP 
rapidly translocates to sites of DNA damage under conditions where only a 
portion of the nucleus is irradiated with UV. Finally. if the whole cell is 
irradiated with UV. GFP fluorescence increases over time. indicating a 
general stabilization of XPC as a result of DNA damage. Both these latter 
observations were completely HR23-dependent. There are at least two 
possible mechanisms by which XPC-GFP is tranSiently stabilized as a result 
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of DNA damage: (i) binding of XPC-HR23 to DNA damage might protect XPC 
from proteolysis. or (ti) DNA damage may trigger a secondary response that 
inhibits degradation of XPC. regardless of whether or not the protein is 
bound to DNA. Expertments involving induction of local DNA damage in the 
nucleus suggest that there is a general stabilization of XPC (Chapter VI). 
Tak.en together. these findings reveal a novel level of regulation in the NER 
pathway and clarify the link between NER and the ubiquitin system. The 
damage-induced. mHR23-dependent stabil.i7..ation of XPC provides an 
explanation for long knOVJI1 phenomena such as enhanced reactivation that 
lacked an adequate mechanistic basis (Cornelis et al. 1980: Hagedorn et al. 
1985). The multiple engagements of rnHR23 proteins may connect stress 
response mechanisms including cell cycle control to known damage sensors 
like XPC paralleling the E.coli SOS system (reviewed in Sutton et al. 2000). 
Interestingly. RAD23 transcription is also damage inducible in yeast 
(Madura and Prakash. 1990). although this property appears not preserved 
in human keratinocytes (van der Spek et al. 1996). 
One conclusion of this thesis is that DNA damage in the presence of 
HR23 stabilizes XPC. Continued studies in living cells stably transformed 
with fluorescently-tagged XPC can further elucidate the roles of HR23 and 
ubiquitin in NER and other processes. The GFP tag"Oing of XPC will permit 
in vivo analysis of dynamic properties of this crucial NER factor including 
rapid migration of the XPC-GFP to local damage observed in this study 
using sophisticated photobleaching techniques (Houtsmuller et al. 1999). 
For instance. FRAP (fluorescence redistribution after photobleaching) 
,","pertments will allow uS to determine whether XPC-GFP moves freely 
throughout the nucleus and then becomes fixed once the DNA is damaged. 
Furthermore. ,","ploiting (real-time) confocal microscopy and the XPC-GFP. it 
is possible to determine the turnover rate of XPC-GFP (in concert with 
immunoblotting). and dynamics of XPC-dependent recruitment of other 
NER factors to the sites of DNA damage. Moreover. it will be very interesting 
(although complicating) to transfect the XPC-GFP cell line with other repair 
genes fused with different fluorescence tags to study the entrance of these 
essential NER components in the repair complex at the site of DNA injury. 
Such studies will enable a more precise determination of the steps and 
proteins involved in DNA damage recognition and processing by NER. 
Finally. the cell line expressing GFp-tagged XPC will also be useful for 
screening and detection of genotoxic agents that induce (helix-distorting) 
leSions recognized by GG-NER 
Further characterization of mHR23B"/' mice will permit better 
predictions as to the additional function(s) of mHR23B outside the context 
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of NER However such an analysis is complicated for two reasons: (i) the 
frequency of mHR23H1- mice born alive is lO-fold lower than expected. 
requiring large scale breeding protocols to obtain sufficient mutant mice. 
and (li) the phenotype is too severe to discIiminate between primary effects 
of a loss of mHR23B and secondary consequences of severe illness. Thus. to 
comprehensively study the function of mHR23B in specific tissues in. the 
whole organism. a conditional mHR23B mutant mouse would be 
informative and convenient. This approach makes it possible to create a 
genetically modi.fied mouse in which the gene of interest can be turned off 
in a time- and/or tissue-specific manner (extensively reviewed in Nagy 
2000). Briefly. the insertion of a "loxP' recombinase recognition sequence in 
an intron as well as at the end of the mHR23B gene enables the removal of 
the entire sequence between the loxP sites by ere recombinase. The ere 
recombinase transgene can be regulated by a tissue-specific or drug-
inducible promoter. This results in conditional knockout of the mHR23B 
gene. thereby preventing elimination of the mHR23B gene during cIitical 
stages of mouse development or in tissues in which mHR23B is essential for 
gro"\Vth. Production of large numbers of conditional mHR23B-i- mice that 
survive until adulthood will also permit direct analysis of the role of 
mHR23B in carcinogenesis. However. it should be kept in mind that the ere 
endonuclease may cause chromosomal aberrations (Loonstra et al. 2001). 
Another approach that may lead to increased longevity of mHR23B" 
1- mice is to breed them with p53 mutant mice. It is known that a p53-!-
background partially rescues the embryonic lethality of a number of gene 
defects including BRCArl - (Welcsh et al. 2000). BRCAI encodes a breast 
cancer susceptibility gene implicated in homologous recombination and 
double strand break repair (Welcsh et al. 2000). The increased survival on 
the p53-!- background can be explamed by the assumption that in BRCArl -
(and perhaps mHR23H/1 mice DNA damage perSists. which in a p53-
proficient background triggers apoptosis. The removal of the p53-dependent 
apoptotic pathway thereby reduces cell death. Generation of cell lines from 
p53-1-/mHR23H1- mice will also permit detailed analysis of the link between 
GG-NER and apoptosis. Ultimately. if the survival of mHR23B"1- mice can be 
improved. tissues can be isolated for gene expression profiling studies using 
DNA micro-array technology (reviewed in Lockhart and Winzeler 2000). This 
technique is being applied to a number of transgenic mouse models. in 
order to discover the consequence of a highly defined genetic disruption of a 
particular cellular pathway (such as GG-NER). It is e".-pected that such 
studies will reveal gene expression patterns that might be predictive of 
human disease or the specific response to therapeutic intervention. Last 
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but not least. it \Vi.ll be challengmg to find a link between HR23 gene 
dysfunction and human disease (e.g. fertility syndromes and developmental 
disorders). 
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Summary 
DNA carries the genetic information that ultimately encodes all of the 
proteins requlred for proper cellular function. Yet. the integrity of the code 
is continuously challenged by exposure to substances that are able to 
chemically modi:ty the DNA. Environmental factors that negatively impact 
DNA include the IN component of sunlight. ionizing radiation. and 
chemical compounds present in for example cigarette smoke and industIial 
pollution. In addition. endogenous products of cellular metabolism such as 
oxygen radicals can modi:ty DNA. DNA damage can. in turn. perturb vital 
cellular processes such as transcription. replication. and cell cycle 
progression. Persistent damage can induce mutations and ultimately lead to 
cancer (uncontrolled cell growth) and likely contributes to aging. or to 
(controlled) cell death. In order to malntaln the integrity of genetic material. 
cells have evolved an intricate network of DNA repair mechanisms. 
Chapter I provides an overview of the different repair mechanisms 
that are currently knmvn to function in higher organisms including man. 
Although overlap in substrate specificity eXists. eacb repalr pathway is 
responsible for the recognition and elimmation of a particular class of DNA 
lesions. 
In Chapter n. the mechanism of nucleotide excision repair (NER) and 
the genes encoding the different repair proteins are discussed in more 
detall. NER is one of the primary DNA repalr pathways and is highiy 
conserved from yeast to man. It is responsible for the removal of a wide 
spectrum of DNA lesions that have in common their ability to distort the 
DNA helical structure. These leSions include UV-induced photoproducts 
and bulk"}' chemical DNA adducts. The NER pathway requires the 
coordinated activity of approximately 30 proteins. The mechanism involves 
a multistep ~cut and patch~ -like reaction in which a short segment of the 
damaged DNA strand is excised and replaced by a copy synthesized from 
the intact complementary strand. 
Furthermore. Chapter n describes the clinical consequences of a 
defect in NER in humans. This is highlighted by three human syndromes: 
xeroderma pigmentosum cxP. caused by a mutation in one of seven genes: 
XPA to XPG). Cockayne syndrome (CS. caused by a mutation in one of two 
genes: CSA or CSB~ and sometimes occurring in combination with XP) and 
trtchothiodystrophy ("lTD. caused by a mutation in one of three genes: 
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ITDA XPB or XPD). Extreme sensitivity to sunlight is the hallmark of all 
three hlUllan disorders. However. the remainder of the clinical picture is 
very heterogeneous. Only XP patients exhibit the expected predisposition to 
skin cancer. In contrast. CS and TID patients suffer severe developmental 
and neurological abnormalities that are difficult to explaln as a 
consequence of a NER defect. The fairly recent observation that several of 
the NER proteins are also involved in transcription (xpB. XPD. CSA and 
CSB) provides an alternative cause of the severe CS and ITD phenotype (L e. 
a transcriptional defect instead of a NER defect). This also demonstrated 
that NER. as well as other repair mechanisms. is closely intertwined with 
other essential cellular processes. To study the human NER deficiency 
syndromes. repair-deficient mouse models that may mimic several aspects 
of the phenotype of XP. CS. and TID patients were generated. 
Two distinct NER subpathways can be distinguished: Le. global 
genome repair (GG-NER) operating over the entire genome and 
transcription-coupled repair (TC-NER) which repairs only the transcribed 
strand of active genes. Most XP patients have defects in both GG-NER and 
TC-NER. However. in patients of complementation group C (XP-C) only GG-
NER is affected. The XPC protein was found to be in a tight complex with 
the hHR23B protein. hHR23B is one of two human homologs of the 
Saccharomyces cerevisiae ubiquitin-like DNA repair protein RAD23. Both 
homologs contain two ubiquitin-associated domains. which is a unique 
feature amongst the NER proteins. Thus far. no human NER-deficiency 
syndrome was linked to a mutation in the hHR23B gene. This could be 
because the hHR23A protein is functionally interchangeable with hHR23B. 
This thesis describes the biological characterization of the XPC-hHR23B 
complex and the generation of knockout mice for both of the mammalian 
RAD23 homologs. 
Chapter ill describes e":pertments that address the hypothesis that 
the rnro hHR23 homologs are functionally redundant. The NER reaction was 
reconstituted in vitro using purified recombinant proteins and this was used 
to demonstrate that hHR23A and hHR23B are functionally interchangeable 
in their ability to complex with XPC and to stimulate the DNA repair. This 
demonstrated for the first time that the hHR23 proteins are directly 
involved in NER and that their repair function is mediated by interaction 
with XPC. Within the NER reaction. six (sometimes multimeric) core factors. 
XPA XPC-hHR23B. TFlIH. ERCCI-XPF. XPG. and RPA are required for 
recognition and removal of DNA damage by NER in vitro. 
Chapter IV describes e":pertments that ",,--plore the role of the XPC-
hHR23B complex in NER Usmg a DNA damage recognition-competition 
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assay. the complex was identified as the primary DNA-damage sensor and 
repair protein-recruitment factor of the GG-NER subpathway. DNAse I 
footprinting demonstrated that the XPC-hHR23B complex by itself can bind 
to damaged DNA. 
The biological function of the mammalian RAD23 homologs in cells 
and whole organisms is investigated extensively in experiments described in 
Chapters V and VI. Consistent with in vitro results. which showed the 
RAD23 homologs to be redundant. both mHR23A and mHR23B single 
Imockout cells have a normal capacity for NER The picture in the intact 
organism. however. is different. Both mHR23A- and mHR23B-deficient mice 
were generated by standard gene targeting methodologies. The mHR23A-/-
mouse is phenotypically normal. In striking contrast. mHR23B-1- mice have 
a very severe phenotype. Features include intrauterine death. growth 
retardation. male sterility. and facial dysmorphology. and are indicative of 
an essential role for rnHR23B in mouse development. We attrtbute the 
enormous disparity between the phenotype of mHR23F/- and mHR23A/-
mice to the inability of mHR23A to completely compensate for the absence 
of mHR23B. As might be expected. mHR23A/B double Imockout mice are 
not viable. A severe mHR23B--like phenotype. including embryOniC lethality 
as observed in the absence of both HR23 genes. has not been described for 
any other mouse model carrying specific GG-NER and/or TC-NER defects 
(Le. XPA. XPC. CSA. and CSB mice) and implies that the mammalian RAD23 
proteins have additional functions outside NER Based on the fact that both 
proteins contain ubiquitin -associated domains it is likely that the additional 
functions are related to the ubiquitin/proteasome protein degradation 
pathway. 
Importantly. mHR23A/B double Imockout cells from day 8.5 
embryos are viable. which allowed us to generate a mHR23A/B-deficient cell 
line. Characterization of the cells revealed a NER deficit similar to XPC-!-
cells. This phenotype was directly linked to the observation that XPC is 
unstable in the absence of both mHR23 proteins. Stable cotransfections of 
the mutant cells with cDNAs encoding either a fluorescently-tagged XPC 
(xpC-GFP) and/or hHR23B rescued the UV-sensitivity and stabilized the 
fluorescent signal from the XPC in nuclei. The fluorescent XPC was further 
stabilized by the addition of DNA damaging agents that cause lesions 
specifically recognized by the NER pathway. Damage-induced stabilization 
of XPC-GFP was HR23-dependent. Furthermore. in line with the proposed 
role of the hHR23 proteins in ubiquitin pathways. destabilization of XPC 
was found to be mediated by ubiquitin-dependent proteolysis. Induction of 
local UV damage in only one portion of the nucleus of XPC-GFP expressing 
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cells revealed that the fluorescently-tagged protein translocates very rapidly 
to sites containing DNA damage. This translocation was also HR23-
dependent. In addition. the presence of DNA damage in concert v.rith 
expression of HR23 causes a gradual increase in the amount of 
fluorescence in the entire nucleus of UV-irradiated cells compared to non-
damaged nuclei. indicating further stabilization of XPC-GFP. At least two 
mechanisms might explain the transient stabilization of }(PC-GFP in the 
face of DNA damage: (i) the binding of }(PC to DNA damage might protect it 
from proteolysis. or (til DNA damage may trigger a specific response. that 
inhibits degradation of }(PC. independent of DNA binding. The results of 
local DNA damage expertments argue in favor of the latter mechanism of 
HR23-dependent}(PC stabilization. In conclusion. the main findings of this 
thesiS elucidate the primary function of HR23 in NER. and reveal that 
HR23-dependent }(PC stabilization. and likely the entire global genome 
repair pathway is tightly damage-regulated. In addition. both HR23 proteins 
are essential for proper emb:ryonic development, pointing to a broader 
function that (analogous to their role in NER) is expected to involve the 
ubiqultin/proteasome pathway. 
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samenvatting 
DNA is de drager van genetische informatie en codeert v~~r aile eiwitten die 
noodzakelijk zijn VQar het functioneren van de eel en uiteindelljk het hele 
orgamsme. Bet DNA staat voortdurend bloot aan stoffen. die de chemische 
structuren kunnen veranderen en ze1fs ernstig beschadigen. 
Omgevlngsfactoren die een dergelijk schadelijk effect op het DNA uitoefenen. 
zijn onder andere: de UV stralen van het zonJicht. ioruserende straling en 
chernische stoff en die aanwezig zijn in bijvoorbeeld sigarettenrook en 
industriele vervuiling. Daarnaast kunnen endogene producten die ontstaan 
tijdens het metabolisme van de cel (zoals zuurstofradicalen) het DNA 
beschadigen. DNA schade kan op zijn beurt vitale cellulaire processen zoals 
transcrtptle (overschrijven van genen) , replicatie (het verdubbelen van het 
DNA voer iedere celdeling) en voortgang van de ce1cyclus verstoren. 
Blijvende DNA schade kan vervolgens leiden tot kanker (mutaties en 
ongecontroleerde celgroei) en draagt zeer waarschijnlijk ook bij aan 
veroudering en aan celdood. Om de integriteit van het genetisch matertaal te 
bewaren. is in de loop van de evolutie een complex netwerk van DNA 
herstelmechanismen ontstaan. 
Hoofdstuk I geeft een overzicht van de verschillende DNA 
herste1mechanismen die momenteel bekend zijn in hogere organismen. 
waaronder de mens. Elk herstelmechanisme is verantwoordeJijk voor de 
herkenning en verwijdering van een specifieke categorte van DNA schades. 
waarbij echter ook emge overlap tussen de verschillende mechanismen 
bestaat. 
In Hoofdstuk n worden Nucleotide Excisie Reparatie (NER) en de 
eiwitten die bij dit proces betrokken zijn. besproken. NER is een van de 
belangrijkste DNA herstelsystemen en is in de evolutie sterk geconserveerd 
van gist tot mens. NER is verantwoordeJijk voor het verwijderen van een 
breed spectrum aan schades die over het algemeen de DNA helix sterk 
verstoren. zoals IN-geinduceerde fotoproducten. De gezamenJijke activiteit 
van ± 30 eiwitten is noodzakeJijk voor het juist functioneren van NER Dit 
mechanisme is te vergeJijken met een "lmip en plak' reactie waarbij een 
aantal stappen is te onderscheiden. waaronder herkenning van de schade. 
excisie (uitsnijden) van het beschadigde DNA fragment en vervanging van 
dit fragment door een nieuwe kopie vervaardigd aan de hand van de intacte 
complementaire streng. 
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Vervolgens beschrijft Hoofdstuk II de klinische gevolgen van een 
NER defect in patienten. Deze zijn af te leiden aan de hand van drie 
ernstige. gelukkig zeldzame syndromen: xeroderma pigmentosum (XP. 
veroorLaakt door een mutatie in een van de zeven genen XPA tim XPG). 
Cockayne syndroom (CS. veroorzaakt door een mutatie in de genen eSA of 
eSB. en soms ook voorkomend in combinatie met XP) en 
trichothiodystrophy (TID. veroorzaah.-t door een mutatie in de genen TTDA. 
XPB of XPD). Extreme gevoeligheid v~~r zonlicht is een belangrijk 
gemeenschappelijk kenmerk van deze drie ziektebeelden. De ovenge 
klinische kenmerken zijn erg heterogeen. Alhoewel CS en TID patienten ook 
extreme gevoeligheid v~~r zonlicht vertonen. hebben alleen XI? patienten een 
sterk verhoogde kans (>2000x) op huidkanker. CS en TID patienten 
daarentegen lijden aan ernstige ontwikkelingsstoornissen en neurologische 
afurijkingen. kenmerken die moeilijk te verklaren zijn als gevolg van een 
defect DNA herstel. De recente bevinding dat verschillende NER eiwitten ook 
betrokken zijn bij transcriptie (XPB. XPD. CSA en CSB) geeft een 
alternatieve verklartng voor een aantal van de emstige zieh-teverschijnselen 
van CS en TID. Tevens geeft dit aan dat NER nauw verbonden is met 
andere essentiele cellulaire processen. Om de humane syndromen. die 
voortkomen uit een NER defect te bestuderen. zijn muismutanten 
gegenereerd die deficient zijn in DNA herstel. en die de situatie in X1? CS en 
TID patienten ten dele zouden kunnen nabootsen. 
Er hllnnen twee duidelijk verschillende routes onderscheiden 
worden in NER: het zgn. globaal genoom herstel (GG-NER) dat DNA 
repareert in het gehele genoom. en transcriptie-gekoppeld herstel (TC-NER) 
dat zich richt op de afgeschreven streng van actieve genen zodat die snel 
hersteld worden. De meeste XI? patienten hebben een defect in zowel GG-
NER als TC-NER. maar er is een groep patienten waarbij alleen GG-NER is 
aangedaan. Dit zijn de XP patienten van de complementatie groep C (XP-C). 
Het XPC eiwit bevindt zich in een complex met het eiwit hHR23B. hHR23B 
is een van de 1:v.ree humane homologen van het ubiquitine-geassocieerde 
DNA herstel eiwit RAD23. afkomstig wt de bakkersgist Saccharomyces 
cerevisiae. Beide homologen bevatten twee ubiquitine-geassocieerde 
domeinen. hetgeen een uniek kenmerk is binnen de groep van NER 
eiwitten. Tot op heden zijn geen patienten beschreven met een NER 
syndroom veroorzaah-t door een mutatie in het hHR23B gen. Een verklartng 
hiervoor zou kunnen zijn dat de DNA herstel functies van hHR23B 
overgenomen worden door de andere homoloog hHR23A. Dit proefschrift 
beschrijft de biologische karalctensering van het XPC-hHR23B complex en 
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de generatie en de karah-terisatie van mutant muizen waarbij een (of beide) 
RAD23 homologen is uitgeschakeld. 
Hoofdstuk ill beschrijft experimenten waannee de hypotbese wordt 
getest dat de beide hHR23 homologen functioneel uitwisselbaar zijn. De 
NER reactie is in vitro nagebootst met gezuiverde recombinante eiwitten. 
Deze experimenten wezen uit dat hHR23A en hHR23B daadwerkelijk 
elkaars functie kunnen overnemen wat betreft complexvorming met XPC en 
stimuiatie van DNA herstel. Voor de eerste keer wordt hier aangetoond dat 
de hHR23 eiwitten direct betrokken zijn bij NER en dat deze betrokkenheid 
tot stand komt door interactie met XPC. Voor het herkennen en verwijderen 
van DNA schade door NER in vitro zijn 6 factoren van belang: XPA XPC-
hHR23B. TFIIH. ERCCI-XPF. XPG en RPA 
In Hoofdstuk. IV worden experimenten beschreven waarin de rol 
van het XPC-hHR23B complex in NER wordt bestudeerd. Met behulp van 
een DNA schade herkenning-competitie test wordt aangetoond dat het 
complex de primaire sensor is voor het herkennen van DNA schades. Ook is 
het complex in staat om andere DNA herstel ei\Vitten aan te trekken die 
noodzakelijk zijn voor de uitvoering van GG-NER. DNAse footprinting 
experimenten tonen aan dat het XPC-hHR23B complex zelf aan DNA schade 
kan binden. 
De biologische functie van de RAD23 homologen in zowel cellen als 
het gehele orgarusme is uitgebreid onderzocht en wordt beschreven in de 
Hoofdstukken V en VI. In vitro gegevens tonen aan dat de RAD23 
homologen elkaars functie kunnen overnemen. In overeensternming met 
deze bevinding hebben zowel de mHR23A als mHR23B knock-out cellen een 
normale DNA herstel capaciteit. In het intacte orgarusme is de situatie 
echter anders. Zowel mHR23A als mHR23B knock-out muizen zijn 
gegenereerd door middel van standaard methodes om genen gericht uit te 
schakelen. De mHR23A knock-out muis blijkt een normaal fenotype te 
hebben. De mHR23B knock-out IDuizen daarentegen vertonen zeer ernstige 
afwijkingen. Kenmerken van deze muis zijn onder andere intra-uteriene 
dood. groeiachterstand. onvruchtbaarheid bij de mannetjes en misvorming 
van het gelaat. Dit ernstige fenotype impliceert een belangrijke rol v~~r 
mHR23B in de ontwikkeling van de muis. Het grote verschil tussen het 
fenotype van mHR23A en mHR23B muizen kan worden veroorLaah..-t doordat 
mHR23A Diet in staat is het gebrek aan mHR23B compleet te compenseren. 
Zoals verwacht op basis van het mHR23B knock-out fenotype zijn 
mHR23A/mHR23B dubbel knock-out muizen niet levensvatbaar. Het 
gegeven dat een knock-out van de mHR23 genen een veel ernstiger en 
dUidelijk verschillend fenotype vertoont vergeleken met een muis die 
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deficient is in het gehele NER (zowel GG-NER als TC-NER). wijst op andere 
functies van de RAD23 elwitten naast een rol in NER Gezien het feU dat 
beide ei"Witten ubiquitine-geassocieerde domeinen bezitten. is het Diet 
onwaarschijnlijk dat deze andere functies te maken hebben met afbraak 
van eiwitten via de ubiquitine-proteasoom route. 
Het feit dat mHR23A/mHR23B dubbel knock-out embyro's van 8.5 
dagen nog levensvatbaar bleken te zijn. stelde ons in staat een 
mHR23A/mHR23B deficiente cellijn te isoleren. Karakterisering van deze 
cellijn liet een NER defect zien dat sterk vergelijkbaar is met XPC- I - cellen. 
Een verklartng hiervoor wordt gegeven door de bevincting dat in afwezigheid 
van beide mHR23 eiwitten XPC instabiel is. Stabiele cotransfectie van deze 
mutante cellen met hHR23B cDNA en/of fluorescerend XPC (XPC-GFP) 
leidde tot herstel van de UV gevoeligheid van deze cellen en tot stabilisatie 
van het fluorescente XPC in de kern. Ret fiuorescente XPC werd neg sterker 
gestabiliseerd door blootstelling van de cellen aan stoffen die resulteren in 
NER specifieke DNA scbades. De stabilisatie van XPC-GFP. geinduceerd 
door DNA schade. was HR23-afhankelijk. In overeenstemming met de 
mogelijke rol van hHR23 in ubiquitineIing. werd aangetoond dat 
destabilisatie van XPC verOOT7..aah1: wordt door ubiquitine-alhankelijke 
eiwitaibraak. Experimenten waarbij lokale DNA schade in slecbts een dee! 
van de kern van XPC-GFP cellen wordt geinduceerd. tonen aan dat het XPC 
eiwit zich zeer snel verplaatst naar de plek waar DNA schade zicb bevindt. 
Ook deze verplaatsing was alhankelijk van aanwezigheid van HR23. De 
aanwezigheid van zowel DNA schade als HR23 resulteerde tevens in een 
toename van fluorescentie in de gehele kern door verdere algehele 
stabilisatie van XPC-GFP. Concluderend: de bevindingen beschreven in dit 
proefschrift geven inzicht in de primaire functie van HR23 in NER en laten 
bovendien zien dat HR23-alhankelijke XPC stabilisatie en dus 
waarschijnlijk ook het totale GG-NER strikt gereguleerd wordt door DNA 
schade. Daarnaast zijn de HR23 eiwitten onmisbaar v~~r embryonale 
on'h:vikkeling. Dit duidt op een een bredere functie van deze eiwitten. 
waarbij (net als voor de NER functie) het ubiquitine/proteasoom systeem 
betrokken is. 
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Appendix 
Figure 7 . mHR23B" males show impai red spermatogenesis 
and dysfunct ion of Sertoli cells. 
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Figure 3. Developmental impairment in mHR23B embryos at E15.5 . 
Figure 4 . Placental defect in mHR23B . embryos at E18.5. 
Chapter V 
Chapter VI 
Figure SC-F . Effect UV on hXPC -GFP levels (1' . 152). 
Figure 6. Effect NA~AAF lA-D) and proteasome 
inhibitor (E-H) on hXPC-GFP levels (p.154) . 
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Figure 7 A-B. Local UV damage induces 
overall XPC stablizatio ll (po 156). 
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Figure 8 . A novel m echanis m of regulation of XPC and GG- NER 
by HR23 - s triking parallels "ith E.coli SOS response - (p. 159). 
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